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Abstract
African trypanosomes are vector-borne haemoparasites that cause animal and 
human African trypanosomiasis. Survival in the mammal host is mediated by 
antigenic variation, an immune evasion mechanism based on the sequential 
replacement of the Variant Surface Glycoprotein (VSG) coat that covers the parasite 
surface. As the main factors in the host-trypanosome interaction, VSG expression 
and structure has been extensively studied in Trypanosoma brucei. Since 
trypanosome genomes contain hundreds of highly dynamic VSG genes, studies of 
VSG diversity are challenging and have been limited to reference strains. However, 
we expect VSG diversity to be vitally important to disease, both during individual 
infections and across parasite populations. This thesis examines VSG sequence 
diversity within and between trypanosome populations to produce new approaches to 
measuring VSG diversity and a holistic view of antigenic diversity in trypanosome 
genomes.
In chapters two and five, I present ‘variant antigen profiling’ as a method to 
characterise VSG repertoires in genomic and transcriptomic data from T. congolense 
and T. vivax respectively. Due to species differences in VSG repertoire composition, 
bespoke methodologies were required. Analysing VSG diversity over space and time 
was a challenge to conventional techniques that can now be overcome. 
In chapter three, I apply variant antigen profiling to metacyclic transcriptomes to 
characterise T. congolense metacyclic VSG expression in the tsetse fly. This 
revealed that specific phylotypes might be preferentially expressed in infective, 
metacyclic-stage parasites, which can be taken forward in field experiments.
In chapter four I present a description of putative T. congolense expression sites, 
which are compared to T. brucei. In chapter six, I present a comparative analysis of 
the balance of evolutionary forces affecting molecular evolution of VSGs in T. brucei, 
T. congolense, and T. vivax. These two chapters bring new insights into antigenic 
variation evolution in African trypanosomes, aiding the reconstruction of the process 
of host-parasite coevolution.
Collectively, this work makes a substantial, original contribution to our understanding 
of antigenic diversity in African trypanosomes, whilst revealing the need for revisiting 
vbasic questions of the mechanisms of antigenic variation in T. congolense and T. 
vivax. Such projects will certainly be aided by the multiple applications of variant 
antigen profiling to gene expression, functional and population studies.
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1Chapter 1. Introduction
The Kinetoplastida (Euglenozoa) are unicellular flagellates that include the free-living 
Bodonids and the parasitic trypanosomatids. In addition to the nuclear genome, 
these organisms have defining characteristics, such as the kinetoplast, a 
mitochondrial-derived genome, and a glycosome, a spherical organelle with a 
protein-dense matrix but no genome (Lopes 2010). Trypanosomatids include the 
genera Trypanosoma and Leishmania.
Leishmania parasites cause leishmaniasis, a disease with worldwide distribution that 
can cause visceral leishmaniasis, in which parasites invade and proliferate in liver, 
spleen and bone marrow of the host; cutaneous leishmaniasis, which is 
characterised by a localized long-term chancre at the bite site; and mucocutaneous 
leishmaniasis, which progresses from the cutaneous form to chronic destruction of 
mucosal tissue (Peacock et al. 2008). 
The genus Trypanosoma includes hundreds of different species with a vast 
vertebrate and invertebrate host range. The stercorarian (American) and salivarian 
(African) trypanosomes are clinically relevant as the causes of Chagas disease, 
sleeping sickness, nagana, and surra (Lopes 2010). 
Chagas disease, caused by T. cruzi and transmitted by triatomine bugs (Triatominae 
sp.), is characterised by an acute phase that can be lethal, and a chronic, long-
lasting phase, defined by cardiomyopathy or digestive mega-syndromes, and 
ultimately death (Stuart et al. 2008). 
Sleeping sickness, or human African trypanosomiasis (HAT), is a disease transmitted 
by tsetse flies (Glossina sp.) and caused by T. brucei rhodesiense in East Africa and 
T. brucei gambiense in West Africa (Malvy & Chappuis 2011). 
Nagana, or animal African trypanosomiasis (AAT), is a wasting disease of livestock, 
cyclically transmitted by tsetse flies in sub-Saharan Africa, and mechanically 
transmitted by other haematophagous flies in Africa and South America (Giordani et 
al. 2016). It is caused by Trypanosoma brucei brucei, Trypanosoma congolense, and 
Trypanosoma vivax. 
2Dourine and surra are diseases with worldwide distribution, caused by Trypanosoma 
brucei equiperdum and Trypanosoma brucei evansi, respectively (Brun et al. 1998). 
In this thesis, I will focus on African trypanosomes. African trypanosomes are 
extracellular protozoan parasites of the subgenera Trypanozoon, Nannomonas, 
Duttonella, and Pycnomonas, which cause severe wasting diseases in a range of 
mammal hosts. Taxonomy of African trypanosomes has been a subject of debate, 
but at present there are eight species identified (Table 1). Veterinary relevant 
species include T. (Trypanozoon) brucei spp., T. brucei evansi, T. brucei 
equiperdum, T. (Nanomonas) congolense, T. (Duttonella) vivax, and T. 
(Pycnomonas) suis. Medically important species are T. brucei gambiense and the 
zoonotic agent T. brucei rhodesiense, both causes of human sleeping sickness. 
3Table 1 Species of African trypanosomes. Details compiled from Gibson (2007) and Hutchinson & Gibson (2015).
4The majority of African trypanosomes are transmitted by tsetse files (Glossina sp.). 
Therefore, most biological transmission of AAT is restricted to the tsetse belt, the 
endemic region of tsetse flies, spanning from the Sub-Saharan region to the Kalahari 
Desert. However, T. vivax, T. brucei evansi, and T. brucei equiperdum have evolved 
tsetse-independent life cycles. T. vivax and T. brucei evansi are transmitted by 
tabanids (Tabanidae) (Hoare 1972) and stable flies (Stomoxys spp.) (Levine 1973), 
which allowed the spread of both species into Latin America (Osório et al. 2008) and 
of T. brucei evansi to North Africa, Middle East, and Asia. Mechanical transmission of 
these two species also exists within the tsetse belt (Desquesnes & Dia 2003; 
Desquesnes & Dia 2004; Mossaad et al. 2017). T. brucei evansi has other 
transmission modes that include mechanical transmission by bats, and vertical, 
horizontal, iatrogenic, and per-oral transmission (Brun et al. 1998; Desquesnes et al. 
2013). T. brucei equiperdum is sexually or vertically transmitted and therefore can 
spread worldwide (Brun et al. 1998). With the exception of T. brucei equiperdum, 
vertical transmission of AAT through transplacental transmission is of 
epidemiological relevance in South America only, having been documented in 
Venezuela and Brazil (Ogwu & Nuru 1981; Osório et al. 2008).
1.1 Biology of the parasite
When a tsetse fly is infected with T. brucei, stumpy bloodstream forms colonise the 
insect gut, where they lose their variant surface glycoprotein (VSG) coat and 
differentiate into rapidly dividing procyclic forms, expressing procyclin in their cell 
surface. The parasites migrate anteriorly towards the salivary glands, where they 
differentiate into epimastigotes attached to the epithelial layer, and subsequently into 
small, free-swimming infective metacyclics, which express metacyclic VSG (mVSG). 
This VSG coat is the first line of defence against the initial immune response of the 
mammal host (Turner et al. 1988). The differentiation from epimastigotes to 
metacyclics often involves intermediate stages. When the fly feeds on a mammal, the 
parasites are injected with the saliva into the bloodstream, where they develop to 
slender bloodstream forms within the first 10 days of infection. As the bloodstream 
infection evolves, a proportion of slender bloodstream forms transforms into non-
dividing short stumpy forms, which make the link between the host and the vector 
infections (reviewed in Macgregor & Matthews 2010). Human-infective T. brucei 
often invades the central nervous system (Malvy & Chappuis 2011). Recently, T. 
brucei has been reported in the skin and adipose tissue of the mammal host 
5(Capewell et al. 2016; Trindade et al. 2016; Tanowitz et al. 2017), and such 
dissemination may be under-represented. The greatest developmental differences 
between African trypanosomes are observed in the vector stages (Hoare 1972). 
T. congolense has a similar life cycle to T. brucei, although differentiation into 
epimastigotes starts in the proventriculus, followed by migration to the proboscis and 
hypopharynx, where they become infective metacyclics, bypassing the salivary 
glands (Peacock et al. 2012). There is no morphological change between slender 
and stumpy forms (Figure 1), although at peak parasitaemia, T. congolense also 
reduces the number of proliferative forms (Silvester et al. 2017). In both species, 
bottleneck selection occurs during migration from the midgut to the salivary glands or 
proboscis. 
T. vivax lacks a procyclic stage. Following a short colonisation of the proventriculus 
and foregut as long trypomastigotes, T. vivax migrates to the tsetse mouthparts, 
where it differentiates into an epimastigote in the cibarium and proboscis and then 
into infective metacyclic trypomastigotes in the proboscis and hypopharynx (Ooi et al. 
2016). From the hypopharynx, it can be injected into a new mammal host at the next 
bloodmeal. In the mammal host, T. vivax has also been reported outside the vascular 
system, particularly in the heart, lymphatic and central nervous system tissues, 
causing neurological symptoms and sporadic acute haemorrhagic infections 
(Magona et al. 2008).
6Figure 1 Life cycle of T. brucei, T. congolense, and T. vivax. A tsetse fly takes a blood meal on an infected mammal and becomes a vector of 
trypanosomiasis. Procyclics establish in the midgut where clonal expansion occurs. The parasites travel to the proventriculus, salivary glands and/or proboscis, 
where they become epimastigotes and then infective metacyclics. In the following bloodmeal, the fly transmits a portion of these parasites in the saliva to the 
mammal host. The parasites relocate to the bloodstream as metacyclic trypomastigotes and differentiate to bloodstream forms. Parasites may be found in the 
central nervous system (T. brucei, T. vivax), skin (T. brucei), adipose tissue (T. brucei), and heart (T. brucei, T. vivax). 
71.2 Parasite genetics
African trypanosomes are diploid organisms, whose karyotype has been historically 
challenging to clarify due the absence of chromosome condensation during cell 
division (Vickerman & Preston 1970). The development of pulsed field gel 
electrophoresis (PFGE) as a means to separate chromosomes based on size and 
genome sequencing have allowed great improvements in the field.
The T. brucei TREU927 genome, which is the reference but one of the smallest T. 
brucei genomes analysed to date, contains 11 megabase chromosomes and a 
large, but variable number of small and intermediate chromosomes of 30 to 700 kb 
in size, which have similar sequences to those in the subtelomeres of megabase 
chromosomes (Melville et al. 1998; Berriman et al. 2005). The subtelomeres, which 
are the regions between the telomere and the first housekeeping genes, are 
unusually long in African trypanosomes (Callejas et al. 2006). They can account for 
up to 75 % of the chromosome length due to copy number polymorphisms derived 
from divergence of conserved multi-copy gene families (Callejas et al. 2006). In T. 
brucei, they encode more than 20 % of the genes, the majority of which are species-
specific and linked to the mechanism of antigenic variation (Berriman et al. 2005). 
The megabase chromosomes are organised into long non-overlapping gene 
clusters, which are transcribed as polycistrons and undergo trans-splicing and 
polyadenylation (Berriman et al. 2005). Coding sequences account for 50 % of the 
nuclear genome of T. brucei. 
The genome was sequenced by a combination of whole chromosome shotgun and 
bacterial artificial chromosome walking strategies. Therefore, most subtelomeric 
regions, the intermediate and small chromosomes were not included in the genome 
(Berriman et al. 2005). At publication, it contained 9068 genes and 904 
pseudogenes, with 50.9 % GC content. Of these coding sequences, 806 were 
VSGs. These numbers were vastly underestimated. In fact, further analysis revealed 
that the subtelomeres are three times larger than the core, mostly comprised of 
VSG arrays (Callejas et al. 2006). The genome assembly is actively being curated, 
currently including 1482 VSG-like sequences, 1313 (89 %) of which are 
pseudogenic or degenerate sequences
(http://www.genedb.org/Homepage/Tbruceibrucei927). The T. brucei Lister 427 
genome is much larger than TREU927, particularly due to differences in the size of 
8the subtelomeres between homologous chromosomes (Melville et al. 2000). This 
results in a larger VSG pool of 2563 sequences (Cross et al. 2014), indicating that 
the size of the megabase chromosomes and the VSG repertoire can vary between 
strains. 
The T. congolense genome shares the karyotype characteristics of the T. brucei 
genome. The cell surface related genes account for the main differences in genomic 
content (Jackson et al. 2012). The same applies to T. vivax, with the exception that 
this species only has one or two mini-chromosomes (Dickin & Gibson 1989). This 
might potentially impact on the capacity for antigenic variation because, in T. brucei 
and T. congolense, the mini-chromosomes are rich in VSGs (Wickstead et al. 2004). 
1.3 Biology of the vector
Tsetse flies include thirty-one species of the genus Glossina, usually classified into 
three sub-genera: Nemorhina (palpalis group) common in vegetated areas near 
water in Western and central Africa; Glossina sensu stricto (morsitans group) found 
in woodland ‘savannah’ where animals are common; and Austenina (fusca group), 
endemic in forest belts and therefore endangered by increased human activity in 
these areas. Although all tsetse species can potentially be biological vectors of 
African trypanosomiasis, G. fuscipes, G. palpalis, and G. morsitans (subgroups 
palpalis and morsitans) are the most relevant in nature (Franco et al. 2014). 
Tsetse flies require specific conditions of temperature (16°C–38°C) and humidity (50 
%–80 %) and thus prefer regions with water bodies and dense vegetation, avoiding 
direct sunlight and dry wind. These conditions are also ideal for most terrestrial 
mammals where tsetse flies feed, making it optimal foci for African trypanosomiasis. 
Tsetse flies are robust flies (6-14mm) that can live up to four months (Figure 2). 
They are holometabolous and viviparous, as the larvae develop from the egg in the 
uterus of the female fly, where they progress through all three larval stages. The 
female fly gives birth to a single adult larva, which burrows into the soil where it 
pupates in the first five hours. Adult flies emerge from pupal stage after three weeks. 
The teneral adult fly searches for its first bloodmeal, a point where is most 
susceptible to trypanosomal infection. Maturation, mating and first birth occur within 
12-14 days, and then a single larva will be produced every 9 days for the rest of the 
9fly life. Tsetse flies have a slow rate of reproduction, which would facilitate vector 
control measures, however, fly populations are resilient and persist at very small 
levels. Their fast movement (20km/hour, 2x30min everyday) also promotes fast re-
infestation by neighbouring populations after local eradication.
Trypanosome species have divergent developmental cycles in tsetse flies. T. brucei 
and T. congolense first colonise the fly midgut and subsequently travel anteriorly, 
crossing the proventriculus towards the salivary glands and mouthparts respectively, 
where they differentiate into infective metacyclics. Although T. vivax can be found as 
posteriorly as the foregut and proventriculus during the first day of infection (Ooi et 
al. 2016), it is mostly restricted to the proboscis. This feature allows mechanical 
transmission by non-tsetse flies. 
Fly infection rates in the field are about 0.1 % for T. brucei, 2 % for T. congolense 
and 10-20 % for T. vivax (Haines 2013), which are consistent with the susceptibility 
of adult flies to become infected with trypanosomes: T. brucei mostly infects teneral 
flies during their first blood meal, T. congolense preferentially affects teneral flies, 
but can infect later on, whereas T. vivax is thought to infect flies of any age (Haines 
2013). Transmission of AT to the mammal host is dependent on number of 
trypanosomes inoculated at the bloodmeal, but a single bite from an infected fly can 
transmit the infection to a naïve mammal host (Thuita et al, 2008). Therefore, 
disease transmission is affected by trypanosome species, vector and host 
susceptibility to infection, density of fly population, fly age at infection, and frequency 
of host-vector contacts (Roditi & Lehane 2008; Haines 2013). 
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Figure 2 The anatomy of the tsetse fly (Glossina sp.). Cartoon shows the positioning of 
key organs of the tsetse fly. The hypopharynx and proboscis, the proventriculus, the salivary 
glands, and the gut are colonised by African trypanosomes at different points of the 
parasites’ life cycle. Adapted from ITM (2016).
1.4 Disease pathogenesis
HAT is a two-stage disease. The first stage, ‘the haemolymphatic stage’, is 
characterised by parasites colonising the vascular system, which causes fever, 
malaise, pruritus, lymphadenopathies, and oedema of the face and/or extremities. 
Sporadically, myocarditis, splenomegaly and hepatomegaly may occur (Malvy & 
Chappuis 2011). In the second stage, “the meningo-encephalitic stage”, parasites 
invade the central nervous system, causing neurological and endocrinal symptoms, 
and ultimately leading to death (Malvy & Chappuis 2011). Specific symptoms 
include circadian rhythm dysregulation, confusion, tremor, involuntary muscle 
twitching, weakness, unilateral paresis, akinesia or dyskinesia, diffuse hyperpathia, 
speech impairment, thyroid and adrenocortical dysregulation, and progressive 
dementia (Malvy & Chappuis 2011). 
T. b. gambiense and T. b. rhodesiense are morphologically indistinguishable, but 
the dynamics of disease progression are species-specific. Whilst in T. b. gambiense 
infection the time between each disease stage averages 3 years and symptoms are 
often intermittent, T. b. rhodesiense infection is rapid, causing an acute disease with 
little separation between stages and culminating in death within a few months 
(Malvy & Chappuis 2011). Furthermore, whilst in T. b. gambiense infections a 
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chancre rarely develops at the tsetse bite site, this happens in T. b. rhodesiense. 
The chancre is characterised by general local inflammation symptoms, such as 
redness, swelling, and pain, but no suppuration (Malvy & Chappuis 2011).
AAT is caused by T. congolense, T. vivax, and T. brucei spp. Whilst in wild animals 
these parasites cause only a mild infection, domestic cattle, camels, and horses 
tend to be severely affected after an incubation period varying from 4 days to 
approximately 8 weeks. Common symptoms range from fever, hair loss, stupor, 
oedema, anaemia, eye discharge, keratitis, weight loss, abortion and eventually 
death. Nagana owes its name to the Zulu word “N’gana”, meaning “useless”, 
because it is a progressive, wasting disease, and causing the animals to become 
less and less active. For instance, in high-risk areas, animal productivity can be 
reduced by 38 % (Swallow 1999). Additionally, milk and animal off-take is estimated 
to be reduced by 8-12 % and 4-10 %, respectively (Swallow 1999). Furthermore, 
bones lose density, and neurological signs have also been reported. Trypanosomes 
can also cause immunosuppression, making the host more susceptible to co-
infections, such as secondary bacterial infections (Steverding 2008). T. congolense 
is the most virulent aetiological agent of AAT in West Africa, relating to higher levels 
of anaemia (Dayo et al. 2010).
AAT can be acute or chronic, but the latter is more common in enzootic areas, 
where prevalence is higher. External factors such as malnourishment, pregnancy-
related stress, lactation, excessive work, co-infections, and water deprivation may 
worsen the disease, but virulence is dependent on both the parasite and host 
species (Steverding 2008). For instance, trypanosome-susceptible cattle produce 
lower levels of IgG against trypanosome-specific antigens than tolerant cattle, a 
phenomenon accentuated during re-infections (Authié et al. 1993).
1.5 Diagnosis
The diagnosis of trypanosomiasis is particularly hard due to non-specific symptoms, 
low parasitaemia, and abundance of subclinical infections, which act as persistent 
reservoirs of disease. In most tsetse-infected areas, signs of trypanosomiasis are 
well recognized, although co-infection with other parasites may mask 
trypanosomiasis. If available, treatment is given at the first sign of disease, using the 
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response to therapy as a retrospective diagnosis (Connor 1992). This approach 
results in poor drug resource management and increased drug resistance.
Firm diagnosis can only be made through the identification of parasites in body 
fluids, but the number of detectable parasites does not correlate to infection 
severity, precluding predictions on disease outcome (Luckins 1992). Parasites are 
usually detected through blood sampling from the tail or ear. Fresh blood can be 
screened microscopically for live, motile trypanosomes or blood smears can be 
prepared which are subsequently stained and examined under an oil immersion 
lens. The latter is more sensitive, allowing parasite speciation, yet time consuming 
(Luckins 1992). Microscopy methods are useful to screen for several diseases 
simultaneously, but the most sensitive direct method to detect T. congolense and T. 
vivax is the examination of wet preparations of a microhaematocrit buffy coat, under 
phase contrast illumination. The assessment of blood PCV as a measure of 
anaemia is a commonly used technique in the field (Figure 3) (Connor 1992).
Figure 3 Sample collection in microhaematocrit capillaries for assessment of blood 
PCV and examination of wet preparations of the buffy coat. Capillary tubes are filled 
with animal blood from the ear and spun for diagnosis. Personal photograph (Kenya, 2016).
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Antigen variation strongly impairs detection of trypanosomes in the blood by 
immunological tests and therefore several indirect diagnostic tests have been 
developed to facilitate fieldwork. Anti-trypanosomal antibodies cannot be used as 
diagnostic markers since they do no distinguish between current and past infection 
and cross-reaction between trypanosome species is common. The adapted card 
agglutination test (CATT) used to assist in the diagnosis of West African human 
sleeping sickness is also not suitable for AAT (Luckins 1992). The most successful 
tools are the indirect fluorescent antibody test (IFAT) and the enzyme linked 
immunosorbent assay (ELISA), always performed in conjunction with another 
method (Luckins 1992). These require, however, expensive equipment and 
laboratory expertise. 
Recently, several immunochromatographic rapid diagnostic tests have been 
developed for T. brucei gambiense, T. brucei evansi, T. congolense and T. vivax. 
The first, called HAT Sero-K-SeT, is specific for T. brucei gambiense and targets a 
combination of T. brucei gambiense-specific variant surface glycoproteins (Buscher 
et al. 2013; Büscher et al. 2014); the second, which is called Surra Sero K-SeT, 
follows the same rationale by targeting the T. brucei evansi recombinant VSG RoTat 
1.2 (Birhanu et al. 2015). The third, not commercially available yet, is specific for T. 
vivax and targets two invariant surface glycoproteins (TvY486_0045500 and 
TvY486_0019690); whereas the fourth can successfully diagnose both T. 
congolense and T. vivax infections in the same test, is commercially available in 
Africa, and targets the TcoCB1 antigen, a cathepsin-B protease, and the GM6 
antigen a T. vivax flagellar-associated protein (Figure 4) (Pillay et al. 2013). 
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Figure 4 An example of VerY Diag diagnostic test (CEVA, France), which detects T. 
vivax and T. congolense, separately or in a multiple infection of the same host (Pillay et 
al. 2013). Photograph by Alessandra Romero-Ramirez (Liverpool, 2017).
In laboratory settings, species identification can be achieved with restriction 
fragment length polymorphism (RFLP), isoenzyme electrophoresis, DNA 
hybridization, and polymerase chain reaction (PCR) assays. Current primers for 
PCR include T. congolense ‘savannah’ type: IL 0344-0345 (Majiwa et al. 1993), T. 
congolense riverine-forest type TCF 1,2 (Masiga et al. 1992), T. vivax VOL 1,2 
(Dickin & Gibson 1989), T. simiae TSM 1,2 (Masiga et al. 1992), and T. brucei s.l. 
TBR 1,2 (Moser et al. 1989). The sensitivity of the PCR is species-dependent as T. 
congolense achieves the best diagnostic rates to a subspecies level, in contrast with 
T. vivax. 
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1.6 Treatment
Trypanocidal chemotherapy is usually successful, except in areas of ‘savannah’ 
tsetse, due to their high vectorial capacity and higher virulence of carried strains. In 
these areas, drugs need to be complemented with vector control measures (Connor 
1992).
Trypanocides have been available for the past 50 years and include both curative 
and prophylactic drugs. Curative drugs include diminazene derivatives, 
quinapyramin sulphate and homidium salts, whereas the only used prophylactic 
drug is isometamidium (Kroubi et al. 2011). These drugs act on different pathways 
and therefore have different efficacy rates depending on the trypanosome species. 
Diminazene has the highest therapeutic index and the broader species range since 
it binds to DNA, preventing replication. However, it tends to accumulate in tissues, 
causing a problem for meat consumption. Quinapyramin sulphate, although efficient 
against T. congolense, is not recommended due to cross-resistance mechanisms 
with other trypanocides (Haroun et al. 2003). Homidium salts are more efficient 
against T. vivax than T. congolense and T. brucei, but are commonly used as a 
prophylactic agent. 
However, in recent years resistance to trypanocides has been a major problem, 
particularly in T. congolense, due to their prolonged used, lack of dosage control, 
and high genetic diversity of trypanosomes (Melaku & Birasa 2013). Resistance 
may be genetically inherited, although is mostly acquired due to drug exposure, 
cross-resistance, or mutagenesis. Prophylactic drugs are more prone to resistance 
because of their longer half-life, whereas curative drugs tend to be rapidly 
eliminated. The predominantly used drugs, isometamidium, homidium and 
diminazene, are more affected by resistance, which has already been reported in 17 
countries of Central Africa (Delespaux et al. 2008).
The mechanisms of drug resistance in African trypanosomes are not completely 
understood, but several studies suggest alterations of adenosine transporters 
involved in the uptake of melaminophenyl arsenicals and diamidines (Barrett & 
Fairlamb 1999). For example, the loss of TbAT1 gene expression results in 
resistance to melarsoprol and diamidines in T. brucei evansi and T. b. brucei, as this 
transporter mediates influx of these drugs (Stewart et al. 2010). Mitochondrial 
electrical potential modulation has also been linked to drug resistance, particularly of 
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isometamidium (Wilkes et al. 1997). The prolonged use of isometamidium has also 
been shown to increase resistance to both isometamidium and diminazene of T. 
congolense populations (Peregrine et al. 1997). 
1.7 Impact
Efforts to reduce human sleeping sickness have been vastly successful, following a 
large epidemic in 1998, where 300–500,000 cases were reported. Now, the target of 
less than 2,000 new cases per year is on track to be reached by 2020 (Franco et al. 
2017). Nonetheless, AAT continues to challenge the economic and social 
development of Central Africa, being a major contributor to poverty. AAT not only 
has an ecological impact of high cattle mortality rates, but also directly affects 
Central African economies and demographic distribution, creating persistent, 
adverse effects on productivity and costing up to US$4.5 billion per year 
(HaileMeskel 2016). T. vivax has been reported in 11 countries of South America 
(Venezuela (Clarkson et al. 1971; Garcia et al. 2005), Colombia (Wells et al. 1982; 
Dirie et al. 1993), Brazil (Shaw & Lainson 1972), Bolivia (Silva et al. 1998), Ecuador 
(Ortega-Montalvo et al. 2014), Peru (Quispe et al. 2003), Argentina (Monzon et al. 
2018), French Guiana, Suriname, Guyana, Paraguay [reviewed by Stephen (1986)], 
and in five countries of Central America (Costa Rica (Oliveira et al. 2009), 
Guadeloupe, Martinique, Panama, El Salvador [reviewed by Stephen (1986)]. In 
Brazil alone, 270M animals are at risk of infection, which usually causes severe 
epidemics with high mortality rates (up to 40 %) (Silva et al. 1996; Batista et al. 
2007; Carvalho et al. 2008; Batista et al. 2009; Batista et al. 2012; de Souza 
Pimentel et al. 2012; Cadioli et al. 2012; Fávero et al. 2016; Bastos et al. 2017).
1.8 Host-parasite interactions
As obligatory extracellular parasites, African trypanosome bloodstream forms are in 
constant contact with host tissue fluids where they are challenged by various 
immunological surveillance mechanisms. Trypanosome survival strategies must rely 
on complex host cell-parasite interactions to neutralize immunological attacks and 
ensure parasite survival and longevity (Namangala 2011). Selection pressures have 
driven trypanosomes to evolve elaborate mechanisms of immune evasion. 
Combined, they allow the parasite to successfully establish infection and 
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transmission, while also increasing susceptibility of the host to secondary infections, 
strongly contributing to the progressive profile of the disease and decreasing 
responsiveness to vaccination (Namangala, Baetselier, et al. 2000; Shi et al. 2003; 
Dagenais et al. 2009). 
The most remarkable immune evasion mechanism in trypanosomes is antigen 
variation of VSGs. However, there are other mechanisms, which include generalized 
immunosuppression targeting macrophages (Namangala, Baetselier, et al. 2000; 
Gómez-Rodríguez et al. 2009) and T-cells (Jayawardena et al. 1978); induction of 
complement activation and antigen-presenting cell deficiencies (Namangala, Brys, 
et al. 2000; Dagenais et al. 2009), suppression of lymphocyte proliferative 
responses (Sileghem et al. 1994; Radwanska et al. 2008), modulation of T-cell and 
B-cell activity (Schleifer et al. 1993; Radwanska et al. 2008), and acquisition of 
resistance to human trypanolytic activity by T. brucei gambiense and T. brucei 
rhodesiense (De Greef & Hamers 1994; Van Xong et al. 1998; Uzureau et al. 2013; 
Capewell et al. 2013). VSGs also play a role in some of these mechanisms. For 
example, VSGs prevent trypanosome cell complement-mediated lysis (Vincendeau 
& Bouteille 2006). They also induce continuous cytokine production (particularly 
TNF-) and autoantibody synthesis (Tachado & Schofield 1994; Okomo-Assoumou 
et al. 1995).
Host-parasite interactions are mediated at the surface of the cell, the point of 
contact between the parasite and the extracellular environment. The surface of 
African trypanosomes is mostly composed of a glycoprotein monolayer of proteins, 
which varies with the life stage. In the procyclic form, they express procyclin; in the 
metacyclic stage, they are coated with mVSG (Pedram & Donelson 1999); and in 
the bloodstream form, African trypanosomes express bloodstream form VSGs. 
However, buried within these coats are multiple surface proteins, the majority of 
which belong to multi-copy gene families (Table 2). In 2013, Jackson et al. 
presented a three-way comparison of the surface architecture of T. brucei, T. 
congolense and T. vivax with the aim to identify species-specific genes or gene 
families that could be linked to the phenotypic variation observed in AAT, be it 
virulence, pathology, host range, or transmission mode (Jackson et al. 2013). 
Surface genes families were identified and characterised based on a combination of 
sequence similarity searches, clustering analyses and phylogenetic estimation and 
reconciliation (Jackson et al. 2013). 
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The ‘Cell-surface Phylome’ revealed that T. brucei, T. congolense and T. vivax 
share 34 non-VSG gene families encoding surface proteins, which include multiple 
membrane transporters, invariant surface glycoproteins, major surface protease, 
trans-sialidase, protein kinases, adenylate cyclase, lipase, cysteine peptidases, few 
isomerases, and several hypothetical proteins (Jackson et al. 2013). T. brucei and 
T. congolense share three additional gene families, which comprise two families of 
transferrin receptors (Fam14 and 15) and a putative secreted protein (Fam10), 
reflective of the shorter genetic distance between these species and their procyclic 
life stage. Of the three species, T. vivax has the most complex surface phylome, 
containing 23 T. vivax-specific gene families, of which 19 are non-VSG. These 
genes are mostly putative secreted or putative membrane proteins, but also include 
the known mucin-associated surface protein (MASP, Fam35). 
This study concluded that the essential features of the African trypanosomes 
surface are conserved between species, and thus were established in the common 
ancestor. However, there are prominent gene families that have expanded rapidly in 
each organism and a set of genes that reflect recent species-specific adaptations 
(Jackson et al. 2013). 
 
Table 2 The surface of African trypanosomes according to the Cell Surface Phylome 
(Jackson et al. 2013).
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1.9 Antigenic variation
Antigenic variation is a mechanism of immune evasion used by several pathogens, 
such as African trypanosomes, Babesia, Plasmodium, Giardia, Neisseria 
gonorrhoeae, Borrelia hermsii, Anaplasma, and Pneumocystis, consisting of the 
sequential substitution of cell surface antigens, which coat the whole surface of the 
pathogen. 
In African trypanosomes, antigenic variation was first documented in the early 20th 
century, through the observation of the survival of specific subsets of trypanosomes 
in otherwise lethal sera [reviewed by Soltys (1963)]. This led to the discovery of 
‘variable antigen types’ (VATs), which elucidated the trypanosome survival strategy 
in the mammal host. The sequential expansion of particular VATs resulted in ‘waves 
of parasitaemia’, cyclical fever and long-lasting infection (Barry & McCulloch 2001). 
Trypanosoma brucei is the model organism for antigenic variation (Deitsch et al. 
2009). 
VSGs are highly antigenic and induce a strong B-cell dependent immune response. 
However, infection persists because clearance of VSG-bound antibodies results in 
the proliferation of parasite variants that express a different VSG. This process 
results in characteristic ‘waves of parasitaemia’, where parasitaemia peaks are 
followed by periods of undetectable parasite levels (Figure 5a). If untreated, the 
cycle persists until exhaustion of the host immune system or of the antigenically 
distinct VSG variants.
VSGs are expressed from dedicated cassettes at the telomeres of megabase 
chromosomes called VSG expression sites (ES) (Berriman et al. 2002; Becker et al. 
2004; Hertz-Fowler et al. 2008) (see section 1.10.3). To avoid parasite clearance by 
anti-VSG antibodies, the parasite has the ability to switch the monoexpressed VSG 
to one of the hundreds of VSGs in the genome. VSG switching occurs following 
transposition of another VSG to the ES (a process known as gene conversion), or 
through activation of a different ES (see section 1.10.4). Both processes result in 
VSG replacement in the parasite surface, independently of the host immune 
pressure. This mechanism successful impairs antibody-mediated lysis (Balber et al. 
1979) and promotes clearance of VSG-bound antibodies (Engstler et al. 2007). 
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Whilst traditionally each peak of parasitaemia has been associated with clonal 
expansion of a single variant, Hall et al. (2013) showed that, in T. brucei, they 
comprise a minimum of 15 variants, indicating that the waves of parasitaemia result 
from expansion of antigenically-distinct populations. Furthermore, Mugnier et al. 
(2015) showed that, in T. brucei, the ‘waves of parasitaemia’ are restricted to early 
infection and not as radical as depicted in Figure 5a. The number of VSGs being 
expressed by the population during infection increases disconcertedly; therefore, 
although defined waves of parasitaemia are observed at the individual variant level, 
the total parasitaemia never drops abruptly (Figure 5b). In late infections, this effect 
is accentuated so the total parasitaemia becomes almost constantly high. 
Figure 5 Host-Parasite interactions: ‘waves of parasitaemia’ in a trypanosome 
infection. A. Classical View: sequential growth and decay of five trypanosome variants 
expressing different VSGs. Clonal populations of parasites rapidly proliferate, triggering a 
strong antibody response against the expressed VSG and resulting in population clearing. 
Meanwhile, minority parasite populations expressing a different VSG can proliferate until a 
second antibody response is triggered. Theoretically, the cycle can continue until exhaustion 
of the host immune system. B. Contemporary View: Waves of total parasitaemia are due to 
multiple variants (Hall et al. 2013) and are less obvious because the emergence of alternative 
variants is disconcerted (Mugnier et al. 2015).
1.10 Variant Surface Glycoproteins
1.10.1 VSG structure 
The VSG surface coat has the main function of protecting the trypanosome 
population against the host immune response. However, as the mammal hosts elicit 
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innate (non-specific) and adaptive (specific) immune responses, VSGs are under 
two opposite pressures: structural conservation so that the invariant surface 
molecules remain protected from the immune effectors, and epitope variation so that 
each VSG coat is sufficiently distinct to undergo antigenic variation and elicit a new 
antibody response. To achieve these demands, the VSG tertiary structure is 
conserved (Carrington et al. 1991; Blum et al. 1993) and they organise in a densely 
packed monolayer that protects against complement mediated lysis (Figure 6). 
Each glycoprotein is attached to the cell membrane by a 
glycosylphosphatidylinositol (GPI) anchor. Buried within the VSG coat, and 
protected from the immune system, are invariant molecules. 
Figure 6 The VSG structure. a) The 3D model of VSG221 dimer from T. brucei. N-
terminal domains are shown in blue and grey, representing each monomer. C-terminal 
domains are shown in purple. Adapted from Schwede et al. (2015). b) Hypothetical model 
of antibody (IgM) binding to VSG. The model reflects the dense packing of the plasma 
membrane. VSG N-terminal domains are shown in blue and the C-terminal domains in 
purple. Adapted from Mugnier et al. (2016). 
VSG have a long highly variable N-terminus, with two antiparallel α-helices 
separated by a turn, and a shorter conserved C-terminus that anchors to the plasma 
membrane through a GPI anchor (Figure 6). VSG are often N-glycosylated, which 
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may impact the structure and accessibility of the VSG epitopes or adjacent 
molecules (Mehlert et al. 2002), and contribute to dimensional conservation 
between variants (Blum et al. 1993). After translation, the VSG is coupled to a 30-40 
amino acid signal peptide at the N-terminal domain, whose cleavage directs the 
protein for further post-translational modification, including GPI anchor addition and 
N-linked glycosylation (Ferguson et al. 1986; Mehlert et al. 2002). After that, the 
VSG is directed to the flagellar pocket to reach the plasma membrane. VSG 
molecules are indeed subject to rigorous quality control steps. A series of mutations 
in two T. brucei VSG drastically reduced the expression levels of the proteins, even 
though the GPI anchor was maintained (Wang et al. 2003). An efficient display on 
the parasite surface seems to require all conserved structural motifs, such as the 
cysteines, tryptophans, and the N-glycosylation sites. 
Most VSGs are clustered in subtelomeric arrays in the megabase chromosomes 
and these genes comprise approximately 20 % of the whole genome (Berriman et 
al. 2005). Although African trypanosomes have mostly diploid genomes (Hope et al. 
1999; Peacock, Ferris, et al. 2014), the subtelomeres are hemizygous, making 
individual VSGs haploid (Callejas et al. 2006; Marcello & Barry 2007a). 
The VSG repertoire is the major source of genetic diversity in the parasite, although 
its size varies by species and strain (Donelson 2003; Cross et al. 2014). The 
physical sequence properties of each species VSGs are distinct. T. brucei VSGs are 
normally the longest (mean length = 498±29 amino acids), whereas T. congolense 
and T. vivax VSG are shorter (mean length = 388±30 and 394±95 respectively) 
(Jackson et al. 2012). These length differences are due to T. brucei VSG having 
longer hypervariable regions at the N-terminal domain (NTD) and a much longer C-
terminal domain (CTD). In terms of physical properties, T. brucei and T. congolense 
VSG have similar GC contents (pGC = 0.488 ± 0.016 and 0.481 ± 0.032, 
respectively). T. vivax VSGs have a higher pGC of 0.599 ± 0.019, although the 
genome-wide GC content is also higher. Yet, T. vivax VSG have a higher codon 
bias towards hydropathic and less aromatic amino acids, which might contribute to 
the disparity in VSG GC content (Jackson et al. 2012). The number of pseudogenic, 
frameshifted or degenerate VSGs is also distinct between species. While less than 
20 % of T. brucei spp. are full-length VSGs, this number rises to approximately 75 % 
in T. congolense and T. vivax (Jackson et al. 2012). In all three species, VSGs are 
mostly arranged in subtelomeric tandem arrays and in the mini-chromosomes. 
However, in T. congolense, the VSG arrays often contain non-VSG multi-copy 
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genes also, such as the transferrin receptors (Fam14/Fam15) and invariant surface 
glycoproteins. 
1.10.2 VSG diversity
VSGs are highly diverse, particularly in their NTDs due to their exposure to the host 
immune pressures. The primary structure of VSGs varies considerably between 
African trypanosome species. Nonetheless, the pattern of conserved cysteine, 
glycine and tryptophan residues reported for T. brucei VSG are also observed in T. 
congolense and T. vivax (Carrington et al. 1991; Blum et al. 1993; Berriman et al. 
2005; Jackson et al. 2013). Two subgroups have been identified, a-VSG and b-
VSG. These groups are characterised by specific amino acid motifs, such as the 
‘GRIDE’ motif of a-VSG (Salmon et al. 1997), of which the transferrin receptors 
(TFR) are members (Jackson et al. 2013), and the central CxC motif of b-VSG 
(Blum et al. 1993; Jackson et al. 2013). 
In 2012, Jackson et al. provided a detailed comparison of the global VSG 
repertoires of T. brucei, T. congolense, and T. vivax with the aim to understand how 
antigenic diversity has evolved in the trypanosome genomes (Jackson et al. 2012). 
This study revealed that T. brucei a-VSGs are more closely related to a-VSG-like 
subfamilies in both T. congolense (TFR) and T. vivax (Fam23) than to T. brucei b-
VSGs. Similarly, T. brucei b-VSGs are more similar to b-VSG-like subfamilies in T. 
congolense (Fam13 and Fam16) and T. vivax (Fam24) (Table 3). These results 
indicate that VSG lineages precede speciation events, suggesting that the genome 
of their last common ancestor contained both a-type and b-type VSG lineages that 
were inherited by the contemporary species (Jackson et al. 2012). 
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Table 3 Summary of VSG-like genes in African trypanosomes (Jackson et al. 2012).
Within a- and b-VSG, there is only 10-15 % peptide conservation at the N-terminus, 
comprising a vast reservoir of antigens. However, there is also little homology 
between VSG of the same type but of different species (Strickler et al. 1987). 
Though a-VSG account for 50 % of the T. brucei VSG repertoire and for more than 
500 genes in T. vivax, a-type variant antigens are absent from the T. congolense 
genome (Helm et al. 2009; Jackson et al. 2013). In T. congolense, the a-type VSG 
family is represented exclusively by the non-variant transferrin receptors (Fam14/15) 
(Table 3).
T. brucei b-type VSG are a diverse family, which share a common C-terminal 
domain. By contrast, T. congolense b-type VSG cluster within two structurally 
different families (Fam13 and Fam16), likely to have originated in the African 
trypanosome ancestor because their closest relative are VSG-like genes in T. brucei 
(ESAG2 and VR9, respectively), rather than each other (Table 3). For this reason, 
T. brucei b-type VSG have been suggested to have passed through a bottleneck 
evolution from a single ancestral lineage arising after speciation (Jackson et al. 
2012). 
The T. congolense VSG families are further split into 15-20 phylotypes with non-
homologous CTDs, all non-homologous to T. brucei. Although the CTD of T. brucei 
is conserved across a- and b-VSG, so it can work as recombination anchor point for 
VSG movement between the subtelomeres and the expression sites, T. congolense 
b-VSG have at least 15 types of CTD, and for T. vivax an obvious CTD has yet to be 
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identified. Relative to T. brucei, T. vivax presents the greatest VSG structural 
diversity, consistent with its early separation from the African trypanosomes 
phylogenetic branch. Its VSG repertoire is divided into four subfamilies (Fam23–26), 
of which two are homologous to a-VSG and b-VSG (Fam23, Fam24) and two are 
species-specific (Fam25, Fam26). It is not clear whether these two T. vivax-specific 
families are functional VSG and whether they are derived from ancestral lineages 
that were lost in T. congolense and T. brucei or have originated post-speciation in T. 
vivax. Sequence variation within these families is very low, although diversity 
between lineages is remarkably high. 
The cladistic structure of T. congolense and T. vivax phylogenies suggests wider 
distances between clades and the conservation of different ancestor lineages 
information within basal nodes (Figure 7). The T. brucei VSG phylogeny contrasts 
with the latter, showing genome-specific long branches with narrower distributions 
and rare basal internodes (Figure 7). This dispersed structure suggests high levels 
of recombination, which is not so likely in T. congolense, mostly due to the 
conserved CTDs, but also due to the evolutionary barrier of a wider distribution of 
sequence variation. T. vivax, on its side, has the lowest rate of VSG recombination 
which might be explained by the same reasons as T. congolense in combination 
with differences in reproduction modes: whereas T. brucei and T. congolense seem 
to undergo sexual recombination, T. vivax may exclusively rely on clonal 
reproduction (Tait & Turner 1990; Tait et al. 2007; Peacock et al. 2009; Morrison, 
Tweedie, et al. 2009; Duffy et al. 2009; Tihon et al. 2017). 
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Figure 7 Phylogenetic tree topologies for VSG-like subfamilies in T. brucei, T. 
congolense and T. vivax. Differences in topologies derive from variation in the ratio of 
internal to terminal branches (‘treeness’). Treeness is highest for T. vivax (0.681 and 0.763), 
and lowest for T. brucei (0.282 and 0.275). All trees are drawn to the same scale. Adapted 
from Jackson et al. (2012).
While Fam13 and Fam16 in T. congolense, and Fam23 and 26 in T. vivax contain 
VSGs with variant antigen functions (Strickler et al. 1987; Rausch et al. 1994; Eshita 
et al. 1992; Helm et al. 2009; Jackson et al. 2013; Jackson et al. 2015), it remains 
unknown whether all VSG homologues encode variant antigens. In T. brucei, the 
VSG repertoire contains closely related genes, such as ESAG2, VR and other VSG-
like genes, which have evolved non-variant roles. Analogous families in T. 
congolense and T. vivax have not been identified to date. 
The system of antigenic variation has evolved as an adaptive mechanism to create 
multiple phenotypes from a clonal population and thus evade immune responses 
(Barry & McCulloch 2001). Therefore, the mechanisms of antigenic variation must 
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include a fine-tuned machinery to allow a rapid change of the surface antigen from a 
gene repertoire large enough that prevents antigenic exhaustion. An example of 
how this can be achieved is the existence of a vast silent gene ‘archive’ (Deitsch et 
al. 2009), that works as a library of antigenic diversity. The potential for variation can 
be increased by recombinatorial mechanisms that allow the combination of 
segments of distinct silent genes to create novel, mosaic, and antigenically distinct 
genes during antigenic switching (see section 1.7.3). Depending on the efficiency 
and frequency of these mechanisms, they have the ability to transform a small 
archive into a much larger antigenic pool (Zhuang et al. 2007).
1.10.3 VSG expression
In the T. brucei metacyclic stage, VSG are expressed from dedicated cassettes 
located at the ends of the longer chromosomes, called the metacyclic expression 
sites (MES). The MES comprises a long transcription promoter of 426 bp, a 
pyrimidine-rich region, the VSG, and a short 70 bp repeat, which facilitates gene 
conversion to the expression site after infecting of the host (Graham & Barry 1995). 
The mVSG expressed by a parasite population are heterogeneous, but limited to up 
to 27 antigen types (Turner et al. 1988). Nonetheless, mVSG expression is essential 
during the first five days of infection. This repertoire has been shown to change 
gradually over time and cyclical transmissions, and varies between strains (Barry et 
al. 1983). Like in T. brucei, the T. congolense mVSG population is heterogeneous 
and its repertoire also thought to be limited to a specific set of antigen types, which 
remain expressed up to 9 days post-infection in the mammal host (Crowe et al. 
1983). The relationship between these antigen types and the T. congolense VSG 
phylotypes remains unclear due to the previous inability to dissect the antigen types 
to the gene level.
Within seven days of infection, as the metacyclic parasites differentiate into 
bloodstream forms, the mVSG is replaced by a bloodstream VSG. In the 
bloodstream life stages, VSG must be produced in very high quantities to cover the 
full surface of the parasite. In fact, 10 % of the total soluble protein of T. brucei 
bloodstream forms is VSG (Cross 1990). To produce such quantities of protein, a 
large number of VSG mRNA transcripts are required. VSG and its associated genes 
are transcribed from a specialised telomeric expression site (ES) called the 
bloodstream ES (BES) by RNA polymerase I (Pol I), representing the sole exception 
of Pol I transcribing mRNA in eukaryotes (Günzl et al. 2003). The T. brucei 
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bloodstream-form VSG ES are specific telomere-proximal transcription units in 
megabase and intermediate chromosomes (Berriman et al. 2002; Hertz-Fowler et al. 
2008), which contain the VSG and a collection of ESAGs that are co-transcribed 
with the VSG. Thirteen families of ESAGs have been identified, all in association 
with VSG in the ES. Although some appear to be constitutively present, such as 
ESAG6 and ESAG7, ES usually harbour only 5 to 10 ESAGs and pseudo-ESAGs, 
which include degenerate, frameshifted, and truncated genes (Donelson 2003; 
Berriman et al. 2005). 
The T. brucei ESAGs derived uniquely in T. brucei from conserved multi-copy gene 
families found in the core chromosomes or subtelomeres. They have been 
independently recruited to the expression site, where they are subject to higher 
sequence recombination, possibly from telomeric exchange, resulting in concerted 
evolution between these distinct genes (Hertz-Fowler et al. 2008; Jackson et al. 
2013). Up to 90 % of the VSG are coupled to an upstream regulatory 70 bp repeat 
region known to facilitate VSG transposition between the subtelomeres and the 
expression sites. In T. congolense, regions homologous to ESAGs and expression 
sites have not yet been found. Extensive telomeric and subtelomeric cloning in T. 
congolense has become an area of great interest with the goal of understanding 
VSG expression, switching and recombination. Phylogenetic analysis of ESAGs 
suggests that they are a T. brucei-specific innovation (Jackson et al. 2013), but it is 
plausible that T. congolense recruited the same or other genes to the expression 
sites to perform ESAG functions. 
In T. brucei, only one VSG is actively transcribed at any given time. VSG 
monoallelic expression is advantageous because it results in a homogeneous 
parasite surface coat, which exposes a single antigen at a time to immune system, 
precluding antigen repertoire exhaustion [reviewed by Horn (2014)]. The VSG is 
expressed from an ‘active ES’ [reviewed by Horn (2014)].
Although ‘double-expressers’, or parasites expressing two VSG at a time, can be 
created in the experimental settings, this is unprecedented in the wild (Muñoz-
Jordán et al. 1996). ES activation is rigorously controlled and various experiments 
have shown that in chemically induced activation of two ES, the parasites become 
unstable, but show highly heritable patterns of dynamic ES switching (Chaves et al. 
1999). The active ES co-localises with the extranucleolar, Pol I-containing 
expression site body (ESB) (Navarro & Gull 2001) and their association is usually 
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inherited, suggesting that monoallelic expression is inherited and epigenetically 
controlled. Epigenetic mechanisms identified to date include chromatin remodelling 
[e.g the reduction of TbISWI (Hughes et al. 2007; Stanne et al. 2015) and histone 
H1 (Pena et al. 2014)] and nuclear location, as inactive ES, all located at the nuclear 
periphery, where interaction with NUP1 ensures ES silencing (DuBois et al. 2012). 
Furthermore, nucleosome depletion and chromatin remodelling (particularly histone 
H1) play an important role in Pol I control (Figueiredo & Cross 2010; Pena et al. 
2014), which in turn might be actively involved in monoallelic exclusion control, as it 
has been recently shown that Pol I inhibition causes fragmentation of the nucleolus 
and loss of ESB (Kerry et al. 2017).
1.10.4 VSG switching and recycling
Despite the mechanism of monoallelic expression, it must flexible enough to allow 
for rapid and frequent switching. VSG recycling occurs at the flagellar pocket, the 
only site of exocytosis and endocytosis. This is a rapid process lasting for about 12 
min that allows the replacement of VSG molecules in the surface coat, functioning 
as a cleaning mechanism and facilitating trypanosomal survival in low titres of anti-
VSG antibodies.
VSG switching is the autonomous and spontaneous process of changing the 
expressed VSG coat independently of the immune system (Doyle et al. 1980). In the 
wild, VSG switching in T. brucei occurs at a rate of 10-2 to 10-3 switches per cell per 
population, although in laboratory-adapted strains the rate drops to about 10-6 
(Donelson 2003). VSG switching can occur through two main mechanisms: 
transcriptional and recombinatorial switching. The former is achieved through the 
transfer of monoallelic expression to another ES, without the need for genetic 
rearrangement. The latter involves the copying or transposition of a VSG into the ES 
and can occur through gene conversion, segmental gene conversion (SGC) and 
telomere exchange (Figure 8). 
Transcriptional switching consists of the silencing of the active ES and subsequent 
activation of a different ES (Majiwa et al. 1982; Young et al. 1982; Young et al. 
1983) (Figure 8A). It has been proposed that this mechanism occurs through the 
transference of the ESB to a different ES (Navarro & Gull 2001), although it may be 
more complex, as the activation of the new ES and the repression of the previous 
ES are independent processes (Figueiredo et al. 2008). Regardless of its players, in 
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situ VSG switching is considered of minor importance for natural infections and 
pleomorphic cell lines (Robinson et al. 1999). In fact, the main mechanism of VSG 
switching is (duplicative) gene conversion, where VSG are duplicated or transposed 
from the subtelomeric arrays to the active ES by homologous recombination (Figure 
8B). This process is usually triggered by damage to the ES, often by double-
stranded DNA breaks (Morrison, Marcello, et al. 2009; Boothroyd et al. 2009; Glover 
et al. 2013), resulting in the deletion of the original DNA sequence and its 
replacement with the template strand. 
For homologous recombination to occur, two DNA strands must be have at least two 
regions similar enough in sequence to allow for strand annealing and binding of the 
newly-synthesised sequence to the ES sequence being repaired. Thus, the regions 
involved in VSG conversion are the 70 bp repeat upstream the VSG and its C-
terminal domain or 3’ UTR, which work as ‘anchor points’ for the VSG switching 
(Bernards et al. 1981; Liu et al. 1983; Liu et al. 1985; Timmers et al. 1987). Whilst 
duplicative gene conversion requires exchange of intact VSG, the vast majority of T. 
brucei VSGs are frameshifted, interspaced by stop codons, or degenerate. These 
VSGs can be repaired or modified into functional VSG by SGC (Figure 8C), which 
can occur through mosaicism and 3’ donation (Barbet & Kamper 1993). Mosaic 
VSG are formed through the combination of segments from multiple donors and can 
contribute not only to a greater use of the VSG archive, but also to an exponential 
increase in antigenic variation potential (Hall et al. 2013). Expression of mosaic VSG 
may be evolutionary favoured due to the pressure for diversity generation imposed 
by the host adaptive immune system, as they can present a massive benefit in 
infection chronicity (Barbet & Kamper 1993). 
The exact mechanisms of SGC are unclear, although likely to be based on 
sequence homology as mosaic VSGs and their donors often share sequence 
similarities. As the flanking regions that allow classical homologous recombination 
are lacking (Barnes & McCulloch 2007) and the segments can be as small as 14 
base pairs (Kamper & Barbet 1992), it was proposed that mosaic VSG were formed 
by series of recombinatorial events, also known as ‘progressive mosaicism’ (Pays, 
Houard, et al. 1985; Barry et al. 2005; Marcello & Barry 2007a). This hypothesis has 
been corroborated by recent experiments. Hall et al. (2013) confirmed that 
mosaicism plays a large role in antigenic variation in T. brucei, as sequence identity 
does not constrain gene conversion; and provided evidence that antigenic variation 
is built continuously by many variants, rather than in a tightly regulated, intermittent 
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manner. Moreover, it was shown for the first time that SGC does repair pseudogenic 
donors, and creates antigenically distinct variants, contributing to great richness of 
VSG expression (Hall et al. 2013). Through rapid accumulation of mosaicism, 
expressed VSGs have a new layer of diversity that exponentially increases the 
potential for antigenic variation.
The last known mechanism of VSG switching is telomeric exchange, through which 
classical recombination allows the exchange of two chromosome ends, resulting in 
the substitution of the telomere-proximal VSG and its downstream sequence (Pays, 
Staerz, et al. 1985) (Figure 8D).
It is believed, although not yet shown experimentally, that the switching rate is 
dependent on a cyclical transmission through tsetse flies, possibly to ensure a labile 
epigenetic state. Regardless of the mechanism, the rapid process of antigenic 
switching is always followed by the slower replacement of the VSG coat. The whole 
replacement of the VSG coat is thought to take two days in vivo, a theoretical 
number that accounts for the rapid gene expression change, the VSG mRNA half 
life of 4.5 hours, and the VSG half life of 30 hours (Cross et al. 1998). The veracity 
of this assumption remains to be empirically tested, although, in T. brucei, the 
change between mVSG and bloodstream VSG has been shown to take 2 days, by 
detection with monoclonal antibodies (Esser & Schoenbechler 1985). 
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Figure 8 Mechanisms of VSG switching. A. Transcriptional or in situ switching consists on 
the activation of a different expression site (ES), without any gene rearrangement. B. 
Recombinatorial Switching can be achieved through gene conversion when an intact VSG is 
transferred to the active ES by homologous recombination usually between the 70 bp repeat 
regions upstream of the VSG and its C-terminal domain. C. Recombinatorial Switching can 
also be achieved by segmental gene conversion, which occurs when segments of a silent 
pseudogenic VSG are transferred to the active expression site, creating a novel, mosaic VSG 
consisting of segments of the original and the pseudogenic VSG. D. The mechanism of 
telomeric exchange by homologous recombination can also contribute to VSG switching.
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1.10.5 Hierarchic activation of VSGs
VSG activation is partially hierarchical. The order of the expressed VSG in the 
infrapopulation (i.e. the trypanosome population of a given host at any given time) is 
somewhat predictable, as specific VSGs tend to be expressed at particular times of 
infection. This hierarchy, which is observed in other pathogens, such as 
Plasmodium and Anaplasma marginale (Bull et al. 2005; Chávez et al. 2012), helps 
to prevent rapid exposure of the full VSG archive to the immune system (Morrison et 
al. 2005), but it may also contribute to maintain the infection at a sub-lethal stage, as 
spontaneous antigen variability could lead to extreme parasitaemia and immune 
exhaustion of the host (Turner et al. 1995). Ordered VSG activation in independent 
T. brucei infections was first observed by (Gray 1965), but has since been 
supported by several studies, which showed that similar subsets of antigen types 
appear in early infections (McNeillage et al. 1969; Van Meirvenne et al. 1975; Miller 
& Turner 1981; Liu et al. 1985). Longer infections in T. brucei equiperdum (one 
month) (Capbern et al. 1977) and T. vivax (several months) (Barry 1986) further 
confirmed the conserved order of VSG expression, although suggested that the 
pattern becomes looser as infection progresses. 
The mechanisms of expression hierarchy is based on the concept of VSGs having 
distinct activation probabilities (Pays 1989). The activation probability of a VSG is 
thought to be partly related to its genomic locus, as several studies have observed a 
correlation between that and the timing of activation (Young et al. 1983; Liu et al. 
1985; Robinson et al. 1999). For instance, in T. brucei infections, minichromosomal 
VSGs arise early in infection, activated mainly by duplicative gene conversion 
between the active expression site and other telomeres, whereas VSGs from 
subtelomeric arrays are activated less often and mostly in late infections. 
Morrison et al. (2005) tested the degree of predictability in VAT expression and its 
association with the VSG locus type, showing that the VSG activation probability is 
directly linked to the complexity of moving it into the expression site. As gene 
conversion is homology-based, it is possible that the sequence similarity between 
the VSG being activated (and its flanking regions) and the VSG being silenced 
contribute to the activation probability (Morrison et al. 2005). As the repetitive and 
unstable nature of the telomeres favours recombination (Barry et al. 2003), it is 
sensible that telomeric VSG are more likely to be activated, and therefore appear 
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early in infection (Liu et al. 1985; Robinson et al. 1999). Accordingly, full VSGs from 
subtelomeric arrays are second in the order of activation probability as they can be 
transposed to the expression site in a single gene conversion step based on 
homologous recombination between the 70 bp repeat and the 3’ end of the VSG 
(Marcello & Barry 2007a). Finally, pseudogenic VSGs have the lowest activation 
probability as SGC requires multiple steps of repairing recombination; therefore they 
tend to appear in later infections, playing an important role in infection chronicity 
rather than acute disease (Pays 1989; Hall et al. 2013). Nonetheless, Hall et al. 
(2013) have shown that the hierarchical activation is loose, not strict. Although the 
frequency of mosaic VSGs increases as infection progresses, they can be 
expressed earlier, particularly due to SGC modifications to early-expressed VSGs.
1.10.6 Role of VSGs in pathology and virulence
Antibodies against VSGs are the key effectors of the host adaptive immune 
response to trypanosomes. As the surface of bloodstream form trypanosome is 
coated with a fluid, tightly packed, highly immunogenic VSG monolayer, the immune 
system recognises the conformational epitopes of the N-terminal domain and elicits 
an antibody response (Mehlert et al. 2002; Pinder et al. 1987; Miller et al. 1984a; 
Miller et al. 1984b; Masterson et al. 1988). Furthermore, VSGs can be secreted from 
the parasite. Soluble VSGs are not very immunogenic, i.e. do not bind antibodies 
strongly (Black et al. 1982), but may assist in B-cell activation and/or alternative 
immune responses, such as complemented-activated cascades (Sendashonga & 
Black 1982; Black et al. 1982). Frequent recombination and mutagenesis generate 
vast antibody diversity. Therefore, trypanosomes have evolved mechanisms of 
generating antigenic diversity to evade it. Simultaneously, trypanosomes induce 
immunosuppression through the activity of suppressor macrophages and induction 
of apoptosis in marginal zone B-cells (Radwanska et al. 2008). Besides the extrinsic 
effect exerted by the immune system in the parasite population, in T. brucei, there is 
an intrinsic population control that prevents abrupt parasite growth and host immune 
exhaustion. A portion of slender bloodstream forms differentiates into tsetse-
infective quiescent stumpy forms, stabilising parasitaemia and amplifying the 
chance of successful tsetse infection. This developmental mechanism is linked to 
repression of VSG transcription (Amiguet-Vercher et al. 2004), reducing the 
frequency of switching to a minority of the population, controlling the pace of 
antigenic diversity generation (MacGregor et al. 2011), and potentially contributing 
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to the survival of parasites expressing alternative VSG coats below the threshold for 
immune detection (Gjini et al. 2010).
The virulence amongst T. congolense ‘savannah’ sub-type strains is mostly 
dependent on whether they are domestic or sylvatic, with highly virulent strains 
being more common in the sylvatic transmission cycle (van den Bossche et al. 
2011). The increase in virulence may be the result of the selective pressure caused 
by the evolution of trypanotolerance in wildlife and may explain why the worst 
epidemics of AAT are seen following the introduction of foreign breeds into wildlife 
enzootic areas, as seen in Mozambique and Ethiopia at different times (Sigauque et 
al. 2000; Ayisheshim et al. 2015). The prevalence maintenance of low virulence 
strains in sylvatic cycles of areas with mixed virulence patterns has been explained 
by the cross-protection between low and high virulence strains shown in mice 
(Masumu et al. 2006). Within the domestic cycle, virulence seems to be highly strain 
dependent, irrespective of geographic area and genetic subgroup (Masumu et al. 
2006).
The cross-protection given by low virulence strains may be susceptible to antigenic 
variation. The VSG repertoire in T. brucei is comprised of hundreds of 
pseudogenes, which constantly form new variants. Pseudogenes contribute to the 
pool of potentially expressed VSGs since they may form temporary mosaic VSGs by 
assembling with highly homologous intact genes (Marcello & Barry 2007a). This 
mechanism potentially confers the ability of the parasite to re-infect previously 
immune hosts. Furthermore, the generation of novel VSGs by recombination of the 
existing repertoire may offer a dynamic way of virulence and transmission increase 
through preservation of the parasite at subclinical levels and a greater host range. 
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1.11 Aims of the thesis
Despite being a major contributor to parasite’s fitness, efforts to study antigenic 
diversity have been limited. Population genomics studies of African trypanosomes 
[in T. brucei (Sistrom et al. 2014; Weir et al. 2016) and T. congolense (Tihon et al. 
2017)] have ignored VSG diversity perhaps because existing read mapping 
methods cannot be safely applied to labile VSG loci. Yet, VSGs and related genes 
are intimately linked to disease biology, particularly host range and virulence (Pays 
2006). The size, complexity and dynamics of the VSG repertoire have challenged 
the development of tools for antigenic diversity and expression from big data. The 
purpose of this thesis was to develop a bioinformatics tool that allows the 
quantification and characterisation of the VSG repertoire from high-throughput data. 
Using next-generation sequencing (NGS) to produce genomes of natural African 
isolates, and transcriptomes from experimental tsetse fly infections, this thesis 
aimed to further characterise the VSG repertoires of T. congolense and T. vivax on 
a population scale, and to introduce the Variant Antigen Profile (VAP) as a metric of 
VSG diversity and expression. The VAP can define genetic signatures of parasite 
isolates, allowing a fast and reliable analysis of VSG diversity and expression, and 
bypassing gene annotation or individual VSG manipulation. As the VAP brings the 
unprecedented ability to discriminate among variant antigens, it will ultimately allow 
the association of variant antigens with specific infection phenotypes. This will 
trigger exceptional epidemiological mapping of T. congolense and T. vivax, leading 
to a better understanding of disease outcomes. Furthermore, I present putative VSG 
expression sites for T. congolense and compare evolutionary pressures in the 
molecular evolution of VSGs. The specific objectives of this thesis are:
1. Develop the VAP, a tool to analyse T. congolense VSG diversity on a large 
scale from genomic and transcriptomic data.
2. Apply the VAP to transcriptomic and proteomic data from experimental fly 
infections to characterise the mVSG repertoire of T. congolense ‘savannah’ 
Tc1/148.
3. Identify and describe the T. congolense VSG ES using long-read genome 
sequencing.
4. Extend the VAP to analyse antigen diversity in T. vivax.
5. Understand the role of recombination in generating VSG diversity in T. 
brucei, T. congolense and T. vivax at a population scale.
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Chapter 2. The Variant Antigen Profile in 
Trypanosoma congolense: quantifying the frequency 
of conserved VSG motifs
2.1 Introduction
Studying antigenic diversity in African trypanosomes is challenging due to the 
‘dynamic nature’ of antigenic variation of VSG sequences. Antigenic variation 
consists on the serial replacement of the cell surface protein, and prevents an 
effective antibody-based response, resulting in infection chronicity and increased 
likelihood of transmission, and hampering vaccine development. Antigenic variation 
is a key determinant both of disease progression and virulence; hence good 
knowledge of its effectors is required to understand how disease is caused and how 
to prevent it. In fact, describing the diversity of major surface antigens has been 
critical to understanding disease dynamics in other antigenically-variable organisms. 
For instance, antigen mapping of hemagglutinin has improved the prediction of 
antigenic drift in influenza A (McHardy & Adams 2009), a vital step for the efficacy of 
the seasonal influenza vaccine. Similarly, understanding of the genetic diversity of 
HIV envelope glycoproteins preceded the formulation of a multivalent subunit 
vaccine (McCutchan et al. 1996). In P. falciparum malaria, studies of var gene 
diversity have exposed the association between particular var genes and disease 
severity (Chen et al. 2011; C. W. Wang et al. 2012).
In T. brucei, the VSG repertoire has been known for a long time to be large, 
dynamic, and under fast evolution as a result of recombination events, such as 
telomeric exchange and gene conversion, and sexual reproduction (Myler 1993). 
However, VSG diversity in T. congolense and T. vivax is known to be generated 
differently (Jackson et al. 2012). For example, while the T. brucei VSG repertoire is 
thought to be effectively unlimited, in T. vivax it might be limited as strains 
expressing similar VSG repertoires can be found further apart and infection can 
provide cross-protection between close isolates (Nantulya et al. 1986). Yet, T. 
brucei remains the current model for antigenic variation and diversity. Most of what 
is known about the biology of T. congolense has derived from T. brucei studies, but 
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major differences in the VSG machinery, evolution and structure strongly advocate 
the need for dedicated study of this species. Much remains unknown about how 
parasite epidemiology, virulence patterns, clinically relevant genotypes, or 
population structure relate to VSGs. This suggests that in-depth study of antigenic 
diversity in T. congolense and T. vivax is necessary to achieve a full understanding 
of the molecular aspects of antigenic variation and reveal their biological 
significance.
The ancestor of African trypanosomes had two structurally different VSG families, a-
type and b-type (Jackson et al. 2012). T. brucei has retained and expanded both 
types, but T. congolense only has b-type VSGs (Jackson et al. 2012). All VSGs 
have a NTD and a CTD, each characterised by different patterns of cysteine 
residues (Carrington et al. 1991). In T. brucei, three different types of NTD and six 
different types of CTD have been described (Carrington et al. 1991; Marcello & 
Barry 2007a). In b-type VSGs, the CTD has a conserved tertiary structure, indicating 
that VSG dimerization occurs via the NTD (Chattopadhyay et al. 2005). T. brucei b-
VSGs derive from a bottleneck evolution from a single ancestral lineage arising after 
speciation (Jackson et al. 2012). Furthermore, the same NTD can be linked to 
different CTDs, showing that the NTD and the CTD are decoupled and indicating 
that the CTD is the downstream anchor point for recombination (Marcello & Barry 
2007a). As all VSGs share a homologous CTD, recombination constraints are low, 
resulting in a VSG phylogeny of genome-specific long branches with narrower 
distributions (Jackson et al. 2012). This is a genome-specific feature as is observed 
in both a- and b-VSGs. Therefore, although the two lineages are structurally distinct, 
they share similar antigenic variability mechanisms (Jackson et al. 2012).
The scenario is different in T. congolense. At publication, the VSG repertoire of the 
T. congolense reference genome, IL3000, contained 875 genes. However, this is 
underestimated as 182 new VSG sequences have been added since. The repertoire 
contains only b-type VSGs and is organized into two structurally different families 
(Fam16 and Fam13), each combining multiple ancestral b-type VSG lineages 
(Jackson et al. 2013). The N terminus of a VSG is highly variable, but the tertiary 
protein structure remains conserved due to highly conserved amino acids at defined 
positions, mainly cysteine, glycine and tryptophan residues. Unlike T. brucei, the 
CTDs are distinct and can be used to differentiate VSGs into at least 15 distinct 
clades or ‘phylotypes’ (Figure 9). In T. congolense, the CTD is defined as the region 
up to 100 amino acids long between a conserved tryptophan residue and the GPI-
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anchor. They are variable in length and composition, although, unlike the NTDs and 
the GPI-anchor, generally rich in polar residues. There is a clear compositional and 
structural difference between the CTD of Fam13 and Fam16, the latter being more 
homogenous. The degree of variation within the families is also distinct: the CTD of 
Fam13 phylotypes are more conserved than those of Fam16, which reflects higher 
genetic distances within the former. 
The VSG phylogeny of T. congolense suggests wider distances between 
phylotypes, wider distribution of sequence variation, and the conservation of 
different ancestor lineages information within basal nodes. The lineage-specific CTD 
indicate that T. congolense VSGs lack a common recombination anchor point and 
the robust cladistic structure indicates little recombination among members of 
different phylotypes so the phylogenetic signal can be retained. This was confirmed 
by VSG quartet analysis, which supported scarce recombination between clades 
(Jackson et al. 2012). The lower VSG recombination rate proposed for T. 
congolense in comparison to T. brucei is also supported by the much lower 
occurrence of pseudogenes (30 % vs. 70 %), likely to result from gene conversion 
events.
Besides antigenic variation, VSGs and VSG-like sequences are important disease 
markers (Ross et al. 1987; Tetley et al. 1987; Allred et al. 1990; Carrington et al. 
1991; Schwede et al. 2015) and have been implicated in disease biology, 
particularly host range and virulence (Pays 2006), as well as resistance to 
complement-mediated lysis (Ferrante & Allison 1983; Devine et al. 1986) and 
stimulation of cytokine dysregulation among innate immune cells, which ultimately 
leads to immune suppression and disease symptoms (Vincendeau & Bouteille 
2006). Examples of VSG-like sequences that have evolved invariant roles are the 
serum resistance associated (SRA) gene in T. brucei rhodesiense, or the T. brucei 
gambiense-specific glycoprotein (TgsGP), both of which provide resistance to the 
human trypanolytic factor and therefore allow human infection (Van Xong et al. 
1998; Uzureau et al. 2013; Capewell et al. 2013), as well as the transferrin receptors 
(TFR), which allow iron uptake into the cell in both T. brucei and T. congolense 
(Salmon et al. 1997), and ESAG2, a T. brucei-specific gene family derived from b-
type VSGs, which have an unspecified function in the flagellar pocket of 
bloodstream-form T. brucei (Gadelha et al. 2015). The conservation of distinct 
lineages within the T. congolense VSG repertoire is consistent with negative 
selection, which might be driven by functional differentiation of particular clades. 
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The intimate relationship between VSGs, virulence, and pathology further 
strengthens the hypothesis that these phylotypes may hold important biological 
functions. Yet, population genomic studies to date have not been able to address 
VSGs, perhaps because current read-mapping methods cannot accurately handle 
such great variability in copy number, sequence composition and chromosomal 
localisation. Characterisation of hundreds of VSGs, including many novel mosaics 
and pseudogenes, is a daunting process and has so far only been undertaken for 
reference genomes (Marcello & Barry 2007a; Jackson et al. 2010; Jackson et al. 
2012; Hall et al. 2013). There is an urgent need for a systematic classification 
capable of dealing with the complexity of VSG repertoires, but simple and sensitive 
enough to be applied to large sets of samples of variable genome quality. Manual 
analysis of the antigen repertoire is arduous, time consuming and requires specific 
expertise in VSG recognition and sequence manipulation. The high percentage of 
pseudogenes in the repertoire takes this challenge even further. However, the 
predictability of the T. congolense VSG repertoire facilitates the development of a 
tool to quickly screen a genome and estimate its relative VSG repertoire 
composition. Here, I introduce the VAP as an automated method to quantify 
pathogen antigenic diversity and define antigenic signatures of parasite strains, 
allowing a fast and reliable analysis of T. congolense VSG variation from genome 
sequence data which can potentially impact disease phenotypes or strain virulence, 
and trigger unprecedented epidemiological mapping of T. congolense in Africa. 
This chapter aims to:
1. Investigate the universality of the VSG phylotypes identified in the reference 
strain using phylogenetic analysis;
2. Present VAPs for a historical collection of 41 field strains from across Africa 
using a manual method based on sequence similarity search to quantify 
population variation in the VSG repertoire; 
3. Introduce the VAP as a method to dissect antigenic diversity in T. 
congolense;
4. Quantify VSG variation at the population level and link it to geography and 
population structure.
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Figure 9 C terminal domains (CTD) of T. congolense IL3000 VSGs. Phylotypes (denoted 
by ‘PX’) are marked on the left. The lineage specific CTD is shown unaligned in the centre, 
flanked by a conserved tryptophan (W) on the left and the beginning of the GPI-anchor 
sequence on the right.
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2.2 Methods 
2.2.1 Sample identification and storage
Samples were collected between 1966 and 1982 by International Livestock 
Research Institute (ILRI, Kenya) staff from livestock, tsetse flies and wild animals as 
part of various experiments. They were passaged into a naïve host to increase 
parasitaemia. At peak parasitaemia, naïve hosts were bled and multiple 50µl blood 
stabilates in 10-30 % glycerol prepared and stored at -80C. Samples were 
transferred to liquid nitrogen at a later date. Samples for this project were chosen 
from the ILRI Biobank based on area of collection and number of passages. All 
samples used had had a maximum of 4 passages, as passaging through multiple 
hosts may affect the VSG repertoire. Samples were imported from ILRI during 2014 
and 2015 and kept in liquid nitrogen at the Biosciences Building, University of 
Liverpool (Table 4).
2.2.2 Cell lysis and DNA extraction
Blood stabilates were subject to magnetic antibody cell sorting to deplete host cells 
and enrich for parasite DNA using anti-CD15 and anti-CD45 antibodies, as most 
leukocytes have one or both of these antigens. DNA was extracted using a 
magnetic bead protocol. The magnetic bead: sample ratio was adjusted to 2:1 to 
increase recovery of small DNA.
150 l blood samples were transferred to 2.0 ml Lo-Bind tubes (Eppendorf, UK) and 
1.5 ml ACK lysing buffer (0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA) was added. 
Samples were incubated for 3 min at room temperature, and centrifuged for 10 min 
at 650 g. Supernatant was discarded and the pellet washed in 500 l MACS buffer 
(2mM EDTA, 5xBSA in PBS pH7.2). Samples were centrifuged for 10 min at 650 g. 
Supernatant was discarded and 80 l MACS buffer, 10 l antiCD15, and 10 l 
antiCD45 were added, gently mixed until pellet dissolved, and incubated at 4 °C for 
15 min with gentle shaking after 7.5 min. Cells were washed in 1 ml MACS buffer 
and centrifuged for 10 min at 650 g. Supernatant was discarded and pellet 
resuspended in 500 l MACS buffer. MACS columns were washed with 500 l 
MACS buffer and cell suspension was added to individual columns. The first eluate 
was collected and centrifuged for 10 min at 650 g. Supernatant was discarded and 
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the pellet resuspended in 100 l lysis buffer (aqueous solution of 1 M Tris-HCl 
pH8.0, 0.1 mM NaCl, 10 M EDTA, 5 % SDS, 0.14 M Proteinase K). 
Samples were incubated at room temperature for 1 hour and DNA was extracted 
with magnetic Sera-Mag Speedbeads (GE Healthcare Life Sciences, UK). Samples 
were transferred to 1.5 ml LoBind tubes (Eppendorf, UK), two volumes of previously 
vortexed, room temperature Sera-Mag Speedbeads were added, and incubated for 
15 min at room temperature. Tubes were placed on magnetic stand for 2 min and 
the supernatant was removed. 500 l of freshly made 70 % ethanol was added, 
incubated for 2 min and removed. The latter step was repeated to maximise DNA 
precipitation. All visible ethanol was carefully removed and the pellet air-dried for 5 
min or placed on a 37 °C heat block for 3 min. The pellet was rehydrated in 20l 
nuclease-free water and placed on the magnetic stand for 1 min. The supernatant 
was transferred to a sterile 0.5ml LoBind tube (Eppendorf, UK) and kept at -20 °C 
after Qubit® fluorometric dsDNA quantitation (dsDNA HS Assay Kit) (Life 
Technologies, UK).
DNA outputs obtained ranged from 2.0 ng to 57.2 ng.
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Table 4 T. congolense strains used in this study. Table shows sample ID, year and location 
of collection, host, and species used for passaging.
2.2.3 Magnetic antibody cell sorting control
Success of the magnetic antibody cell sorting was observed by PCR to amplify the 
mouse 18S rDNA region and the ITS1 rDNA region of T. congolense. PCR was 
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performed in a reaction volume of 25 l with the following conditions: Bioline 2X Taq 
mix (Bioline, London), 2 M of each forward and reverse primers, and 1mM dNTPs. 
The reaction conditions were as follows: 1 cycle of 94 °C for 3 min followed by 30 
cycles of 94 °C denaturation for 1min, 58 °C hybridisation for 1 min, and 72 °C 
elongation for 1 min, and a final extension step of 5 min at 72 °C.
The primers used were as follows: 
- Mouse 18S rDNA primers: 5’-GTAACCCGTTGAACCCCATT-3’ and 5’-
CCATCCAATCGGTAGTAGCG-3’ 
- T. congolense ITS1 rDNA 5′-GCG TTC AAA GAT TGG GCA AT-3′ and 5′-CGC 
CCG AAA GTT CAC C-3′ (Desquesnes et al. 2001).
PCR products were resolved by gel electrophoresis (1h at 100V) in 1.5 % agarose 
gels stained with 1:10,000 dilution in TBE of SYBR safe DNA Gel stain (Thermo 
Fischer Scientific, UK) and visualised under UV light. 
2.2.4 Genomic amplification 
To maximise the chance of success through genomic library preparation, genomic 
amplification using the illustra GenomiPhi V2 DNA Amplification Kit was perfomed to 
all samples according to the manufacturer’s protocol (GE Healthcare Life Sciences, 
UK). Amplification products were quantified with Qubit® fluorometric dsDNA 
quantitation (dsDNA Broad Range Assay Kit) (Life Technologies, UK).
Genome amplification products from 11 samples were used for library preparation 
because the library preparation procedure failed to yield sufficient material from the 
direct DNA extraction (samples IL274, IL374, IL396, IL409, IL439, IL3022, IL3296, 
IL3775, IL3900, IL3954 and ILC22). The remaining products were stored at -20C. 
2.2.5 Next-Generation Sequencing (NGS)
To proceed with genomic sequencing, genomic libraries were prepared using the 
Accel-NGS 2S DNA Library Kit (Swift Biosciences, Inc., USA). This library kit was 
chosen because it is designed to produce effective yields from DNA inputs as low as 
10pg, includes sequential repair steps and produces high complexity libraries, which 
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are required for successful deep sequencing. Furthermore, it uses a magnetic bead 
protocol for library purification similar to that used in the DNA extraction step. 
Protocol was followed as per manufacturer’s instructions and is comprised of 6 
steps: DNA was mechanical sheared using the Covaris ADA process (Covaris, UK) 
in 500 bp fragments, followed by two repair steps and two ligation steps. Libraries 
were amplified by PCR using 10-18 cycles. 
Following preparation, DNA library concentrations were measured with Qubit® 
fluorometric dsDNA quantitation (dsDNA Broad Range Assay Kit) (Life 
Technologies, UK). Genomic libraries with detectable DNA levels were bioanalysed 
using a High Sensitivity DNA Analysis Kit (Agilent Technologies, USA). Samples 
with desirable concentration (>0.15 ng.l-1) and fragment lengths (300-1000 bp) 
were kept. Samples with different fragment lengths (N = 15) were subject to Pippin 
preparation (Pippin Prep, Sage Science, USA) for targeted size selection, as 
recommended for Illumina sequencing. 
Genomic libraries were sequenced on a MiSeq platform (Illumina Inc, USA) as 150 
or 250 bp paired ends, at the Wellcome Trust Sanger Institute (Cambridgeshire, 
UK). The whole genome shotgun project has been deposited in SRA under the 
accession number ERP023223.
2.2.6 Analysis of NGS data
De novo assembly
Draft genomes were produced for each strain so that VSG-like sequences could be 
recovered. De-novo assembly was manually optimised for the dataset (see Results 
section 2.3.2). 
Recovered reads were used to produce de novo assemblies of each strain using 
velvet version 1.2.07 (Zerbino & Birney 2008) with the following settings: kmer of 65, 
insert length adjusted for 400 base pairs with standard deviation of 50, minimum 
pair count of 20, and coverage cut-off between 0 and 5, depending on sample 
quality.
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VSG-like sequence recovery
To recover all VSG-like sequences in the genomes, a sequence similarity search 
was performed. Since the genetic distance between strains was unknown and VSG 
are dynamic genes, it was difficult to predict the degree of similarity to expect 
between VSGs. Therefore, identity thresholds were kept low to ensure any novel or 
atypical VSGs were recovered.
Assembled contigs were examined for VSG-like sequences by sequence similarity 
search with tBLASTx using a database of T. congolense IL3000 VSG as query. 
Although IL3000 lacks a-type VSGs (Jackson et al. 2012), a separate sequence 
similarity search was performed using T. brucei Fam1 and a-type VSGs as query to 
confirm the absence of a-VSGs in this dataset. 
A threshold of p-value > 0.001, contig length >150 amino acids, and % identity >=75 
was applied to select significant results. Sequences with 40 to 75 % similarity to the 
reference were manually inspected and their inclusion in the analysis empirically 
decided. This search would allow for the recovery of VSG sequences that were 
absent from the reference, yet no novel phylotypes were identified in the analysis. 
Recovered sequences were assigned a phylotype based on their top hit from the 
reference and phylotype relative frequencies used to estimate manual VAPs. VAPs 
are defined as the proportions of each VSG phylotype for a given strain.
Multiple sequence alignment and phylogenetic estimation
VSG-like nucleotide sequences were manually retrieved from the assembled contigs 
files, translated with BioEdit 7.2.5 (http://www.mbio.ncsu.edu/BioEdit/bioedit.html), 
and aligned to a subset of the IL3000 VSG database with ClustalW (EBI, UK) 
(Larkin et al. 2007). 
Fam16 and Fam13 multiple sequence alignments and phylogenies were produced 
for each strain to investigate whether the cladistic structure of the IL3000 VSG 
phylogeny was conserved throughout the species. For each strain, a phylogeny was 
estimated from a protein sequence alignment of recovered VSG-like sequences and 
IL3000 VSG sequences with the neighbour-joining (NJ) method and the WAG+ 
substitution model (Whelan and Goldman 2001) using MEGA7 (Kumar et al. 2016). 
Each phylogeny was manually investigated for the presence of novel phylotypes, 
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which would be reflected in particular clades or branches of strain VSGs, with no 
orthologue in IL3000.
All full-length VSG sequences from IL3000, IL3675 (The Gambia), and IL3900 
(Burkina Faso, Forest sub-type) were translated to amino acid and aligned with 
ClustalW (EBI, UK) (Larkin et al. 2007) to produce a VSG phylogeny representative 
of the T. congolense species. The alignment contained 1037 sequences in total, 778 
from IL3000, 214 from IL3675, 31 from IL3900, 12 from T. brucei ESAG2 and 2 from 
T. vivax b-type VSG as the outgroup. The representative VSG phylogeny was 
estimated from protein sequence alignments with the maximum likelihood (ML) 
method and the WAG+ substitution model (Whelan and Goldman 2001) using 
RAxML v.2 (Stamatakis 2014) and PHYML (Lefort et al. 2017) following amino acid 
model selection in PHYML (Lefort et al. 2017). Robustness was assessed with 100 
bootstrap replicates. Bayesian inference (BI) trees were estimated with gamma 
rates function in MrBayes v3.1.2. (Huelsenbeck & Ronquist 2001; Ronquist & 
Huelsenbeck 2003) and two Markov chain Monte Carlo chains run in parallel over 
5,000,000 generations, with a burnin of 2,500 and a fixed WAG+ model to ensure 
the program would reach stationary convergence. Posterior probabilities of each 
node were used to assess accuracy of BI trees. Neighbour-Joining (NJ) trees were 
estimated in Phylip (Felsenstein 1989) using the executables protdist and neighbour 
for a multiple dataset of 100 bootstrap replicates and a random seed of 99. 
To evaluate the robustness of each phylotype and whether the allocation of 
particular VSGs to each clade was significant, maximum likelihood ratios of each 
clade were calculated and compared with RAxML (Stamatakis 2014) in triplicate. 
For each strain and clade, a VSG was randomly chosen and forced to cluster in the 
adjacent clade and negative log-likelihood of unconstrained trees was compared to 
that of constrained trees.
To investigate the population structure and strain relationships of the dataset, A 
SNP phylogeny was estimated from SNP alignment with ML method under the 
JTT+ substitution model with RAxML v.2 (Stamatakis 2014). Robustness was 
assessed with 500 bootstrap replicates. For details on SNP calling process, see 
section 2.2.7.
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Phylotyping
The representative VSG protein sequence alignment was used to identify unique 
strings of 9-59 amino acids that could serve as diagnostic markers for each 
phylotype. Twenty-eight motifs were identified through consecutive VAP estimation 
simulations using a positive control of reference VSGs. This includes 593 
sequences from all 15 clades, which are captured by 28 amino acid motifs (Figure 
10). These motifs were included as query to each assembled contigs file of the field 
strains in HMMER under default parameters (Eddy 1998) and their relative 
frequency used to create the automated VAP. 
Figure 10 shows the consensus sequence of the motifs used and their distribution 
through the VSG primary structure. The number of motifs required to unequivocally 
capture VSGs of a certain phylotype is dependent on the genetic distance between 
phylotypes and sequence variation level within the phylotype. For example, 
phylotype 10 contains three groups of genetically distant sequences, which have to 
be targeted specifically. On the other hand, genetically homogenous phylotypes, 
such as phylotype 1, 5, 6, 7 and 12, only required a single motif. There is also the 
case of very large phylotypes, such as phylotype 15, which although homogenous 
and with a defined CTD sequence, required multiple motifs. In this situation, the size 
of the phylotype introduces a higher number of polymorphisms. The motifs, although 
very similar to each other, must be searched for individually so that all sequence 
variations can be identified and accounted for. 
To compare the stability of the composition of the VAPs to the background random 
variation, the total pool of VSGs recovered in the study was used to create 41 
randomised simulated VAPs based on 250 VSGs each. 
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Figure 10 Diagnostic motif consensus sequences of 15 T. congolense VSG phylotypes and their positioning in the primary amino acid structure (1 to 
450 amino acids). Phylotypes are colour-coded according to key. Amino acid sequences of the protein motifs are shown for each phylotype at the 
corresponding location on the VSG primary structure.
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2.2.7 Strain variation 
To produce an alignment comparing single nucleotide polymorphisms (SNPs) 
across the whole genome of the sample cohort, MiSeq reads were retrieved and 
mapped against the T. congolense IL3000 genome using BWA mem (Li 2013), 
converted to bam format, sorted and indexed with Samtools (Li et al. 2009). Sorted 
bam files were cleaned, duplicates marked and then indexed with Picard 
(http://broadinstitute.github.io/picard/). Single Nucleotide Polymorphisms (SNPs) 
were called and filtered with Genome Analysis Toolkit (GATK) suite according to the 
recommended protocol for multi-sample variant calling (Van der Auwera et al. 
2013). Reads were realigned and loci called with GATK (Van der Auwera et al. 
2013). SNPs were called for individual samples, but genotypes were called 
simultaneously for all samples. Finally, SNPs were extracted as a multi-sample file 
and filtered using default parameters using GATK (Van der Auwera et al. 2013). The 
multi-sample vcf file obtained from GATK was converted to fasta format using 
vcftools v0.1.14 (Danecek et al. 2011) and a maximum likelihood phylogeny was 
estimated with RAxML, using the JTT+ model of nucleotide substitution, following 
nucleotide model selection on MEGA7 (Kumar et al. 2016).
2.2.8 Statistical analysis
The statistical comparisons between the BLAST and the VAP performances in 
recovering VSGs were done using the Pearson’s correlation test in R (RStudio 
Team 2016). Outliers were identified using a threshold of 2x with the function 
‘removeOutlier’ in R (RStudio Team 2016). Outliers were manually inspected before 
removal as described in section 2.3.6. F-tests were performed to analyse variance 
between observed and simulated data. 
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2.3 Results
2.3.1 Antibody-based cell sorting efficacy
The CD45 antigen, formerly called leukocyte common antigen, is a protein tyrosine 
phosphatase, receptor type C, exclusively expressed by leukocytes. To maximise 
parasite DNA recovery from the blood stabilates, CD45+ cell depletion was 
performed (Figure 11 and Figure 12).
 
Figure 11 shows fluorescence-activated cell sorting of CD45+ cells before and after 
CD45+ cell depletion using magnetic anti-CD45 antibodies on an MACS column. 
The post-treatment graphs (right) show a clear reduction of the immunofluorescent 
CD45+ population, suggesting a successful depletion. Figure 12 shows the result of 
the CD45+ depletion on DNA recovery by PCR of host and parasite markers. Host 
DNA was amplified with mouse 18S RNA primers and parasite DNA with ITS1 
primers. The absence of a band in lane 2 shows that mouse DNA was successfully 
depleted. The presence of a band in lane 7 suggests that some parasite DNA is lost 
during the procedure, remaining in the mouse cell fraction. However, this loss has 
less impact in the sequencing results than a high ratio of host: parasite DNA would 
have. 
With the evidence that host cell depletion can be successfully achieved using 
magnetic antibody cell separation, CD15+ antibody was also added to increase 
depletion success. CD15+ is a cluster of differentiation antigen widely expressed in 
phagocytic leukocytes, particularly in neutrophils. The addition of this antibody 
results in a higher depletion chance, therefore contributing to better parasite fraction 
enrichment.
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Figure 11 Fluorescence-activated cell sorting of CD45+ cells. Whole mouse blood 
infected with Trypanosoma congolense was lysed with ammonium chloride and leukocytes 
were stained for CD45. Pre-treatment refers to original blood sample, post-treatment refers 
to eluate after CD45+ cell depletion using magnetic beads column. CD45+ population in 
marker M1 (bottom) is backgated onto forward scatter (FC)/ side scatter (SS) in blue (top). 
(Noyes, H., unpublished).
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Figure 12 Gel electrophoresis UV picture of PCR products from CD45+ cell depletion. 
Lane 1: Mouse 18S rRNA primer, before depletion. Lane 2: Mouse 18S rRNA primer, 
parasite fraction after depletion. Lane 3: Mouse 18S rRNA primer, Mouse cell fraction after 
depletion. Lane 4: Mouse 18S rRNA primer, negative control. Lane 5: T. congolense ITS1 
primer, before depletion. Lane 6: T. congolense ITS1 primer, parasite fraction after 
depletion. Lane 7: T. congolense ITS1 primer, Mouse cell fraction after depletion. Lane 8: T. 
congolense ITS1 primer, negative control. Marker: Bioline 100 bp ladder. (Noyes, H., 
unpublished).
2.3.2 De novo assembly
Sequencing of the clinical isolates resulted in an average of 3.02x106 paired reads 
per sample, ranging between 6.19 x105 and 1.33 x107.
To find the best de novo assembly software for the dataset, three programs (i.e. 
Velvet, SOAPdenovo2, Abyss) were tested against four strains under default 
conditions and kmer of 65 (Figure 13). Optimal assemblies produce long contigs, 
which is reflected on low total contig number, high N50 and high maximum contig 
length. Whilst occasionally the Abyss assembly had a higher n50 (IL438), Velvet 
1.2.10 (Zerbino & Birney 2008) provided the best balance of all parameters. Abyss 
(Simpson et al. 2009) assemblies resulted in higher contig number, whereas 
SOAPdenovo2 (Luo et al. 2012) performed poorly overall. 
After choosing Velvet, different kmers were tested in three strains to identify the 
optimal assembling conditions for the dataset. Kmers between 49 and 75 were 
tested in intervals of 5 until the maximum N50 could be established. A kmer of 65 
was found to yield the best assembly results and therefore was used for subsequent 
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assemblies (Figure 14). De novo assemblies of the clinical isolates had an average 
n50 of 803 with a range of 161 to 3257.
Figure 13 Comparison of performance de novo assemblers. Velvet, Abyss and 
SOAPdenovo2 were compared, using N50, contig number and maximum length of contigs as 
measured in three different T. congolense strains.
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Figure 14 Assembly quality comparison with different kmer values, using Velvet 1.2.10 
(Zerbino 2010). Three strains (IL410, IL374, and IL3688) have been used in the 
comparison. With the exception of the kmer, all assembly parameters were kept constant. 
2.3.3 Sampling test 
Obtaining the complete repertoire of VSGs from a field sample is unlikely due to the 
frequently low parasitaemia of natural infections. To understand whether profiling 
could be accurately done with partial repertoires, a sampling test was performed on 
the IL3000 VSG repertoire. Random selections of increasingly smaller VSG 
numbers were subject to manual profiling. Although the variant antigen profile may 
be affected by the quality of the sample, the relative proportions of each phylotype 
are maintained with as little as 20 % of the repertoire. Simulations of various profiles 
of the reference IL3000 with decreasing sampling numbers showed good 
correlations to the original (Table 5). This indicates that samples containing at least 
20 % of VSG repertoire can still be accurately profiled. 
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Table 5 Correlation analysis results (partial vs. full repertoire VAP). r = Pearson’s 
moment correlation.
2.3.4 Phylotype universality and phylogeny revision
For each strain, a VSG phylogeny was estimated to investigate if all reference 
phylotypes were represented and if novel phylotypes existed. All sequences from 
field strains placed at the terminal nodes of the phylogeny with the reference 
sequences and all phylogenies maintained the cladistic structure observed in 
IL3000. As a representative of the species VSG structure, a phylogeny combining 
VSGs of the reference (IL3000, Kenya), a West African strain (IL3674, The Gambia) 
and ‘forest’ sub-type strain (IL3900, Burkina Faso) was estimated to confirm that no 
strain-specific clades, absent from IL3000, were observed. These isolates were 
chosen because they incorporate the maximum amount of variation due to their high 
geographical and genetic distance. The topology of this consensus VSG phylogeny 
is similar to the reference phylogeny, showing that the phylotypes identified in 
IL3000 are present in every strain and that the internal relationship between 
phylotypes is conserved (Figure 15). No novel phylotypes were identified. 
Log-likelihood ratio tests were performed to confirm that all VSG sequences could 
be robustly placed within established phylotypes. For each VSG, the log-likelihood 
of an unconstrained tree was compared to another in which the VSG was 
constrained within the adjacent clade. Log-likelihood ratio tests were conducted for 
randomly sampled VSGs of IL3675 and IL3900, in triplicate for each clade. The 
negative log-likelihood of unconstrained trees was significantly higher than 
constrained trees in all cases (p<0.01), except for phylotype 2 of IL3900. This was 
significantly different from the adjacent phylotype 1, but not from the adjacent 
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phylotype 3. These tests confirm that the 15 VSG phylotypes seen in T. congolense 
IL3000 are robust. 
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Figure 15 Maximum likelihood phylogeny of T. congolense full-length VSG using 
IL3000 (Kenya), IL3674 (The Gambia), and IL3900 (forest sub-type). The phylogeny 
was estimated from protein sequences with RAxML (Stamatakis 2014) using a maximum 
likelihood method with a WAG+Γ model and 100 bootstrap replicates. The fifteen 
phylotypes identified in IL3000 are colour-coded according to key. Position of example 
sequences from IL3674 and IL3900 are indicated according to key. Internal nodes are 
labelled with bootstrap percentages for maximum likelihood (ML) from the complete tree 
(RAxML), and ML (PhyML) (Guindon et al. 2010), ML (MEGA7) (Kumar et al. 2016), 
neighbour joining (NJ) (Felsenstein 1989), and posterior probabilities (BI) (Huelsenbeck & 
Ronquist 2001) estimated from a pruned tree containing 147 sequences. Tree is rooted with 
two T. vivax VSG sequences (Fam23).
2.3.5 Positive Control 
Unique structural motifs were designed to distinguish between phylotypes and 
obtain a VAP from assembled contigs. An automated system for motif search was 
developed and the designed motifs were tested on a positive control set composed 
of 593 IL3000 VSG sequences from all phylotypes. The positive control shows a 
very high correlation with the full IL3000 repertoire (R2 = 0.97, Pearson’s product 
moment correlation, t(13) = 21.98, p<0.001). The motif search correlates well with 
the manually-curated profile obtained by both manual phylogenetic localisation and 
sequence similarity search (R2=0.98, Pearson’s product moment correlation, t(13) = 
379.77, p<0.001), showing that motif search can recover phylotype proportions that 
are known.
2.3.6 Sequence similarity vs. structural motif searches
Sequence similarity and structural motif-based profiles were produced for each 
strain. Correlation analyses were performed to compare the two outputs. The motif 
search recovered more VSGs than the sequence similarity search (mean ±  = 721 
± 277 vs. 669 ± 292, paired t-test, p = 0.005) and individual phylotype correlations 
were often poor. A closer analysis of the data revealed outliers in particular 
phylotypes, these were manually inspected and removed (from this stage of the 
analysis only) and correlations re-estimated (Table 6). 
60
Table 6 Correlation values for individual phylotypes before and after improvement 
(Pearson’s Moment Correlation) and description of the outliers removed.
The initial comparison between methods showed a very high correlation to the 
manually-curated IL3000 repertoire (R2 = 0.88, Pearson’s product moment 
correlation, t(13) = 9.7321, p < 0.001) (Figure 16, left), but a weak correlation to the 
full dataset. Several outliers were identified and closer analysis revealed one strain 
with recurrently poor results (i.e. IL2281 with 8 out of 15 datapoints being outliers), 
whereas the remaining outliers were sporadic and from different strains. Reasons 
for the sporadic mismatch between the sequence similarity sbearch and the motif 
search seem to be related to both sequencing data quality and filtering thresholds in 
the sequence similarity software. In instances where the sequence similarity 
software recovered more VSGs than the motif search, these were often due to an 
individual VSGs being divided between 2 contigs, resulting in the software counting 
every partial VSG as an individual entry, meaning that BLAST finds high identity in a 
contig containing the N terminus and then the same in the contig containing the 
CTD. In strains with poorer assembly, i.e. shorter contigs and fewer full sequence 
VSGs, this effect is accentuated. 
In instances where the motif search recovered more VSGs than the sequence 
similarity search (e.g. IL2281), the cause was often the opposite. Unusually long 
contigs with multiple VSGs result in the sequencing similarity search software 
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allocating those contigs based on the best matching VSG (ignoring the other). In 
contrast, the motif search allocates them according to the presence of the structural 
model for every appropriate phylotype. This way, a single contig containing multiple 
VSGs and therefore multiple diagnostic motifs will be placed multiple times, whereas 
BLAST will consider it a single entity and allocate only one single similarity hit. 
The removal of 40 outliers (6.5 %) resulted in an improvement of individual 
phylotype correlations (Table 6) and a good positive correlation in the full dataset 
(Figure 16, right) (R2=0.67, Pearson’s product moment correlation, t(566) = 34.39, 
p < 0.001), supporting the use of the motif search for profiling. Besides recovering 
the reference strain VSG repertoire, our motif-based method is more sensitive to 
VSG sequences than a BLAST-based annotation.
Figure 16 Performance of the protein motif-based VAP compared to the manual 
estimation of phylotype proportion in IL3000 and all the field isolates. Manual VAPs 
were estimated by counting the results from sequence similarity search [BLAST (Altschul et 
al. 1990)]. The adjusted R2 statistics showing the correlation of both methods is indicated in 
red. Phylotypes are colour-coded according to key.
The Variant Antigen Profiling pipeline has been compiled in a Perl script hosted in 
the Galaxy server (https://usegalaxy.org/) and available to download for local 
installation from GitHub (https://github.com/ssilva1/VAPPER). The pipeline 
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processes raw genomic sequencing data of a single isolate and produces a table of 
phylotype frequencies, heatmaps of phylotype abundances and variations, and a 
PCA plot putting the sample in the context of the available T. congolense genomic 
isolates. This currently includes our dataset and the isolates published by Tihon et 
al. (2017).
2.3.7 Antigenic diversity in T. congolense
The global scale of VSG gene diversity is commonly thought to be very large, similar 
to that observed for P. falciparum var genes due to the effect of immune selection. 
To examine this issue, we compared the VAPs in our T. congolense sample set and 
observed that the composition of the VAP is stable across T. congolense isolates 
(Figure 17, heatmap). Phylotypes 1, 11 and 15 are consistently the most 
numerous, whereas phylotypes 4, 8, and 9 consistently scarce (Figure 17, bar 
chart). To assess whether the stability observed was statistically significant, the 
observed frequencies were compared to 41 simulated VAPs, each estimated from 
250 VSGs, randomly selected from the pool of VSG retrieved for all samples 
combined. The simulated VAPs showed significantly more variation in relative 
phylotype proportions than strain genomes (F-test, p<0.001) (Figure 18), showing 
that the stability of the genomic VAPs is significant.
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Figure 17 The relationships between the VSG repertoire, geography and population 
structure in Trypanosoma congolense. On the left, the strain relationships are described by 
a ML phylogeny estimated from whole-genome SNP data, using RAxML (Stamatakis 2014) 
with a GTR+ model and 100 bootstrap replicates, which are shown as thick branches. The 
heatmap describes the phylotype proportion across the strain genomes. VAPs are organised 
according to the SNP phylogeny. On the right, a dendrogram illustrates the VAP 
relationships within the population. Strains are colour coded by location of collection 
according to key. Labels i to v are referred in the text. Average phylotype proportions 
(mean+) are shown at the top.
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Figure 18 Variation in phylotype proportions estimated from the real (left) and the 
randomized (right) data (N = 41 for each condition). Simulated VAPs were estimated 
from random selections of 250 VSGs from a pool of all VSGs recovered in this study. The 
observed VAPs show less variation than the randomized data (F-test, p-value<0.001).
To compare how the VAP correlates to the whole genome variation, SNPs were 
called and converted into a sequence alignment to produce a phylogeny of the all 
strains included in the dataset (Figure 17, left). The tree shows a clear separation 
between ‘savannah’ and forest sub-types (denoted by ‘i’). Within the ‘savannah’ sub-
type, there is a clear geographical signature only on the top part of the phylogeny 
(IL274 to IL3304, denoted by ‘ii’), where strains separate according to country of 
collection. The remaining isolates lack a geographical signature, particularly when 
looking at the short phylogenetic distance between IL3954 and IL1180 (denoted by 
‘iii’), from Nigeria and Tanzania, respectively. This suggests that these isolates 
represent at least two, but possibly more subpopulations of T. congolense 
‘savannah’, highlighting the complexity of the T. congolense population structure 
and the need for extensive sampling in order to accurately represent it. 
There is a tenuous association between the VAP and the population structure. 
When comparing VAPs of genetically close isolates, conserved patterns can be 
seen for some, but not all groups. For instance, among seven Kenyan samples 
(IL274 to ILC55, denoted by ‘iv’), there is very little variation in SNPs. Yet, ILC55 
has a very distinctive VAP, specifically due to the abundance of phylotypes 5-7 and 
the scarcity of phylotypes 1-3. ILC55 clusters with IL3932, IL588, IL2326 and 
IL2068, three of which are from a different population group and were isolated in 
different countries (i.e. Kenya, Uganda and Tanzania). Another example is ILC22 
from Tanzania, which is genetically close to the Kenyan strains IL3349 to IL3775 
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(denoted by ‘v’), but whose VSG repertoire is similar to the Kenyan strains depicted 
in ‘iv’, particularly due to lower abundance of phylotypes 7 and 12. 
Whilst labelling and sample handling errors are a possibility when working with 
historical isolates, these differences may indicate a genuinely weak association 
between the VAP and both geography and population structure, which might 
suggest that genetic variation segregating in the sub-telomeres is decoupled from 
core chromosomal loci. Importantly, this could suggest that other factors are 
involved in inheritance of the VSG repertoire and consequently in how antigenic 
diversity is generated in T. congolense. 
Although the relative proportions of VSG phylotypes appear to be a fixed feature of 
the T. congolense genome, they are not entirely invariant. After normalisation by the 
cohort mean, fluctuations in phylotype size can be detected and signature patterns 
start to emerge (Figure 19). For example, a subset of samples from Kenya, 
Uganda, Tanzania and Burkina Faso (IL3978 to IL3578, denoted by ‘i’) show a 
signature of under-represented phylotypes 1-3, whereas the Gambian samples 
show over-representation of phylotypes 5 and 6 (denoted by ‘ii’). Additionally, the 
‘forest’ sub-type isolates show a distinct over-representation of phylotype 15 
(denoted by ‘iii’). Furthermore, the degree of variation in phylotype abundance is 
positively correlated to gene number itself, as high-abundance phylotypes express 
the highest variation (phylotype 11 and 15) and low-abundance phylotypes are less 
variable (e.g. phylotype 8 and 9) (R2 = 0.74). This variation may reflect gene gain 
and loss within phylotypes on a population scale, which may have functional 
implications.
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Figure 19 Phylotype variation across the population. The heatmap describes phylotype 
variation across the population expressed as the deviation from the mean. The dendrogram 
describes the relationships among the VSG repertoires of each strain. Strains are colour 
coded by location of collection according to key. Labels i to v are referred to in the text.
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2.4 Discussion 
2.4.1 Antigenic diversity in T. congolense
Previous research on T. congolense VSGs has been restricted to the reference 
strain IL3000; therefore, this study is the first to put VSG diversity in a population 
context. I have sampled 41 isolates from 6 countries that were collected at different 
times. 39 out of 41 isolates were passaged into rodents, which may have led to 
some diversity selection in the sample set because some T. congolense isolates 
may not expand in mice. Due to the low parasitaemia of natural trypanosome 
infections, this is inevitable when dealing with field isolates, at least until targeted 
sequencing is further developed. Here, I show that the 15 T. congolense VSG 
phylotypes proposed for IL3000 (Jackson et al. 2012) are present in a diverse 
collection of strains from both ‘savannah’ and forest sub-types. The absence of 
novel gene lineages among strain genomes suggests that the original phylotypes 
are exhaustive and capable of accommodating all VSG diversity observed to date. I 
have shown that their genomic proportions can be quantified using protein structural 
motifs. Hence, I believe that the VAP allows the high-throughput analysis of VSG 
repertoires from any T. congolense genome sequence.
The fact that the T. congolense VSG repertoire is self-contained and restricted to 
these 15 defined groups is a major disparity in VSG evolution between T. brucei and 
T. congolense. Sequences from similar phylotypes, but belonging to different 
strains, are more closely related to each other than to other sequences from the 
same strain but different phylotypes. This is consistent with the view of Jackson et 
al. (2012) that T. congolense VSG repertoire is a combination of multiple ancestral 
b-type VSG lineages with distinct CTDs, as opposed to T. brucei, where a and b-
type VSG share a common CTD. Restricted recombination between phylotypes 
indicates opposite evolutionary pressures to maintain antigenic diversity, whilst 
conserving phylogenetic structure. This, together with differences in size and 
variance across the dataset, suggest these phylotypes may have distinct purposes, 
which empowers them as potentially diagnostic if related to pathology, virulence, or 
host use.
The VAP is important because understanding antigenic diversity is critical to 
appreciate disease distribution, virulence patterns, and immune evasion pathways, 
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as observed in many other organisms. For instance, in pathogenic Neisseria spp., 
the effector proteins of antigenic variation are linked to virulence (Helaine et al. 
2007). Like VSGs, pilins are antigenically variable, heavily glycosylated, surface 
glycoproteins that exist in both truncated soluble and membrane-bound forms. The 
number of expressed pilins and their variation degree is strain-dependent and their 
main function is cell adhesion (Virji 2009). However, minor forms are also involved 
in other roles, such as environment adaptation, e.g. low-iron response and foreign 
DNA uptake (Virji 2009). The latter is crucial for increasing the transformation 
frequency of bacteria and thus sustaining genetic diversity (Fussenegger et al. 
1997). Additionally, pilin complexes act directly on pilus fibres for movement 
retraction and the mechanical force generated may be involved in cell signalling and 
immune modulation by triggering the cortical plaque structure formation and the 
shedding of regulatory factor CD46, respectively (Winther-Larsen et al. 2005; Maier 
et al. 2002).
In the bacterial pathogen Anaplasma marginale, antigenic variation occurs due to 
variation of the Major Surface Protein genes (msp). There are five families of msp 
genes (msp1-5); they modulate infection, development of persistent infections, and 
transmission [reviewed by de la Fuente et al. (2005)]. Whilst msp1 is a single-copy 
gene involved in cell adhesion (De la Fuente et al. 2003), Chávez et al. (2012) have 
shown that msp2 expression pattern is dependent on the host cell type. Specifically, 
the number of A. marginale MSP2 variants was found to be different in various cell 
lines, experimental and natural infected tick cells and mammalian cells, and unique 
variants were found in each of the cell types. These data show that the composition 
of MSP2 variant populations changes according to host cell characteristics, and 
suggest MSP2 has a role in infection and survival ability in divergent hosts (Chávez 
et al. 2012). Recently, Anaplasma phagocytophilum was genotyped in natural 
endemic cycles by PCR amplification of 16S rRNA, groEL, msp2, and msp4 genes 
(Frölich 2017). A relationship with continent of isolation was investigated and found 
for the antigenically variable msp2 gene and groEL, but not for msp4 genes, which 
instead separate by host. The geographical signal of msp2 was also reported by 
Morissette et al. (2009) when analysing North-American strains of A. 
phagocytophilum. 
In Plasmodium falciparum, var genes are the major surface antigens of the blood 
stage of the parasite. They play a role in establishing chronic infection and in 
promoting transmission to the mosquito, and they are thought to be functionally 
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differentiated (Chen et al. 2011). More importantly, var genes encode the 
Plasmodium falciparum erythrocyte membrane protein-1 (PfEMP1), an important 
player in virulence through the mediation of adhesion to host endothelial receptors 
and evasion of splenic clearance (Lavstsen et al. 2003). Analysis of the genetic 
diversity of var genes in clinical isolates of variable disease severity has uncovered 
a relationship between var gene subsets with different roles in host-parasite 
interactions (C. W. Wang et al. 2012). Expressed var gene repertoires of severe 
malaria isolates were compared to asymptomatic controls and isolates from severe 
malaria patients were found to preferentially transcribe group A var genes, a result 
that appears to be reproducible in Brazil, Kenya and Mali (Kirchgatter & Del Portillo 
2002; Bull et al. 2005; Kyriacou et al. 2006). Wang et al. (2012) also found multiple 
unique var sequences in the severe malaria isolates only, which could potentially be 
associated with disease severity. 
Var genes have also been linked to geography. Whilst Wang et al. (2012) found little 
overlap between var repertoires from Tanzania, Albrecht et al. (2010) found that the 
Plasmodium isolates circulating in Western Amazon had a limited var gene 
repertoire. In the largest epidemiological study of var genes to date, small scale 
spatial diversity was found, represented by repertoire conservation within each 
country, but little overlap between the repertoires of African isolates and even less 
between those from South America, Africa and Asia (Chen et al. 2011). The degree 
of diversity uncovered in local African populations was also found to be much 
greater than the previously reported diversity in Brazil or Papua New Guinea, which 
is consistent with wide genome diversity and microsatellite analysis (Anderson et al. 
2000; Mu et al. 2005). 
All these examples show that variant antigens are important players in disease 
progression and phenotype, disease distribution, transmissibility and virulence, but 
that they can also have functions other than antigenic variation. On that basis, such 
roles can also be predicted for VSGs. 
In kinetoplastid research, the potential usefulness of studying VSG patterns to 
differentiate between strains and understand disease distribution have long been 
recognised (Meirvenne et al. 1977). In 2007, Hutchinson et al. reported for the first 
time that VSG repertoires evolved to become strain-specific. In a comparison 
between the T. brucei gambiense strain TbgDal isolated in Ivory Coast, the Kenyan 
T. brucei brucei strain Tb927, and strains collected from eight field isolates of the T. 
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b. rhodesiense-endemic district Tororo, in Uganda, it was found that the Ugandan 
strains had VSG homologues (greater than 40 % identity) of similar genetic 
distances in both East and West African T. brucei genomes, suggesting they all 
share a common ancestor. However, sequence divergence between homologues 
was found to be non-random with respect to protein structure. Also, sequence 
change was concentrated in antigenic regions, i.e. amenable to immunoglobulin 
recognition (those both solvent accessible and at the distal end of the VSG), 
suggesting an independent pressure for the creation of antigenically novel VSGs 
within each strain. In T. brucei, pathogenicity is partly strain-specific (Morrison et al. 
2010), being strongly influenced by host: parasite interactions and requiring distinct 
host mechanisms. Specifically, Morrison et al. (2010) showed that infection with 
different strains results in different patterns of innate immunity, suggesting that 
innate immune response modulation is a major element in trypanosomiasis and 
greatly dependent on the parasite genetic background. Together these findings 
emphasise the importance of an integrated host-parasite approach that incorporates 
parasite diversity into future studies of pathogenesis. 
Besides diagnostic potential, the results of this chapter provide some evidence of 
functional differentiation among the T. congolense VSG repertoire. Functional 
differentiation among T. brucei VSGs is well documented. For example, the TFRs 
(present in T. congolense also) have evolved from VSGs expressed at the parasite 
surface to become essential iron-binding proteins expressed at the flagellar pocket. 
TFRs have diverged since speciation, having expanded considerably in T. 
congolense and becoming VSG expression site associated proteins in T. brucei 
(Jackson et al. 2013). 
The origins of human infectivity in some T. brucei strains provides examples of 
VSG-like genes evolving to non-variant functions by independent mechanisms (De 
Greef & Hamers 1994; Berberof et al. 2001; Van Xong et al. 1998; Uzureau et al. 
2013; Capewell et al. 2013). In T. brucei rhodesiense, human infectivity is conferred 
by the expression of the SRA gene from the active VSG expression site. The SRA is 
a VSG-like gene positioned either in long tandem arrays with VSG genes or at a 
specific expression site. It contains 6 of the 8-conserved cysteine residues 
characteristic of T. brucei a-VSG, but has lost the surface-exposed antigenic loops 
(Blum et al. 1993; De Greef & Hamers 1994; Campillo & Carrington 2003; 
Vanhamme et al. 2004). When T. brucei rhodesiense comes into contact with 
human serum, which is rich in trypanolytic factors (TLF-1 and 2) associated with 
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expression of the apolipoprotein L1 (APOL-1) protein, the expression site containing 
SRA becomes active (Van Xong et al. 1998). The SRA protein is targeted to the 
endolysosomal compartment where it directly binds and inactivates APOL-1 
(Vanhamme et al. 2003).
In T. brucei gambiense, human infectivity has evolved independently, but also from 
a truncated VSG-like sequence (Capewell et al. 2013; Uzureau et al. 2013). TgsGP 
is a VSG-like sequence lacking the VSG CTD and located in the sub-telomeric 
region of chromosome 2 (Capewell et al. 2013; Uzureau et al. 2013). Unlike SRA, 
TgsGP does not directly interact with APOL-1. In contrast, TgsGP induces 
membrane stiffening and haptoglobin-hemoglobin (Hp–Hb) receptor inactivation. 
This prevents TLF-1 to enter the parasite, resulting in in acceleration of APOL1 
degradation (Uzureau et al. 2013) These examples in T. brucei provide basis for the 
prediction that in T. congolense particular VSGs or VSG phylotypes may also have 
evolved novel roles within the complexities of host-parasite interactions. 
Following these examples in T. brucei, the segregation of T. congolense VSGs into 
15 conserved clades seems consistent with functional divergence within the 
repertoire of this species. This is reinforced by the lack of recombination between 
phylotypes (Jackson et al. 2012) and the evidence for them being under purifying 
selection comparable to the genomic background. The average value for  (dn/ds) 
among orthologous VSGs in different strains is 0.27 (N = 1034). With the exception 
of phylotypes 8-10, which show a more neutral substitution rate (0.73; N = 123), this 
is not significantly different from the average  for single-copy orthologues across 
the genome (0.19; N = 694; p >0.05). This indicates that VSG primary structure 
does not evolve especially fast, but rather is strongly conserved, and further 
suggests that recombination provides the sole means of VSG diversification in T. 
congolense. 
As the VAP appears to be a fixed feature of T. congolense ‘savannah’ (and is not 
substantially altered in ‘forest’ sub-type either), it is possible that these phylotypes 
have different functions. Under the hypothesis that phylotypes are functionally 
redundant, existing to increase VSG structural diversity, I would expect a trace of 
neutral or positive evolution. In both cases, phylotype sizes in the genome would 
vary randomly across the sample set due to gene gains and losses that were 
selectively neutral. Such process would result in low-abundance phylotypes (e.g. 8) 
being sporadically absent. Instead, the results show that the proportions of each 
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phylotype vary little across the sample cohort and that variation is lower in low-
abundance phylotypes. This signature, consistent with negative selection, strongly 
suggests that VSG phylotypes are maintained in specific proportions because they 
fulfil distinct roles. 
2.4.2 Strain relationships with space and time
When investigating the patterns of phylotype variation, East and West African 
samples do not separate clearly. When these findings are put into the context of 
whole genome variation, it becomes clear that even at the genomic level East and 
West African samples of the ‘savannah’ sub-type are not two mutually exclusive 
populations of T. congolense. This contrasts with the epidemiology of human-
infective T. brucei, which fall into geographically-defined populations: the western T. 
brucei gambiense and the eastern T. brucei rhodesiense (Gibson 2001). Instead, T. 
congolense forms two clades comprising strains from various locations. In only one 
clade (denoted by “ii” in Figure 17) samples cluster geographically. Clearly, there 
is a danger that this may reflect inadequate and non-systematic sampling. However, 
the addition of data from another population genetic study of 52 T. congolense 
strains by Tihon et al. (2017), confirms that variation in VSG profile is not coupled to 
population history, and only partially explained by geography (Figure 20). 
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Figure 20 The relationships between the VSG repertoire, geography and population 
structure in Trypanosoma congolense including the isolates published by Tihon et al. 
(2017). On the left, the strain relationships are illustrated by the whole genome single 
nucleotide polymorphisms maximum likelihood phylogeny. The phylogeny was estimated 
with RAxML (Stamatakis 2014) with a GTR+ model and 100 bootstrap replicates, which 
are shown as branch labels. The heatmap illustrates the phylotype variation across the cohort 
expressed as deviation from the mean. VAPs are organised according to the cluster analysis 
shown in the dendrogram on the right. Strains are colour coded by location of collection 
according to key.
The uncoupling of VSG repertoire and population history suggest at least three 
different interpretations: first, that T. congolense ‘savannah’ has genetically distinct 
populations that precede the species spreading across Africa, resulting in multiple 
populations circulating in the same region; second, that it derives from cattle 
movement across Africa, triggering parasite migration and diversification; third, that 
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it results from mating, as the hemizygous subtelomeres telomeres would be 
inherited in a non-Mendelian fashion during meiosis. The latter is supported by 
evidence for sexual reproduction in T. congolense (Morrison, Tweedie, et al. 2009; 
Tihon et al. 2017). In Gambian T. congolense ‘savannah’, a high level of diversity 
with a large number of distinct genotypes and a population division in four sub-
populations was reported (Morrison, Tweedie, et al. 2009). Tihon et al. (2017) 
provided robust confirmation of genetic recombination amongst T. congolense 
populations by showing evidence of diploid hybrid parasites circulating in natural 
populations in Zambia. 
Indeed, the literature confirms that T. congolense has a complex population 
structure. For example, microsatellite loci from Cameroonian T. congolense ‘forest’ 
sub-type vary greatly in size and are not strictly structured (Simo et al. 2013; Simo, 
P. S. Fogue, Melachio, et al. 2014). Population sub-structuring in T. congolense is 
consistent with the observations in other parasites, specifically the small scale 
geographic structuring in African P. falciparum (Chen et al. 2011) and T. brucei 
(Maclean et al. 2007; Echodu et al. 2015). 
Nonetheless, the T. congolense population structure may be affected by various 
factors, including host species and geography. In fact, host selection certainly 
affects the population structure of T. brucei (MacLeod et al. 2000). Simo et al. 
(2014) reported that the T. brucei population circulating in tsetse flies and domestic 
mammals of the Fontem district of Cameroon was subdivided according to host 
species. Smetko et al. (2015) further noted that AAT is a potential driver of selection 
in West African cattle as a result of multiple crosses between trypanotolerant and 
susceptible breeds. 
In terms of geography, different pathologies have been linked to distinct T. brucei 
rhodesiense strains circulating in the same district in Uganda (Maclean et al. 2007), 
one causing more severe symptoms associated with late-stage disease. 
Furthermore, the Ugandan and Southern-Kenyan populations of T. brucei have 
been shown to group into distinct genetic clusters according to location of collection, 
but retained strong evidence for recent gene flow between them (Echodu et al. 
2015). Unlike in Cameroon (Simo et al. 2014), collected isolates did not cluster by 
host species, date of collection, or parasite subspecies. 
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As there is ample evidence showing that the population structure of T. brucei is 
dependent on a multiplicity of factors, the same may apply to T. congolense and be 
reflected on the VSG repertoire. In this dataset, whilst there are examples of strains 
with shared geography, host, and collection time that are genetically close and show 
similar VAPs (e.g. samples from Kabete isolated in 1976), there are also strains 
from the same region that do not (e.g. samples IL3954 and IL2281, which were 
collected from the same region and species on different years, but have closely 
related VAPs, even though they are not genetically close). These results show that 
the population genetics structure of T. congolense is complex and thus requires 
extensive, systematic sampling to be well understood. Yet, they suggest that the 
VSG repertoire is under independent evolutionary pressures and might evolve at a 
different rate to the entire genome, perhaps through recombination of closely related 
VSGs. This brings exciting research opportunities regarding the basis of 
recombination constraints in T. congolense compared to T. brucei and how VSG 
sequences are evolving at a genomic scale, including the importance of arbitrary 
mutagenic events and intra-phylotype homologous recombination in T. congolense. 
2.4.3 The VAP methodology 
The ability to profile antigenic diverse genes is an objective for researchers of all 
organisms expressing antigenic variation. The complexity, conservation and size of 
the gene repertoire are important aspects to note when developing a tool to quantify 
antigenic diversity. 
In P. falciparum, profiling of var genes was achieved through a population genomic 
framework (Barry et al. 2007). Unlike the VAP, the var gene population genomic 
framework does not assess variation throughout the full gene, but rather uses only 
the ubiquitous 500- bp fragment marker, the Duffy binding like alpha (DBL) 
domain, to sample the diversity in natural P. falciparum populations. This method 
lacks the ability to explain the global range of var gene diversity since it would 
require too intense sampling, but the issue of partial repertoire sampling is 
overcome by computing a cumulative diversity curve and thus estimating the 
number of isolates required for an accurate representation of diversity. Although this 
approach fails to include all the global diversity of var genes, due to the high degree 
of variation in the population, it has been helpful in linking var gene diversity to 
geography and uncovering small scale spatial diversity, represented by country-
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specific repertoires, with little overlap among them (Chen et al. 2011). By contrast, 
the VAP can not only handle the global diversity of T. congolense, but has also 
shown that the T. congolense population VSG repertoire is stable and not strongly 
geographically-defined, in this sample set at least.
For profiling, I have used protein motifs to differentiate between phylotypes, but the 
use of protein groups to classify variant repertoires is not unprecedented. 
Immunoproteogenomics is an area of growing interest as it combines NGS and 
mass spectrometry (MS) to predict antibodies interacting with specific antigens. 
Accurate MS searches require accurate databases, but predicting antibody 
databases from NGS is not easy due to both antibody sequence diversification by 
recombination and mutations and NGS read error rate. The IgRepertoireConstructor 
corrects errors in immunosequencing reads to construct an immunoglobulin 
repertoire validated by MS. In the study, rather than single antibodies, antibody 
clones (or groups) are quantified so that better correlations between genomics- 
based and proteomics-based quantifications can be achieved. This tool has solved 
the problem of analysing the highly variable and repetitive antibody subfamilies and 
has moved the field towards studies of evolution of antibody repertoires (Safonova 
et al. 2015). Likewise, the VAP has solved the issues of handling the large numbers 
of VSGs by conventional population genomics methods, by presenting a faster, 
more sensitive and precise alternative. I anticipate the VAP to be useful in the 
association between disease phenotypes and host range with particular VSGs; 
tracking and characterising VSG expression in natural longitudinal and experimental 
infections; and in any antigen variation-associated study, such as non-variant VSG-
associated genes knockouts. 
Being able to profile antigens in a fast and high-throughput manner from NGS data 
with little need for bioinformatic processing is a key requirement of the VAP. I have 
shown that the VAP is effective by comparing its performance to manual, BLAST-
based curation. For benchmarking, VAPs were obtained manually by sequence 
similarity search and compared to the motif-based VAP results. Interestingly, higher 
total numbers of VSGs were recovered using the latter than by the former, due to 
the high length thresholds applied to the sequence similarity search (i.e. 150 amino 
acids). These constraints were essential to account for sequence duplication and 
partial sequences. The automated process, however, did not require such 
considerations because it relies on fully probabilistic profile hidden Markov models 
(HMM), which are specific non-ambiguous structural models for homology searches 
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(Eddy 2004). The software used, HMMER3 (Finn et al. 2011), has the ability to 
accept multiple domains and sequence fragments, and allows insertions and 
deletions anywhere in the sequence. In contrast, BLAST can be deceived in the 
analysis of proteins with multiple distinct domains and high sequence variability 
(Eddy 1998). Homology searching through BLAST is the most widely used tool for 
sequence characterisation (Pearson 2013). However, for variable gene families its 
limitations increase considerably. This analysis revealed issues with the sequence 
similarity search method and showed that the VAP is faster, more sensitive and 
precise, and avoids many bioinformatic processing intersteps. The VAP method is 
better at first, distinguishing between partial sequences belonging to the same gene, 
and second, grouping together sequences belonging to phylotypes containing 
distantly-related sequences, but sharing a CTD (i.e. phylotypes 4, 8, 9). 
Currently, the VAP deals with assembled contigs, but, ideally, it would be applied 
directly to raw DNA sequencing reads. However, motif discovery in raw reads would 
be influenced by sequencing coverage at that particular region. Although overall 
sequencing coverage can be easily calculated and accounted for in the VAP 
algorithm, this would assume equal sequencing depth across the genome, which 
cannot be verified, especially in repetitive regions such as the subtelomeres and 
telomeres where VSGs are mainly harboured. This would result in regions with 
higher sequencing coverage being preferred in the profile. Performing a de novo 
assembly provides unique contigs that can be searched for the motifs and 
accurately quantified. This computerised process avoids the need for mapping and 
phylogenetic analysis of individual samples. Nonetheless, as research evolves, the 
VAP methodology can be improved to incorporate contigs from long-read 
sequencing; through the segmentation of the current phylotypes into smaller, more 
specific ones, improving the sensitivity of the VAP; and through the attribution of 
functional and/or epidemiological meaning to each phylotype. In the future, I 
envisage particular VSG signatures, or VAPs, to be associated with specific disease 
phenotypes, disease outcomes and host use. As these relationships are unravelled, 
the VAP becomes more and more relevant in the undertanding of host-parasite 
interactions. 
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2.4.4 Conclusion
This chapter showed that the T. congolense VSG repertoire could be dissected into 
15 phylotypes, which accommodate the species variation observed to date. Given 
the ancestry of the phylotypes and the strong purifying selection on them, I believe 
they will accommodate any future T. congolense strain also. These phylotypes were 
used to develop variant antigen profiling, a bioinformatic approach to quantify 
antigenic diversity in T. congolense from high-throughput DNA sequencing data. 
VSGs have long been described as intimately linked to virulence and pathology, but 
they are highly dynamic and refractory to large-scale analysis. This study has 
revealed the extent of global antigenic diversity in T. congolense and provided the 
first approach to its high-throughput analysis in any population or experimental 
setting. Comparison of VAPs across T. congolense isolates showed that, although 
phylotype proportions are broadly conserved, there is individual variation in the 
repertoire, such that the VSG profile might become an epidemiological marker. Yet, 
three questions arise from the work presented in this chapter: first, whether the VAP 
can be applied to functional studies of VSG expression; second, whether all 15 
phylotypes indeed encode functional VSGs; and third whether the VAP can be 
applied to other African trypanosome species. These points will be discussed over 
the next three chapters.
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Chapter 3. The metacyclic VSG repertoire of 
Trypanosoma congolense ‘savannah’ Tc1/148
3.1 Introduction
After ingestion of an infected blood meal by the tsetse fly, T. congolense 
differentiates into procyclic form, colonising the midgut and rapidly proliferating. 
During BSF-PCF differentiation, the parasite coat is completely modified with the 
replacement of VSG with procyclin. After a successful midgut infection, T. 
congolense parasites migrate anteriorly towards the mouthparts, crossing the 
proventriculus valve, in a journey that can take 13-53 days, depending on parasite 
strain (Dale, 1995) and fly permissiveness (Haines, 2013). T. congolense infections 
have higher transmission rates than T. brucei (93 % vs. 25 %) (Peacock, 2012) due 
to morphological and physiological constraints: only short PCF can cross the 
proventriculus to the salivary glands and there is higher attrition in crossing the 
hypopharynx towards the salivary glands than to settle in the proboscis (Peacock, 
2012).
In the mouthparts, PCFs differentiate into epimastigotes, following cell division, re-
positioning of the kinetoplastid and attachment to the epithelial layer (Peacock, 
2012). Differentiation into epimastigotes is also different between T. brucei and T. 
congolense. In T. brucei, cell division is asymmetrical, producing one short (13 ± 1 
m) and one long epimastigote (42 ± 2 m) of moderately constant lengths (Van 
Den Abbeele et al. 1999). In T. congolense, asymmetrical division is not clear and 
the length variability of the daughter cells is high, which occasionally gives rise to 
extremely long epimastigotes (Peacock et al. 2012). Eventually, epimastigotes 
differentiate into infective metacyclics, detaching from the mouthparts and becoming 
small and very motile. Although the details of the epimastigote-metacyclic 
differentiation are not clear, parasites become considerably smaller (from 30 to 
13m), arrest most gene transcription and start expressing VSG known as mVSG. 
T. congolense metacyclics primarily colonise the hypopharynx and sometimes the 
labrum (Gibson et al. 2017), so that they can be injected with the saliva into the 
mammal host during the fly bloodmeal. Although mVSG expression is essential for 
survival in the mammal host in the early stages of infection (Barry & McCulloch 
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2001), not much is known about either the surface coat composition of the 
metacyclics or the mechanisms of mVSG expression.
In 1978, Le Ray et al. showed that T. brucei metacyclic populations expressed 
multiple VSGs, lasting for up to 5 days after infection in the mammal host. These 
findings were corroborated by further studies with monoclonal antibodies by Hajduk 
et al. (1981). Shortly after, Esser et al. (1982) showed that metacyclic parasite 
populations from different flies expressed a shared set of antigen types even though 
they were infected with BSF expressing distinct antigens. Together, these data 
suggested that whilst T. brucei metacyclic populations expressed multiple VSGs, 
these were specific and potentially limited. This raised new questions, such as 
whether these restricted repertoires were conserved across time, strains, and 
cyclical transmissions. The analysis of the metacyclic antigens of parasites from a 
20-year period in East Africa showed that T. brucei populations change their mVSG 
repertoire progressively over time, although the lost variants can still be expressed 
as bloodstream antigens in the early stages of infection (Barry et al. 1983). The 
finding that mVSG expression in T. brucei, unlike in the bloodstream, was 
programmed was corroborated by a study showing that a restricted set of up to 27 
antigen types was repeatedly expressed regardless of the antigenic type expressed 
by the parasites ingested by the fly (Turner et al. 1988). These observations opened 
up new lines of research, for example, to understand how T. brucei could repeatedly 
select such a small set of VSGs in its infective stage; or how they could avoid the 
emergence of gradual immunity from the mammal host. 
An attempt to answer the first question raised the hypothesis that mVSGs were 
expressed from a single expression site, which was supported by (1) the absence of 
gene rearrangement during mVSG expression, (2) very few sequence 
rearrangements around the MES that could move the mVSG to alternative 
expression sites, (3) the very short (and sometimes absent) 70 bp repeats upstream 
of mVSG, which are known to facilitate VSG conversion, and (4) mVSGs and 
bloodstream VSGs being independently controlled (Lenardo et al. 1986). Tetley et 
al. (1987) further showed that the heterogeneous mVSG population is present ab 
initio as activation occurs randomly after trypanosome division. Additionally, this 
confirmed that different mVSGs are expressed simultaneously in the population, 
which contrasts to the sequential activation in the bloodstream stage. 
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Another striking difference is the activation mode. Whilst bloodstream VSG are 
switched mostly by gene duplication events, mVSGs are activated in situ (Graham 
et al. 1990). Unlike the BES, the MES has few or no 70 bp repeats and has low 
homology with other telomeres (Graham et al. 1990). The 70 bp repeats are the 
anchor points for VSG transposition between the subtelomeres and the expression 
site, contributing to VSG switching. Similarly, lower sequence homology between 
the metacyclic and the bloodstream expression sites contributes to a lower 
frequency of homologous recombination and non-specific telomeric exchange, 
which increases stability in the MES and promotes the conservation of a common 
mVSG repertoire (Graham et al. 1990). The MES is also exclusively transcriptionally 
and developmentally regulated, being transcribed as a short monocistronic unit of 
13 to 15 kb (Graham & Barry 1995). So far, the mVSG is the only gene transcribed 
monocistronically in African trypanosomes (Graham & Barry 1995). Whilst the BES 
is rich in ESAGs, the MES is not, being composed of a 426 bp promoter, a 3 kb gap 
containing the transcription initiation site, a pyrimidine-rich region and a short 70 bp 
repeat that may play a role in duplicating the mVSG to the BES (Graham & Barry 
1995). The promoter itself is more complex than that of the BES, but contains an 
essential element that, on its own, can act as a BES promoter (Graham et al. 1998). 
Furthermore, it is recognised by the same class I transcription factor A (CITFA) 
required for BES transcription (Kolev et al. 2017). Its consensus sequence has been 
described both in vivo and in vitro by Ginger et al. (2002).
In T. congolense, the mVSG repertoire in a parasite population is also thought to be 
composed of multiple VSGs and limited to 12 antigen types (Crowe et al. 1983). 
Using mouse monoclonal antibodies raised against metacyclic parasites from the 
West African strain TREU1290, metacyclic parasite populations were labelled by 
indirect immunofluorescence, which showed that 12 antibodies were sufficient to 
label the entire population. Furthermore, the antigen types repertoire remained 
constant in composition in vitro for 6 weeks, although the relative frequencies of 
individual antigen types were variable (Crowe et al. 1983). Similarly to what was 
shown for T. brucei, the metacyclic antigen types were the first to appear as 
bloodstream antigens in T. congolense, but they seemed to be more stable, 
remaining exclusive in the bloodstream for nine days (Crowe et al. 1983; Luckins et 
al. 1994). Yet, the repertoire might be variable between isolates as none of the 
antibodies used to label the metacyclic populations of TREU1290 worked on East 
African strains (Crowe et al. 1983). 
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Based on antibody labelling, these studies lack the ability to distinguish genes 
belonging to the same antigen type, so it is possible that the 12 different VATs 
include multiple genes. In 1992, Eshita et al. cloned and sequenced 2 mVSGs, 
showing that they were 428 and 447 amino acids in length and homologous to 
bloodstream VSGs. The analysis of their genomic context revealed they were in a 
conserved region of at least 27 kb associated with the telomeres. Furthermore, the 
first was shown to be activated without gene rearrangement, whilst the second 
showed evidence for genomic alteration between metacyclic and bloodstream 
conversion in at least one copy (Eshita et al. 1992). These results suggest that the 
composition of the T. congolense mVSG repertoire and the mechanisms of T. 
congolense mVSG expression and activation remain largely unknown and may 
differ from what has been established in T. brucei. Substantial differences in life 
cycles in the tsetse fly, the VSG genomic repertoire and its evolution further 
corroborate the potential differences in regulation and/or expression of mVSGs.
As introduced in Chapter 2, the T. congolense genomic VSG repertoire is divided 
into 15 phylotypes whose relative proportions vary in the population. The VAP can 
rapidly quantify these proportions in the genome and put any given repertoire in 
context of the strains sampled to date. This approach can be of great use for 
population genomic studies, but can potentially be modified for the analysis of 
transcriptomic data. By incorporating transcript abundance values, transcriptomic 
VAPs can be a measure of VSG expression and thus become useful for various 
functional experiments. This chapter aims to characterise the expressed mVSG 
repertoire of a fly transmissible strain of T. congolense (Tc1/148) by applying the 
variant antigen-profiling tool. This approach will provide a realistic example of how 
the VAP can be useful in functional experiments of VSG expression and target a 
long-standing question on the characteristics of the mVSG repertoire in T. 
congolense.
The specific aims are:
1. To extend the VAP to the analysis of transcriptomic data to allow the 
quantification and characterisation of VSG expression.
2. To produce transcriptomic and proteomic VAPs for metacyclic populations of 
Tc1/148 obtained from experimental fly infections to characterise the mVSG 
repertoire of metacyclic T. congolense parasites.
3. To investigate the variability of the mVSG repertoire of parasites from vector 
biological replicates and compare it what is established for T. brucei. 
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3.2 Methods 
3.2.1 T. congolense Tc1/148 strain
T. congolense ‘savannah’ Tc1/148 (MBOI/NG/60/1-148) (Young & Godfrey 1983) 
mouse blood stabilates were obtained from the Department of Vector Biology and 
Department of Parasitology of the Liverpool School of Tropical Medicine, UK. This 
Whole Genome Shotgun project has been deposited at DDBJ/ENA/GenBank under 
the accession NHOR01000000.
3.2.2 Tsetse fly infection and rearing
Pooled flies:
Experimental teneral male tsetse flies (G. morsitans morsitans) were infected 12-48 
hour post-eclosion with 5x105 procyclic forms per ml-1 in sterile defibrinated horse 
blood supplemented with 10 mM glutathione, via a silicone membrane by pouring 
4mls of blood onto three distinct spots on a feeding tray covered with a feeding 
membrane (Moloo 1971). Flies were allowed to feed for 11 min at 27 °C and in the 
dark. One day after infection, unfed flies were sorted and removed. Remaining flies 
were maintained at 26 °C (+/- 1 °C) and 65-75 % relative humidity and fed every 2 
to 3 days with normal sterile defibrinated horse blood. Flies were killed by 
decapitation at day 28 post-infection.
Individual flies:
A frozen stabilate of 1ml of infected mouse blood (20 % glycerol and parasitaemia of 
103 parasites/ml) was thawed and mixed with defibrinated horse blood at a 1:10 
ratio. The sample was used to infect 100-180 teneral male tsetse flies (G. m. 
morsitans) 12-48h post-eclosion following the procedure described in the previous 
section. Flies were allowed to feed for 11 min at 27 °C and in the dark. One day 
after infection, unfed flies were sorted and removed. Remaining flies were fed every 
2-3 days with sterile defibrinated horse blood. Flies were killed by decapitation at 
day 28 post-infection. This procedure was repeated twice for the metacyclic 
enrichment (see section 3.2.4).
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3.2.3 Fly dissection
Pooled and individual flies for direct RNA extraction
In the first two experiments, RNA was extracted directly from the dissected 
mouthparts. Flies were dissected 28 days after infection and 3 days of starvation. 
Midguts were dissected in a drop of PBS and viewed under the light microscope 
(LM) (100x magnification). Mouthparts from flies with midgut infections were 
dissected into a separate drop of PBS and visualised under the light microscope 
(10X magnification). Dissections were performed according to an adaptation of the 
description of Peel (1962). Flies were chilled to 4 ºC to arrest their movement and 
kept on ice until dissection. Using very sharp, anti-magnetic, straight forceps 
(Sigma-Aldrich, UK), flies were decapitated and the proboscis detached by holding it 
strongly and pulling between the head and its base. The proboscis was placed in a 
drop of PBS, opened to separate the labrum, the hypopharynx and the labium, and 
visualised under the light microscope (10X magnification) When metacyclic 
parasites were visible, the hypopharynx and the parasite suspension that was 
released during dissection were collected and frozen in liquid nitrogen. 
Pooled flies for metacyclic enrichment 
In the third experiment, RNA and protein was extracted from metacyclic-enriched 
parasite populations collected from tsetse mouthparts. Flies were dissected 29 days 
after infection and 3 days starvation. Mouthparts were dissected into a drop of PBS 
(method 1, see section 3.2.3) or glucose separation buffer (44 mM NaCl, 57 mM 
Na2HPO4, 3 mM KH2PO4, 55 mM glucose, pH 8.0 at 20 ºC) (method 2, see section 
3.2.3) and visualised under the light microscope (10X magnification). Dissections 
were performed according to the description of Peel (1962) and as described in the 
previous section. When metacyclic parasites were visible, the hypopharynx was 
broken down to release the parasites and the parasite suspension collected by 
aspiration and kept on ice until the metacyclic enrichment procedure. 
3.2.4 Metacyclic enrichment from fly mouthparts
Metacyclic parasites were separated by two methods: the first using poly-L Lysine 
microscope slides to which epimastigote parasites should preferentially adhere to, 
and the second using anion exchange chromatography in an adaptation of the 
previously described DE52 cellulose separation method (Lanham & Godfrey 1970).
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Method 1 - Poly-L lysine adhesion
Parasite suspensions in PBS were separated into nine 1.5 ml tubes (Eppendorf, 
UK), and kept on ice. The parasite suspensions were spread onto a poly-lysine 
microscope slide (Sigma-Aldrich, UK) and kept on a humidity chamber to allow for 
epimastigote adhesion. After an incubation of 10 min, the solution left on the slide 
was carefully recovered with a pipette. The resulting parasite solutions from the 9 
poly-L lysine slides were pooled into a 1.5 ml tube and frozen in liquid nitrogen. The 
epimastigote-metacyclic ratio before and after enrichment was calculated manually 
by cell counting on a haemocytometer. 
Method 2 - DE52 cellulose column separation
Pre-swollen DE52 cellulose granules were activated previous to use through the 
following steps: cellulose was mixed with 4 volumes of 0.5 M HCl in a beaker and 
allowed to stand for 30 min with brief stirring every 10 min. After the last settle, most 
of the supernatant was removed by aspiration and the cellulose transferred to a 
glass funnel lined with filter paper. Cellulose was washed with distilled water by 
gravity until the effluent was pH4 (measured with pH strips with ranges of 1-4 and 4-
6). Cellulose was returned to the beaker and mixed with 4 volumes of 0.5 M NaOH 
in a beaker and allowed to stand for 30 min with brief stirring every 10 min. After the 
last settle, most of the supernatant was removed by aspiration and the cellulose 
transferred to a glass funnel lined with filter paper. Cellulose was washed with 
distilled water by gravity until the effluent was pH8 (measured with pH strips with 
range of 7-10). Cellulose was transferred to a clean beaker containing 1 volume of 
separation buffer (44 mM NaCl, 57 mM Na2HPO4, 3 mM KH2PO4, pH 8.0 at 20 ºC). 
Using pH strips, pH was titrated to 8.0 with orthophosphoric acid. Cellulose was 
transferred to a storage bottle with an equal volume of separation buffer, added 
0.001 volumes of chloroform as a preservative and stored at 4 ºC.
Parasites were kept on ice during dissections and during column preparation. To 
prepare the columns, 200 l DE52-cellulose was added to a Poly-Prep® 
Chromatography Column (Bio Rad, UK) and allowed to settle. Columns were 
equilibrated with 400l glucose separation buffer (44 mM NaCl, 57 mM Na2HPO4, 3 
mM KH2PO4, 55 mM glucose, pH 8.0 at 20 ºC) by gravity to remove chloroform. 50 
l of trypanosome mixture was added to the column and the eluate recovered on 
ice. The column was washed with 5 volumes of glucose separation buffer and eluate 
recovered on ice. The eluate was checked by microscopy and metacyclic: 
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epimastigotes ratio calculated. Parasites were snap frozen on liquid nitrogen and 
kept at -80 ºC until RNA and protein extractions. The epimastigote-metacyclic ratio 
before and after enrichment was calculated manually by cell counting on a 
haemocytometer.
3.2.5 RNA and protein extraction 
Samples from Pooled, Individual flies, and metacyclic-enriched parasite 
solutions from Method 1
Total RNA and protein from dissected hypopharynxes were extracted with the 
AllPrep™ RNA/Protein Kit (Qiagen, UK) according to the manufacturer’s protocol, 
yielding 48-213 ng of total RNA per sample. RNA was quantified with Qubit® 
fluorometric RNA quantitation (RNA HS Assay Kit) (Life Technologies, UK) and 
purity analysed using the NanoDrop™ spectrophotometer (ThermoFisher, UK). 
Pooled samples after metacyclic enrichment
Total RNA from parasite suspensions was extracted with the RNaseay Kit (Qiagen, 
UK), yielding a total RNA output between 48 and 246 ng. RNA was quantified with 
Qubit® fluorometric RNA quantitation (RNA HS Assay Kit) (Life Technologies, UK) 
and purity analysed using the NanoDrop™ spectrophotometer (ThermoFisher, UK).
3.2.6 RNA sequencing
To proceed with RNA sequencing, RNASeq libraries were prepared by the Centre of 
Genomic Research (Liverpool, UK) using the NEBNext® Ultra™ II Directional RNA 
Library Prep Kit with poly-A selection from total RNA (Poly-(A) mRNA Magnetic 
Isolation Module) (New England Biolabs, UK). The protocol was followed as per 
manufacturer’s instructions and included mRNA isolation using AMPure XP Beads 
(Agencourt, UK), bidirectional cDNA synthesis and purification, cDNA end repair 
and adaptor ligation, and PCR enrichment of adaptor ligated cDNA. Following 
preparation, library quality was assessed on the Bioanalyzer® (Agilent High 
Sensitivity Chip, Agilent Technologies, USA). 
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For each infection, RNASeq libraries were sequenced on a single lane of the 
HiSeq2500 platform (Illumina Inc, USA) as 150 paired ends, producing 280 million 
mappable reads, at the Centre of Genomic Research (Liverpool, UK).
3.2.7 Sample preparation for proteomics
Pooled and individual samples 
To solubilise protein, tsetse mouthpart material was sonicated in 50 mM ammonium 
bicarbonate on ice before centrifugation at 12,000 x g for 10 min to pellet debris. 
Proteins present in the supernatant were precipitated with 5 volumes of ice-cold 
acetone and incubated overnight at -20 °C. Samples were then centrifuged at 
12,000 x g for 10 min to pellet protein.
Protein was re-solubilised in 0.1 % (w/v) Rapigest (Waters) in 50 mM ammonium 
bicarbonate then incubated at 80 °C for 10 min before reduction with 3 mM 
dithiothreitol (DTT) at 60°C for 10 min and alkylation with 9 mM iodoacetimde at 
room temperature for 30 min in the dark. Proteomic-grade trypsin (Sigma-Aldrich) 
was added at a protein-trypsin ratio of 50:1, and samples were incubated at 37 °C 
overnight. TFA was added to a final concentration of 0.5 % (v/v) to remove 
Rapigest. Peptide samples were centrifuged at 12,000 x g for 30 min to remove 
precipitated material. 
Pooled samples after metacyclic enrichment
To solubilise protein, tsetse mouthpart material was sonicated in 50 mM ammonium 
bicarbonate on ice before centrifugation at 12000 x g for 10 min to pellet debris. 
Proteins present in the supernatant were precipitated with trichloroacetic acid to 
precipitate any soluble proteins that may have lysed during the sample freezing. The 
resulting protein fractions (pellet and supernatant) were pooled and treated with 
PNGase F for de-glycosylation, with a fetuin positive control. The samples were split 
and treated with either trypsin or chymotrypsin as described in the previous section.
Washed pooled samples exclusively for proteomics
To reduce the tsetse background obtained in the MS analysis, the parasite 
suspensions were washed multiple times by centrifugation. 106 infected-mouthparts 
were dissected and washed in PBS to release parasites. Parasite suspension was 
washed in 100 l of PBS by sequential centrifugation at 1700 g, for 5 min at 4 °C 
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followed by a fast spin at 5,200 g for 30 seconds, until no parasites were visible in 
the eluate by light microscopy. The parasite pellet was snap frozen in liquid nitrogen 
and stored at -80 °C until MS analysis.
GPI-PLC treatment
Endogenous GPI-PLC cleaves the GPI-anchor, resulting in the de-attachment of 
GPI-anchored proteins, such as the VSG, from the parasite membrane. The 
procedure, described previously in T. brucei by Sunter et al. (2013), was carried out 
to increase the specificity of the MS analysis towards VSG.
37 infected-mouthparts were dissected and washed in PBS to release parasites. 
Parasite suspension was washed in 100 l of PBS by sequential centrifugation at 
1,700 g, for 5 min at 4 °C followed by a fast spin at 5,200 g for 30 seconds, until no 
parasites were visible in the eluate by light microscopy. The pellet was resuspended 
in 200 l of 1 mM TrisHCl (pH8.0) and SigmaFast Protease Inhibitor cocktail 
(catalogue number: S8820) (Sigma, UK), kept at 0 °C for 5 min, and then incubated 
in a water bath at 37 °C for 20 min. The suspension was centrifuged at 4 °C for 3 
min at maximum speed and the pellet snap frozen in liquid nitrogen and stored at -
80 °C until MS analysis. 
3.2.8 NanoLC MS ESI MS/MS analysis
Peptides were analysed by on-line nanoflow LC using the Ultimate 3000 nano 
system (Dionex/Thermo Fisher Scientific). Samples were loaded onto a trap column 
(Acclaim PepMap 100, 2 cm × 75 m inner diameter, C18, 3m, 100 Å) at 5 l.min−1 
with an aqueous solution containing 0.1 % (v/v) trifluoroacetic acid and 2 % (v/v) 
acetonitrile. After 3 min, the trap column was set in-line an analytical column (Easy-
Spray PepMap® RSLC 50 cm × 75 m inner diameter, C18, 2 m, 100 Å) fused to a 
silica nano-electrospray emitter (Dionex). The column was operated at a constant 
temperature of 35 °C and the LC system coupled to a Q-Exactive mass 
spectrometer (Thermo Fisher Scientific). Chromatography was performed with a 
buffer system consisting of 0.1 % formic acid (buffer A) and 80 % acetonitrile in 0.1 
% formic acid (buffer B). The peptides were separated by a linear gradient of 3.8 – 
50 % buffer B over 90 min at a flow rate of 300 nl/min. The Q-Exactive was operated 
in data-dependent mode with survey scans acquired at a resolution of 70,000 at m/z 
89
200. Up to the top 10 most abundant isotope patterns with charge states +2 to +5 
from the survey scan were selected with an isolation window of 2.0 Th and 
fragmented by higher energy collisional dissociation with normalized collision 
energies of 30. The maximum ion injection times for the survey scan and the 
MS/MS scans were 250 and 100 ms, respectively, and the ion target value was set 
to 1E6 for survey scans and 1E4 for the MS/MS scans. MS/MS events were 
acquired at a resolution of 17,000. Repetitive sequencing of peptides was minimized 
through dynamic exclusion of the sequenced peptides for 20 s.
3.2.9 Protein identification and quantification
Thermo RAW files were imported into PEAKS studio 7 software [Bioinformatics 
Solutions Inc., Waterloo, ON, Canada, (Ma et al. 2003)]. Peaks were picked by the 
software using default settings. Tandem MS data were searched against translated 
ORFs from T. congolense Tc148 (12,174 sequences). The search parameters were 
as follows: precursor mass tolerance was set to 10 ppm and fragment mass 
tolerance was set as 0.01 Da. Two missed tryptic cleavages were permitted. 
Carbamidomethylation (cysteine) was set as a fixed modification and oxidation 
(methionine) set as variable modification. Only proteins with score of >20 (-10 lgP) 
were considered significant matches. The false discovery rate was set at 1 %. 
3.2.10 Transcriptome profiling
RNAseq reads were mapped to the tsetse fly genome (International Glossina 
Genome Initiative 2014) to deplete host reads using Bowtie2 (Langmead & Salzberg 
2012) and the unmapped data was mapped to the T. congolense IL3000 genome. 
The bam file was used to estimate transcript abundance values using cufflinks 
(Trapnell et al. 2012). The VSG transcripts and their abundances were extracted 
from the cufflinks output, screened for the phylotypes motifs described previously, 
and transcriptomic VAPs were estimated by adjusting the relative frequency of each 
phylotype to the relative abundance of each transcript. To compare the stability of 
the composition of the VAPs to the background random variation and genomic 
compositions, the total pool of VSGs recovered in the study was used to create 24 
randomised simulated VAPs based on 79 VSGs each.
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3.2.11 Statistical analysis
The statistical comparisons between the BLAST and the VAP performances in 
recovering VSGs were done using the Pearson’s correlation test. Outliers were 
identified using a threshold of 2x with the function ‘removeOutlier’ in R (RStudio 
Team 2016). Outliers were manually inspected before removal. The statistical 
analysis of differential profile expression was done using Pearson's chi-squared test, 
F-tests were performed to analyse variance between transcriptomic and simulated 
data, and independent student t-tests were performed to detect statistical 
significances in phylotype relative abundances. All tests were performed in R 
(RStudio Team 2016).
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3.3 Results
It is possible to culture all life stages of T. congolense using the reference strain 
IL3000, although cyclical infections still require infection of a mammal host due to 
the challenge in differentiating from metacyclic to bloodstream forms in culture. 
However, as the tsetse fly is highly refractory to trypanosome infection, the changes 
in physical environments and challenges during development in the vector have a 
critical impact on the parasite, likely affecting gene expression. Therefore, in this 
study a fly-transmissible strain of T. congolense, Tc1/148, was used and the 
parasites were recovered from experimentally-infected tsetse flies. All fly infections 
resulted in a mouthpart infection rate of 86 % or higher. 
3.3.1 Trypanosome populations in the tsetse fly mouthparts
Parasites were visible in the mouthparts as early as day 10 post-infection. However, 
peak mouthpart colonization by metacyclic forms occurred at day 28 post-infection. 
The tsetse fly mouthparts were colonised by a mixture of epimastigotes and 
metacyclics in different stages of differentiation. Parasites of both life stages 
aggregated in patches throughout the hypopharynx, creating distinctly white areas 
inside the transparent hypopharynx (Figure 21B). In general, more than 75 % of the 
cells were epimastigotes, easily identified by their long size, attachment to the 
hypopharynx walls, and slow movement (Figure 21C and 13D). Yet, at the time of 
dissection, many epimastigotes were released to the outside environment. 
Metacyclic forms tended to colonise the internal part of the hypopharynx and a fine 
adjacent duct (Figure 21C and D). As previously described in the literature 
(Peacock et al. 2012), metacyclics were small and motile. 
In fixed preparations, the observations made during dissections were confirmed. 
Epimastigotes were long and showed a posteriorly located kinetoplast very close to 
the nucleus (EF1-2, Figure 22). Some epimastigotes were much longer than usual, 
a feature which has been previously reported in prolonged infections (EF3, Figure 
22) (Peacock et al. 2012). In contrast, metacyclics were 5-10 m in length and the 
kinetoplast was positioned anteriorly and distantly from the nucleus (MF1-2, Figure 
22).
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An attempt to increase the metacyclic: epimastigote ratio in the mouthparts by 
delaying the day of dissection by 7 days (day 35 post-infection) resulted in a greater 
number of long epimastigotes (e.g. EF3, Figure 22) and not a visible difference in 
the metacyclic concentration. Therefore, subsequent dissections were performed at 
day 28 post-infection. 
Figure 21 T. congolense in the tsetse fly hypopharynx. A. Uninfected tsetse mouthpart 
under light microscope (10 X). B. Infected tsetse mouthpart under light microscope (10X), 
showing two agglomerations of T. congolense. C. Live imaging of tsetse hypopharynx under 
the confocal microscope showing a mixed population of metacyclics (1) and epimastigotes 
(2). D. Live imaging of tsetse hypopharynx under the confocal microscope showing distinct 
localization of metacyclics in a fine duct above the hypopharynx (1) and epimastigotes in the 
hypopharynx (2). 
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Figure 22 Immunofluorescence detection of trypanosome populations from the tsetse 
fly mouthparts on a confocal microscope. Trypanosomes were stained with DAPI (blue) to 
reveal nuclei, kinetoplast and their relative positioning. Populations are composed of regular 
epimastigotes (EF1-2), long epimastigotes (EF3) and infective metacyclics (MF1-2). Scale 
bars are shown in individual pictures. 
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3.3.2 Adapting variant antigen profiling to transcriptomic data
Adapting variant antigen profiling to transcriptomic data implies taking into account 
not only the relative frequency of each phylotype, i.e. how many transcripts of each 
phylotype are present in the transcriptome, but also the expression level of each 
transcript. This ensures that the VAP reflects VSG expression accurately for a given 
condition. To achieve this, the de-novo assembly used in the genomic VAP was 
replaced by transcript mapping to the strain genome and followed by transcript 
abundance estimation. Transcript mapping produces mapped RNAseq data in the 
form of a bam file that can be passed to software to quantify the expression level of 
protein coding genes. Here, Bowtie2 (Langmead & Salzberg 2012) and Cufflinks 
(Trapnell et al. 2012) were used in the first and second steps, respectively, resulting 
in a list of transcripts with the reference gene identifiers and the respective 
abundance values. The transcript identifiers are used to recover their nucleotide 
sequence, which is translated and screened for the phylotype motifs. Posteriorly, the 
relative frequency of each phylotype is adjusted for the abundance of each 
transcript, resulting in a weight-based VAP.
3.3.3 The expressed mVSG repertoires of trypanosomes
To understand the degree of variation in the VSG repertoire of different parasite 
populations and to evaluate whether successful transcriptomes and proteomes 
could be obtained from direct RNA and protein extraction of the tsetse fly 
hypopharynx, tsetse flies were infected with cultured procyclic forms and a 
transcriptome and proteome from 40 pooled mouthparts was produced. This first 
infection was done to establish if sufficient RNA could be recovered to produce a 
reliable VAP. We recovered 67 VSG transcripts, relating to various phylotypes, 
although the most abundant VSG transcript belonged to phylotype 8 (Figure 23, 
infection 1). Interestingly, mVSGs were not the most abundant transcripts in the 
samples. The fragments per kilobase of transcript per million mapped reads (FPKM) 
abundance of the 200 most abundant transcripts per sample ranged from to 
5,621.37 to 492.41. This list included 147 different functional annotations, of which 
ribosomal proteins, hypothetical proteins, histones, S-adenosylmethionine 
synthetase, cytochrome oxidase, elongation factors, alpha tubulin and nodulin-like 
proteins were the most frequent.
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At this point, mass spectrometry analysis did not reveal any VSGs. 
Although it was possible to produce a reliable transcriptomic VAP, the biological 
insights gained from pooled data are very limited because we cannot estimate the 
degree of variation between flies that might be caused by epigenetic effects. 
Therefore, transcriptomes and proteomes from twenty-four individual tsetse flies 
were produced. The second infection was done with a T. congolense strain Tc1/148 
blood stabilate after one mouse passage, an effort to optimise infection rates and 
parasite colonisation. The transcriptomes contained 20.4-37.8 million reads per 
sample, of which 6 to 47 % mapped to the T. congolense Tc1/148 genome 
sequence. After transcript abundance estimation, the mapped reads resulted into 
6462 to 11466 transcripts, of which 31 to 147 were VSGs (mean ±  = 79 ± 31; 
FPKM = 103-634) (Table 7). As observed in the pooled transcriptomes, mVSGs 
were not the most abundant transcripts. The transcriptomic VAPs showed 
remarkably low variation among flies, but the VAP was distinct from the genomic 
profile (Figure 23, infection 2). All phylotypes were represented.
Table 7 Sequencing statistics and number and expression values of VSG transcripts 
recovered per transcriptome.
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Figure 23 Transcriptomic Variant Antigen Profiles of trypanosomes extracted from tsetse mouthparts. VAPs from the transcriptomes are remarkably 
similar, yet significantly different from the genomic VSG repertoire (Poisson regression model, p < 0.001) and the VSGs found at the T. congolense telomeric 
expression sites. Infection 1 represents a sample of 40-pooled mouthparts; infection 2 represents 24 individual mouthparts; infection 3 represents a sample of 
131-pooled mouthparts after metacyclic parasite enrichment by anion exchange chromatography. The genomic VAP represents the average profile of 24 sets 
of 79 VSGs randomly sampled from the genome of Tc1/148. Stacked columns are colour-coded by phylotype according to key. The number of VSG 
transcripts recovered in each sample infection is noted in the figure.
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A set of simulated VAPs was created to investigate whether the transcriptomic 
VAPs from different flies were more consistent than expected by chance, and to 
determine under- and over-represented phylotypes in the transcriptomes compared 
to the genome. Using the full genomic VSG repertoire of Tc1/148, 24 sets of 79 
VSGs were randomly selected and profiled to become comparable to the 
experimental data. The simulated data showed a high correlation with the genomic 
repertoire (R2 = 0.99). After comparing the variance of each phylotype in the 
experimental transcriptomic and simulated genomic data, only phylotype 6 and 7 
were less variable in the experimental data, suggesting that the metacyclic VSG 
profile is more variable than a random selection of genomic VSGs. However, as the 
metacyclic VAPs were significantly distinct from the genomic VAP (Poisson 
regression model, p < 0.001), the relative abundances of specific phylotypes were 
compared using two-sample, two-way, student t-tests. This analysis showed that 
seven phylotypes show significantly different relative proportions in the 
transcriptomes compared to the genome: phylotypes 7, 12, and 15 are under-
represented in the transcriptomes (independent t-test, p < 0.001), whilst phylotypes 
4, 8, 9 and 11 are significantly over-represented (independent t-test, p < 0.001) 
(Figure 24). 
In terms of magnitude, phylotypes 6, 7, 12 and 15 show a lower relative abundance 
in the transcriptomes; 6 and 7 have the most accentuated differences being under-
representated by 97 and 91 %, respectively. Phylotypes 4, 8, and 9 are largely 
overrepresented in the transcriptomes by 1291, 2699, and 1305 %, respectively. 
Phylotype 11 shows an over-representation of 98 %. The abundance of the 
remaining phylotypes is not significantly different from their genomic extent. This 
indicates that those over-represented phylotypes may be preferentially expressed in 
the metacyclic stage.
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Figure 24 Comparison of average phylotype relative abundance (adjusted for 
transcript abundance) in transcriptomic samples and genomic profiles from a random 
selection of VSGs of Tc1/148 (mean ± ). Phylotype relative abundance in the 
transcriptomes is shown in bold; phylotype relative frequency in the random simulations 
from the genome is shaded lighter. Statistical analysis reveals that, in comparison to the 
genome, phylotypes 7, 12, and 15 are under-represented in the transcriptomes (independent 
t-test, p < 0.001), whilst phylotypes 4, 8, 9 and 11 are significantly over-represented 
(independent t-test, p < 0.001).
A closer analysis of phylotypes 11 and 8, which are the most abundant and the most 
over-represented in the metacyclic transcriptome, respectively, revealed important 
differences in composition. At the genome level, phylotype 11 contains 146 genes, 
of which 74 (50 %) were expressed across the sample set, with variable, yet 
generally low, transcript abundances (FPKM ranges from 8.38x10-5 to 69.84). Only 
one transcript (Tc14808730) is common to all samples, while 29 are sample-
specific. This suggests that phylotype 11 is collectively abundant at the 
transcriptomic level due to multiple, randomly selected VSGs and not to any specific 
gene(s). In contrast, the relative abundance of phylotype 8 derives from two 
particular transcripts (98 % and 99 % identical to TcIL3000_0_09520 respectively), 
common to all samples and a third transcript common to 23/24 samples (99 % 
identical to TcIL3000_5_650). These correspond to 33.33 % of the phylotype’s 
genomic repertoire (3/9) and have consistently high expression values, mostly within 
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the 6 most abundant VSG transcripts (Figure 25). Therefore, in contrast to 
phylotype 11, the profusion of phylotype 8 derives from reproducible expression of 
particular genes; their phylogenetic position is shown in Figure 26.
Figure 25 VSG transcript abundances. Bar graph shows the median FPKM values for the 
VSG transcripts recovered from the mouthpart transcriptomes (N = 24). VSGs are ordered 
by transcript abundance. Star indicates the presence of the majority of phylotype 8 members; 
21 out of 24 samples have phylotype 8 members within the 6 most abundant transcripts. 
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Figure 26 Maximum likelihood phylogeny of phylotype 8 estimated from protein 
sequences. Tree includes all the phylotype 8 sequences recovered from the isolates 
described in chapter 2; the two mVSG sequences described by Eshita et al. (1992); and 
mVSG1 described by Helm et al. (2009). Internal nodes are labelled with bootstrap values 
higher than 70 %. Arrows indicate positioning of the mVSGs described here and in the 
literature. Tree is rooted on phylotype 9.
Total protein was extracted from the 24 individual samples and sequenced by mass 
spectrometry. Resulting peptides were screened against a protein database of non-
redundant VSGs, non-VSG Tc1/148 proteins and Glossina sp. proteins. After an 
initial analysis with PEAKS (Ma et al. 2003), 6 VSG peptides were observed in 2 
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samples (samples 1 and 10). These peptides corresponded to one protein group per 
sample. The VSG protein group of sample 1 contains 4 potential VSGs from 
phylotype 5, whilst sample 10 contains 2 VSG matches to phylotype 15. The 
proteomic evidence for sample 1 and 10 does not match either the transcriptomic 
profiles or the telomeric expression site profile. Both observations can be due to the 
low degree of confidence in the peptide search. Additionally, the lack of 
concordance between a proteomic or transcriptomic profile and the expression site 
profile may be insignificant for two reasons: first, as with T. brucei, the metacyclic 
expression site may be distinct from the bloodstream form expression site and 
therefore not included in the ES profile; second, if only one expression site is active 
at a time, then the profile of the inactive ES is irrelevant. In summary, the proteomic 
results are conflicting; therefore, the degree of post-transcriptional regulation and 
the composition of the mVSG coat of parasites from the same population remain 
unclear.
3.3.4 The expressed mVSG repertoires of metacyclic-enriched 
populations
Although epimastigotes do not express VSGs on the surface, they could transiently 
express them at the mRNA level. It is also not known how VSG transcription and 
expression occurs in pre-metacyclics, i.e. the stage between epimastigotes and fully 
differentiated metacyclics. To evaluate the effect of such transcripts in final VAPs, 
population enrichment for metacyclics was attempted. Parasites were released from 
the hypopharynx by tissue disruption and gentle shaking and stored on ice in PBS 
and glucose. As transcriptomes from individual flies showed good reproducibility 
and because enrichment would considerably decrease the amount of starting 
material for RNA and protein extraction, samples were pooled into two replicates of 
60 and 71 flies each. 
The composition of the population before and after enrichment was estimated by 
microscopy and cell cytometry, revealing that the non-enriched mouthpart parasite 
population was mostly composed of epimastigotes and other non-metacyclic 
intermediate forms (up to 82 %). After poly-L lysine slide adhesion enrichment, the 
percentage of metacyclics in the population increased by 30 % After DE52-cellulose 
separation, there was a drastic decrease in total number of cells, but the population 
became predominantly composed of metacyclics (56 % and 76 %) (Figure 27). Yet, 
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the VAPs produced from the transcriptomes of both enriched methods show high 
replication (Figure 28) and are very similar to those obtained from non-enriched 
samples (Figure 23, infection 3), suggesting that the non-metacyclic forms present 
in the non-enriched samples from individual flies did not affect the number or 
composition of VSG transcripts recovered.
Figure 27 Trypanosoma populations before and after DE52-cellulose column 
separation (mean ± ). Bar charts show the enrichment of metacyclic populations after 
DE52-cellulose separation.
With the exception of Replicate 1 from the Poly-L lysine slide adhesion method, a 
high number of different VSG transcripts were recovered from the metacyclic 
enriched samples (N = 30, 165 152, and 235, respectively). However, the 
transcriptomes from individual samples recovered 373 distinct VSGs combined, 
which suggests that there were many VSGs common to the 24 individual samples 
and that the sequencing effort was sufficient to capture a true glimpse of the VSG 
transcriptome even when those are a small proportion of the total cells in the fly 
mouthparts.
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Figure 28 Transcriptomic Variant Antigen Profiles of trypanosomes extracted from 
pooled tsetse mouthparts after metacyclic-parasite enrichment. The number of VSG 
transcripts used in the VAPs are as follows: in Poly-L lysine slide adhesion method, 30 and 
165 transcripts were recovered for replicate 1 and 2, respectively; in the samples from the 
DE52-cellulose column separation, there were 152 and 235 VSG transcripts in replicate 1 
and 2, respectively.
The protein extracted from the metacyclic-enriched parasite suspensions 
obtained from DE52-cellulose separation was sequenced by mass 
spectrometry and searched for T. congolense VSGs, using the Glossina sp. 
proteome as host background. The discovery analysis revealed 5 protein 
groups, each group containing multiple VSGs from the same phylotype. The 
results suggest that the metacyclic population expresses phylotypes 1, 5, 3, 
11, and 15, which remains conflicting with the transcriptomic results (Table 
8). However, although the numbers of recovered peptides and their 
confidence value have increased in the enriched, pooled samples compared 
to the individual mouthparts, the sensitivity of the proteomic results remains 
low, prejudicing an accurate biological conclusion. 
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Table 8 Proteomic Results from mass spectrometry sequencing of metacyclic-enriched 
parasite suspensions obtained by DE52-cellulose separation. Data represents the number 
and confidence (-10lgP) of VSG peptides matches obtained for each replicate and for a 
‘combined’ sample. ‘Combined’ relates to an independent search conducted on the merged 
data from the two replicates. Note that VSGs belonging to the same phylotype also share the 
same protein group in the proteomics search.
In summary, the results from this chapter show that the VAP can be applied to 
transcriptomic data to provide a fast and reliable metric of VSG expression. 
Additionally, the analysis of the mVSG repertoire of Tc1/148 suggests that the 
mVSG expression is reproducible between infections and populations, and may be 
epigenetically controlled through the developmental regulation of particular 
phylotypes. 
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3.3.5 Further attempts to detect mVSG by MS
As the proteomic results obtained lacked depth and confidence, a final fly infection 
was carried out with the exclusive purpose of protein extraction. Initially, a parasite 
sample from a pool of 106 mouthparts was thoroughly washed in PBS to reduce the 
signal from tsetse proteins. Although the MS analysis revealed only minor 
contamination from tsetse proteins, no VSG peptides were identified in the sample. 
Lastly, material from 37 infected mouthparts was washed as previously and used for 
GPI-PLC treatment. The latter aimed to enrich the sample for GPI-anchored 
proteins, such as the VSG, and soluble protein. The MS analysis revealed only one 
VSG peptide, representing a single VSG from phylotype 2. 
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3.4 Discussion
The main aim of this chapter was to adapt the VAP for the analysis of transcriptomic 
data to facilitate studies of VSG expression. During that process, I investigated the 
composition and variability of the expressed mVSG repertoire of metacyclic T. 
congolense ‘savannah’ Tc1/148 in the tsetse fly. 
Transcriptomic VAPs provide the ability to characterise and quantify differences in 
VSG expression during experiments. By analysing RNAseq data, VAPs can be 
adjusted for transcript abundance, providing a description of VSG expression. To 
achieve this, the de-novo assembly process used in the genomic profiling was 
replaced by reference mapping and transcript abundance estimation. Although 
transcripts can be assembled de-novo using software like Trinity (Haas et al. 2013), 
transcript mapping to a reference genome is a more sensitive method, particularly 
when there are good reference genomes available. Even though read mapping to a 
different strain may be suboptimal in variable parts of the genome, such as the 
subtelomeres, the transcript abundance estimation software can perform de-novo 
transcript discovery using the mapped RNAseq data. Yet, if de-novo transcript 
assembly is preferred by the user, it can be easily incorporated as a preliminary 
step, before read mapping back to the transcriptome and transcript abundance 
estimation. After transcript abundance estimation, variant antigen profiling is 
performed as described in Chapter 2, using Hidden Markov Model search. Finally, 
VAPs are adjusted for transcript abundance to achieve accurate representation of 
the VSG expression. This step is important because it allows the discrimination 
amongst phylotypes according to the weight each transcript represents in the total 
expressed VSG repertoire, rather than their frequency. This is particularly useful to 
differentiate between phylotypes composed of multiple low-abundance transcripts 
and phylotypes with few high abundance transcripts.
In this chapter, the concept of the transcriptomic VAP was applied to investigate the 
composition and variability of the mVSG repertoire expressed by metacyclic 
parasites in the tsetse fly. Previous analyses of the T. congolense mVSG repertoire 
were either performed in early mammal infections under the assumption that mVSG 
are still expressed up to one week after transmission (Crowe et al. 1983) or in vitro 
(Eshita et al. 1992). Although cultured metacyclic parasites might express similar 
mVSGs to those in the tsetse fly (Luckins et al. 1981), there is evidence in 
Plasmodium falciparum that vector passage can change gene expression, and that 
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var gene expression is reset after one mosquito passage (Bachmann et al. 2016). 
Therefore, this work was performed from tsetse mouthpart infections. 
The first challenge of this approach was to produce transcriptomes from the 
mouthparts of individual flies. Analyses of salivary gland transcriptomes (or sialome) 
have been reported in the literature for over 10 years. Sialomes obtained using 
Expressed Sequence Tag (EST) libraries have been produced for a range of 
insects, including Glossina morsitans morsitans (Alves-Silva et al. 2010), but also 
the dengue and yellow fever vectors Aedes aegypti (Ribeiro et al. 2007) and Aedes 
albopictus (Arcà et al. 2007), and Triatoma infestans, which transmits Chagas 
disease (Assumpção et al. 2008). Furthermore, transcriptomes using the microarray 
technique have been produced for the malaria vector Anopheles gambiae to assess 
differential expression before and after blood feeding (Das et al. 2010). The more 
advanced RNAseq technique has been used recently for the analysis of sialomes of 
other insects, such as the western flower thrips (Frankliniella occidentalis) (Stafford-
Banks et al. 2014).
All these studies focused on the non-infected insect salivary glands and yet all were 
performed with pooled samples ranging from 15 (for the large T. infestans EST 
library) to 300 (for the small F. occidentalis RNAseq library). RNAseq analysis of the 
parasites colonising the salivary glands of an insect has only been done very 
recently for T. brucei (Savage et al. 2016). This work presented a global 
transcriptome of the different parasite stages during development in the tsetse fly 
and was based on the isolation of pools of midgut, proventriculus, and salivary 
glands. As T. congolense bypasses the salivary glands, migrating from the 
proventriculus to the proboscis (mouthparts), this chapter presented mouthparts 
transcriptomes rather than sialomes. Yet, as their size is comparable, the 
challenges of isolating enough RNA from the salivary glands of a single fly are 
similar to those of the proboscis. This chapter shows that it is possible to produce 
transcriptomes from a single mouthpart.
In the study of Savage et al. (2016), metacyclic parasites were isolated from blood. 
Flies with mature salivary gland infections were fed, and the blood remaining on the 
mouthparts was collected, pooled and the parasites isolated by DE52 anion 
exchange. This approach, whilst necessary for the producing an accurate 
metacyclic transcriptome, precludes the use of single flies. As the work presented in 
this chapter had the main purpose of mVSG analysis, a perfect separation of 
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metacyclic from the remaining parasite forms present in the mouthparts was not 
essential. The inclusion of the whole proboscis with all its parasitic contents ensures 
enough RNA can be isolated for deep sequencing. The insect reads can be easily 
removed by read mapping to the tsetse genome and the remaining parasite forms 
do not affect the VSG analysis because only metacyclic parasites contribute to the 
mVSG expression profile (as shown by the metacyclic-enriched VAPs).
Trypanosome gene expression is post-transcriptionally regulated with the sole 
exception of mVSGs in T. brucei, which are transcribed from a transcriptionally 
regulated monocistronic expression site (Lenardo et al. 1986; Graham & Barry 
1995). T. brucei metacyclics are thought to express a single mVSG, presumably 
covering their surface (Tetley et al. 1987; Ramey-Butler et al. 2015). From my data, 
I cannot infer whether T. congolense single parasites express a single mVSG, or 
multiple. For such a conclusion, T. congolense metacyclics would either have to be 
engineered to express fluorescently-labelled mVSGs (if the mVSG expression 
cassette was known) or through single-cell proteomics. However, it does show that 
the metacyclic parasite populations within individual flies express very similar VSG 
profiles. This in itself is a marked difference to T. brucei, where the expressed 
mVSG repertoire is subject to change during tsetse transmission, as shown by Barry 
et al. (1983) who detected changes in expression of 3 metacyclic VATs during 
sequential tsetse transmission of a laboratory parasite clone.
Another difference in T. congolense metacyclic transcriptomes is that the mVSGs 
are rarely within the 200 most abundant transcripts. The low mVSG transcript 
abundances could refer to various factors, such as inefficiency in sequencing due to 
vector RNA contamination, high percentage of epimastigotes in the sample, and the 
fact that metacyclic cells show a drastic decrease in gene transcription. Yet, when 
Savage et al. (2016) sequenced T. brucei populations from tsetse salivary glands, 
they observed that mVSG were amongst the 20 most abundant transcripts, even 
though there was a high percentage of epimastigotes represented, for example, by 
the high abundance of brucei alanine rich protein (BARP). In contrast, the results of 
this chapter show a wide range of distinct mVSG being transcribed in the population 
(average of 79.2 ± 31.8 per sample), at a level approximately ten-fold lower than in 
T. brucei (Savage et al. 2016). Therefore, it is possible that, unlike T. brucei, T. 
congolense mVSGs are not monoexpressed or that the surface of the T. congolense 
metacyclic parasites are not fully coated with VSGs.
109
Whilst mVSG expression in T. congolense is different from T. brucei, perhaps they 
agree on their synchronicity. Ramey-Butler et al. (2015) showed that in T. brucei 
multiple mVSGs are expressed simultaneously in the population and that expression 
onset is rapid and synchronous rather than gradual. Likewise, this chapter suggests 
that T. congolense metacyclic populations may also express multiple VSGs. 
Furthermore, assuming that differences in flies and parasite stocks affect infection 
kinetics, as the VSG expression profiles remain similar between infections, it is 
plausible that expression is also synchronous.
The proteomic results obtained in this work failed to convince and disagreed with 
the transcriptomes. In the enrichment data, the proteomic results are stronger and 
seem to agree in the expression of phylotype 1, 5, 11, 13, and 15, but still disagree 
with the transcriptomes, particularly in the case of phylotype 5 (which is barely 
expressed in the transcriptome), and the absence of phylotype 8, which is highly 
expressed in the transcriptomes. Although it is possible that in T. congolense part of 
the VSG expression control is post-transcriptional, this has never been reported and 
strongly disagrees with the current knowledge for T. brucei, where mVSG 
expression is exclusively transcriptionally regulated (Lenardo et al. 1986; Graham & 
Barry 1995; Barry et al. 1998). Another possibility would be that there is a lag 
between mRNA transcription and protein expression, which, in the event of a highly 
dynamic metacyclic surface, would account for the disparities between 
transcriptomes and proteomes. However, the observation of Ramey-Butler et al. 
(2015) that the delay between mVSG RNA transcription and protein expression in T. 
brucei is negligible, and the fact that the multiple transcriptomes presented in this 
chapter come from different infections and potentially from parasites at distinct 
developmental stages and yet retain a strong reproducible VAP, suggests 
otherwise. 
At the transcriptomic level, the results presented here suggest that metacyclic 
parasites express a distinct, limited, and reproducible set of mVSGs. The extent of 
this reproducibility across strains remains unclear, but it is maintained in Tc1/148 
having survived a full transmission cycle. As phylotype 8 remains consistently over-
represented in the metacyclic transcriptomes, and their members are always among 
the most abundant VSG transcripts, preferential expression of this phylotype could 
be postulated. In fact, this is corroborated by an earlier study of mVSG expression in 
T. congolense ILNaR2 (Eshita et al. 1992), which identified two mVSGs, through 
cDNA expression library in phages and Northern blotting, both belonging to 
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phylotype 8 (M74802.1 and M74803.1) (Figure 26). More recently, the most 
abundant mVSG observed through sequencing of an expression sequence tag 
library from T. congolense IL3000 metacyclics cultured in vitro also belonged to 
phylotype 8 (mVSG1) (Helm et al. 2009) (Figure 26). The described phylotype 8 
mVSGs have orthologues in various strains and cluster across the whole extent of 
the tree, not forming their own independent group, suggesting that if there is 
functional differentiation and/or developmental regulation, this is characteristic of the 
phylotype rather than individual genes. Therefore, there is evidence from distinct 
strains pointing towards phylotype 8 being preferentially expressed in metacyclic 
parasites, and so possibly developmentally regulated.
As discussed in chapter 2 (page 69), developmental regulation and functional 
differentiation amongst variant antigens is present in African trypanosomes as well 
as other protozoan parasites. For example, functional differentiation amongst 
Plasmodium falciparum var genes is well represented by the var2csa gene. This 
gene, unique for retaining orthology across P. falciparum strains, has apparently 
evolved an invariant function in regulating the expression of other family members 
(Ukaegbu et al. 2015). Hence, it is reasonable to hypothesize that subtle yet 
important functional differences underlie the maintenance of VSG phylotypes in T. 
congolense and cause the specific metacyclic profile observed in this study.
It remains to be seen whether phylotype 8 is restricted to metacyclics and whether it 
is enriched in natural fly infections, however, all of these observations contrast with 
what is known in other antigenically variable vector-borne organisms. In T. brucei, 
the mVSG repertoire, although limited, progressively changes over time both in 
natural infections and sequential laboratory tsetse transmissions of the same 
parasite clone (Barry et al. 1983). In P. falciparum, the var gene expression radically 
changes following a single mosquito passage (Bachmann et al. 2016), indicating 
that the specific var genes subset being expressed by a parental line is completely 
converted during the development in the mosquito, resulting in a novel subset being 
expressed when entering a naïve host. In P. chabaudi, vector passaging not only 
alters cir (chabaudi interspersed repeats) expression in the erythrocytic cycle, but 
also leads to virulence attenuation, related to the broad activation of most 
subtelomeric variants (Spence et al. 2013). If the pattern of T. congolense mVSG 
expression is reproducible in nature, then the preferentially expression of phylotype 
8 (and perhaps others) indicates a form of developmental regulation that could 
potentially be exploited in vaccine design. Metacyclic VSGs have long been targets 
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for vaccine development because they are the first point of contact with the host 
immune system. Although their instability in T. brucei has impaired any progress 
towards a vaccine, if the same phylotypes are over-represented in all T. congolense 
strains, vaccination may be plausible in T. congolense. 
Another key question that arises from the results is how certain phylotypes are 
repressed and favoured during the metacyclic stage. In this study, the analysis of 
the physical characteristics of the various phylotypes did not reveal striking 
differences that could explain differences in transcription. However, the growing 
evidence for extensive epigenetic regulation of variant gene expression in parasitic 
protozoa suggests that epigenetic regulators, such as chromatin modifiers, writers 
and chaperones, are likely candidates for the regulation of VSG expression 
(Duraisingh & Horn 2016). Evidence for the role of heterochromatin in controlling 
allelic exclusion in T. brucei is abundant (Figueiredo & Cross 2010) and involves a 
multitude of players, such as Histone 1 and 3 (Pena et al. 2014; Povelones et al. 
2012; Alsford et al. 2012), H3.V, DOT1B (Figueiredo et al. 2008; Batram et al. 2014; 
Reynolds et al. 2016; Schulz et al. 2016), the chromatin remodellers ISWI (Stanne 
et al. 2015) and nucleoplasmin-like protein (NLP) (Narayanan et al. 2011), the 
histone chaperone FACT (Denninger et al. 2010), and the nuclear lamin NUP1 
(DuBois et al. 2012). Additionally, alternative epigenetic machineries, such as 
SUMOylation, appear to be involved in VSG activation (López-Farfán et al. 2014). 
In this light, further experiments targeting over and under-represented phylotypes in 
the metacyclic stage with the aim to identify and characterise the potential 
epigenetic signature of metacyclic VSG expression in T. congolense can help 
explain the mechanisms behind any programmed VSG expression. 
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3.4.1 Conclusions
This chapter shows that the VAP can measure differences in VSG expression and it 
exposed an unexpected degree of reproducibility in antigenic expression. The fact 
that mVSG expression is stable, reproducible and partly distinct from bloodstream 
VSG expression is a key difference from the mechanisms described for T. brucei, 
urging further studies of VSG expression dynamics in T. congolense. The 
systematic over-representation of particular phylotypes during the metacyclic stage, 
coupled with evidence for rare recombination between phylotypes, can revive the 
idea of using metacyclic VSG to vaccinate against T. congolense. Foremost, 
progress towards this objective will require further experiments to characterise the 
stability of the phenotype observed in this study over longer periods, amongst 
isolates of different origins, and in the context of mixed infections, which are a 
common feature of natural settings. 
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Chapter 4. Characterisation of conserved telomeric 
structures in T. congolense
4.1 Introduction
In T. brucei, VSG expression occurs at telomeric expression sites. Initial attempts to 
resolve the structure and regulation of the T. brucei BES revealed that the ES were 
polycistronic units where the VSG and a minimum of 7 non-VSG genes were 
transcribed under regulation from the same promoter (Kooter et al. 1987; Johnson 
et al. 1987; Shea & Van der Ploeg 1988). Through cloning experiments, these units 
were shown to vary between 45 and 60 kb in length and α-amanitin resistance 
assays surprisingly revealed that transcription was driven by RNA polymerase I 
(Shea et al. 1987; Alexandre et al. 1988; Shea & Van der Ploeg 1988; Pays et al. 
1989). The non-VSG genes co-transcribed in the ES were named ESAGs. However, 
homologous genes were also found to be transcribed in procyclic stage, where VSG 
transcription is absent, and not by RNA polymerase I (Gibbs & Cross 1988; Pays et 
al. 1989; Graham & Barry 1991). These results were further supported by the 
observation that ESAG4 was homologous to adenylate cyclases, suggesting that 
ESAGs might be derived from multi-copy gene families conserved in the wider 
genome (Pays et al. 1989). 
In more recent years, research has focused on revealing the fine detail of the ES. 
Subtelomeres and telomeres are difficult to sequence through conventional short-
read sequencing methods, due to their unpredictable length and highly repetitive 
composition. Thus, other approaches have been especially developed to allow the 
study of the VSG system and the resolution of the architecture of all telomeric ES, 
such as bacterial-associated chromosome (BAC) cloning (Berriman et al. 2002) and 
transformation-associated recombination (TAR) in yeast (Larionov et al. 1996). The 
latter yields better outcomes, achieving successful isolation of complete 
chromosome ends and the generation of stable clones of 17 BES from T. brucei 
Lister 427 (Becker et al. 2004). For this method, the TAR cloning vector pEB2 was 
modified to contain a stable yeast telomere and the T. brucei 427 dominant 
expression site promoter as a recombinational target. This strategy resulted in >85 
% successful clones as linear yeast-associated chromosomes (YACs) with no 
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unexpected recombination. Further work on the library of TAR clones allowed the 
detailed study of 14 BES groups and the consequent revealing of the ESAG set 
(Hertz-Fowler et al. 2008), adding to the 4 BES from 4 different strains successfully 
sequenced before (Berriman et al. 2002). This analysis confirmed that T. brucei 
BES are 10-50 kb long polycistronic regions with a canonical structure comprising 
an upstream promoter, a collection of ESAGs, a 70 bp repetitive sequence, and the 
terminal VSG, with individual differences lying in the ESAG sets (Figure 29). 
Nonetheless, all were located within 60 kb from the end of the chromosome and the 
expressed VSG within 2 kb of the telomeric repeat. 
T. brucei has 12 ESAGs: ESAG 9, 10, and 12 are facultative, whereas the 
remaining are present in all Lister 427 BES sequenced to date (Figure 29). ESAG1 
has been described as a T. brucei-specific gene and is located adjacent to the 
subtelomeric end of the 70 bp-repeat. ESAG2 is a gene family adapted from an 
ancestral lineage of b-type VSG, whose closer relatives are Fam16 T. congolense 
VSGs (Jackson et al. 2012). ESAG3 and ESAG5 are membrane-associated 
proteins with divergent homologues in the core chromosomes of T. congolense and 
T. brucei (Hertz-Fowler et al. 2008). ESAG4 is an adenylate cyclase, although not 
orthologous to any adenylate cyclases of T. congolense (Pays et al. 1989; Jackson 
et al. 2013). ESAG6 and ESAG7 are found almost exclusively at the BES as tandem 
pairs (Jackson et al. 2013). They encode transferrin receptors (Salmon et al. 1994), 
which have largely expanded in T. congolense, but are mostly located in the 
subtelomeres and not associated with the VSG (Jackson et al. 2012) . ESAG8 is a 
putative nuclear DNA-binding protein which binds a protein involved in mRNA 
stability (Hoek et al. 2000; Hoek & Cross 2001; Hoek et al. 2002); ESAG9 is a 
stumpy stage-specific molecule of unknown function, with no homologues in 
trypanosomatids other than weak sequence similarity to the MASP proteins of T. 
cruzi (Barnwell et al. 2010), a family of mucin glycoproteins also of unknown 
function (Bartholomeu et al. 2009). ESAG10 is a folate transporter identical to core 
homologues. ESAG11 is a modified invariant surface glycoprotein (Jackson et al. 
1993), and ESAG12 is a T. brucei-specific gene of unknown function (Hertz-Fowler 
et al. 2008). With the exception of ESAG8, all ESAGs have cell-surface roles and, 
with the exception of ESAG10, all are thought to be derived from multi-copy gene 
families distributed throughout the core genome. Furthermore, only ESAG1 and 
ESAG12 seem to have evolved de-novo in the T. brucei genome, whilst all the 
remaining have distant homologues in T. congolense, T. vivax, or T. cruzi (Jackson 
et al. 2013). 
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All T. brucei ESAGs derive from multi-copy gene families present in the core 
chromosomes or subtelomeres. However, following independent recruitment to the 
ES, they have adapted to their new chromosomal location and evolved concertedly 
due to the many pressures for sequence exchange and reorganisation in the 
telomeres (Jackson et al. 2013). Thus, in this chapter I take the view that ESAGs 
are genes that, whilst derived from conserved, multi-copy gene families have 
independently diversified to the expression site, resulting in distinct isoforms present 
exclusively in the expression site context.
Figure 29 The consensus structure of the T. brucei Lister 427 bloodstream expression 
site (BES). Features are scaled and colour coded according to key. Gradient-shaded ESAGs 
in square brackets represent facultative ESAGs. Adapted from Hertz-Fowler et al. (2008).
Research in T. congolense is much less developed. T. congolense VSGs are 
thought to also be expressed from telomeres, but the structure of its ES is yet to be 
described. With the emergence of long-read genome sequencing technologies, such 
as the Single Molecule, Real-Time (SMRT) cell sequencing from Pacific Biosciences 
(Rhoads & Au 2015), recovering and describing telomere-associated regions is 
easier. Telomeres can be sequenced in reads as long as 60 kb, which can often 
represent the telomere-associated structures of the genome in single reads without 
the need for assembly. 
The IL3000 actively-transcribed VSG and its surrounding sequence was cloned, but 
never published, by John Donelson in 2005. The sequences of four clones are 
publicly available in GenBank under the accession numbers HE578911, HE578912, 
HE578913, and HE578914. They show the active VSG immediately upstream the 
telomeric repeat, preceded by two non-coding regions, the transposable element 
ingi, a range of non-VSG genes (i.e. RNase A, cathepsin-B, zinc-finger protein, 
hypothetical protein), and the 369 bp repeat previously described as a feature of the 
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mini-chromosomes (Majiwa et al. 1986; Gibson et al. 1988) (Figure 30). 
Furthermore, two telomeric contigs from megabase chromosomes were recovered 
from the T. congolense genome sequencing (Jackson et al. 2012), which share 
similar features. Whilst these sequences provided preliminary data for the analysis 
conducted in this chapter, they represent a poor sample of not only the megabase 
chromosomes, but of the telomeric context of T. congolense. In this study, two 
strains of T. congolense ‘savannah’ were sequenced with the SMRT cell technology 
to reveal telomere-associated structures. This chapter aims to:
1. Describe T. congolense telomere-associated structures and compare them 
to T. brucei to investigate the presence of a canonical expression site in T. 
congolense.
2. Detect and characterise telomere-associated non-VSG genes to evaluate 
whether they are orthologous or analogous to T. brucei ESAGs.
3. Profile the VSGs found in the telomeres to investigate whether specific 
phylotypes are preferentially recruited to the telomeres.
4. Explore the role of recombination in telomere evolution to understand 
whether they are under similar pressures as T. brucei ES.
5. Understand the role of mini-chromosomes in VSG diversity and expression.
Figure 30 The genomic context of the T. congolense IL3000 actively-transcribed VSG, 
or the ‘Active VSG ES’. The actively-transcribed VSG of IL3000 is preceded by a stretch 
of 369 bp repeats, CNR1, the transposable element ingi, the RNase gene, a cathepsin B gene, 
a zinc-finger protein gene, a gene encoding a hypothetical protein, and CNR2. The VSG 
gene is the most telomere-proximal element.
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4.2 Methods 
4.2.1 Parasite stocks and culture
T. congolense ‘savannah’ Tc1/148 (MBOI/NG/60/1-148) (1/148) (Young & Godfrey 
1983) mouse blood stabilates were obtained from the Department of Parasitology of 
the Liverpool School of Tropical Medicine, UK. A frozen stabilate of 1ml of infected 
mouse blood (20 % glycerol and parasitaemia of 103 parasites/ml) was thawed and 
mixed with ten volumes of defibrinated horse blood. The sample was used to infect 
100 male tsetse flies by pouring 4mls of blood onto three distinct spots on a feeding 
tray covered with a feeding membrane. Flies were allowed to feed for 11 min at 27 
°C and in the dark. Flies were killed by decapitation at day 10 post-infection and 
midguts dissected in sterile conditions. Infected midguts were incubated with 
modified Eagle’s medium (MEM)-based modified differentiating trypanosome 
medium (DTM) (10 % foetal bovine serum, 2 mM L-glutamine, 10 mM L-proline) and 
0.5 mg/mL penicillin/streptomycin to prevent growth of midgut bacteria on 96-well 
plates. Parasite suspensions were serial-diluted 5 times at a 1:2 ratio of parasite: 
medium to remove fly tissue and incubated at 27 °C, 5 % CO2. Cultures were 
passaged at a 1:10 ratio first into 12-well plates and then into 25 ml flasks with fresh 
medium when parasitaemia reached 106 cells/ml. Cultures continued to grow until a 
total of 1.2x109 cells were obtained.
4.2.2 DNA extraction
High molecular weight DNA was extracted from 1.2x109 cells by phenol: chloroform 
protocol. Cells were centrifuged at 1,500 g for 10 min and washed in 10ml cold PBS. 
Cells were centrifuged at 1,500 g for 10 min and supernatant was discarded. Pellet 
was resuspended in 500l PBS and incubated with 6ml TELT buffer (1.5 M LiCl 
anhyd, 50 mM Tris-HCl pH8.0, 62.5 mM EDTA pH8.0, 4 % Triton-X) at room 
temperature for 5 min. In a fume hood, 7 ml of 1:1 phenol: chloroform was added 
and mixed by inversion for 5 min or until an emulsion was formed. The solution was 
centrifuged at >3,000 g for 5 min and the aqueous solution collected in a 50 ml tube. 
The remaining phases were discarded. Two volumes of ethanol were added to the 
aqueous solution, mixed by inversion, incubated on ice for 10 min and centrifuged at 
4,000 g for 20 min. The supernatant was discarded by gentle decantation and the 
pellet was washed in 2 volumes of freeze-cold 70 % ethanol. The solution was 
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centrifuged at 3,000 g for 5 min and the supernatant decanted. The pellet was left to 
air dry at 70 °C for 5 min and then re-dissolved in 600 l TE50 (10mM Tris-HCl 
pH8.0, 50mM EDTA pH8.0). 150 m/ml of RNase A was added to the resuspended 
pellet and incubated for 1 hour at 37 °C. Subsequently, 300 g/l of Proteinase K 
was added to the solution and incubated for 2 hours at 50 °C. After the incubation 
period, 600 l 1:1 phenol: chloroform was added in a fume hood and mixed by 
inversion for 5 min. The solution was centrifuged at > 3,000 g for 5 min and aqueous 
fraction collected in a 1.5 ml tube. To the aqueous solution, 1 volume of isopropanol 
and 0.1 volumes of 3 M sodium acetate (NaOAC) were added. The solution was 
centrifuged at 1,500 g for 15 min at 4 °C. The supernatant was discarded and the 
pellet was washed in 1 ml ice-cold 70 % ethanol. The pellet was left to air dry until 
no ethanol was visible. Finally, the pellet was left to re-dissolve in TE50 (2 l/107 
cells) at 4 °C overnight, without pipetting or mechanical disturbance. 
Tc1/148 DNA output (105 g) was quantified with Qubit fluorometric dsDNA 
quantitation (dsDNA HS Assay Kit) (Life Technologies, UK). DNA quality was 
checked on a Nanodrop (Thermo Scientific, UK) (A260/280 = 1.82 and A260/230 = 
1.78) and integrity checked on a 0.5 % agarose gel run at 30 V for 16 hours at 4 °C, 
using the 1 kb DNA extension ladder (Invitrogen, UK). 
4.2.3 Long-read genomic DNA library preparation and sequencing
DNA was purified with 1x cleaned Ampure beads (Agencourt) and the quantity and 
quality was re-assessed using Qubit fluorometric dsDNA quantitation (dsDNA HS 
Assay Kit) (Life Technologies, UK) and Nanodrop (Thermo Scientific, UK). Fragment 
analyser (Bioanalyzer, Agilent, UK) with a large fragment high sensitivity genomic kit 
(Agilent Genomics, UK) was used to determine the average size of the DNA. 10 g 
of sample was used without further shearing.
DNA was treated with Exonuclease V11 at 37 °C for 15 min. The ends of the DNA 
were repaired as follows: samples were incubated for 20 min at 37 °C with damage 
repair mix supplied in the SMRTbell library kit (Pacific BioSciences, USA). This was 
followed by a 5-min incubation at 25°C with end repair mix. DNA was cleaned using 
a 1:1 volume ratio of AMPure beads (Agencourt, UK) and 70 % ethanol washes. 
DNA was ligated to adapter overnight at 25°C. Ligation was terminated by 
incubation at 65 °C for 10 min followed by exonuclease treatment for 1 hour at 37 
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°C. The SMRTbell library was purified with a 1:1 volume ratio of AMPure beads 
(Agencourt, UK). The quantity of library and therefore the recovery was determined 
by Qubit assay and the average fragment size determined by Fragment analyser as 
before. Size selection was performed on Sage blue pippin prep using 0.75 % 
agarose cassette/S1 marker and the size collected was between 15,000 bp and 
50,000 bp. The final SMRTbell library was recovered and the DNA damage repaired 
as previously done at the start. SMRTbell libraries were annealed to sequencing 
primer at values predetermined by the Binding Calculator (Pacific Biosciences, 
USA) and a complex made with the DNA Polymerase (P6/C4 chemistry). The 
complexes were bound to Magbeads and this was used to set up the required 
number of SMRT cells for each sample. For Tc1/148, 20 kb Libraries were 
sequenced on the PacBio SMRT sequencer, using 360-min movie times and 7 cells.
4.2.4 Genome assembly
Single pass reads generated on the PacBio® SMRT sequencer (Pacific 
BioSciences, USA) were assembled using the Hierarchical Genome Assembly 
Process 3 (HGAP3) (Chin et al. 2013), under default conditions and a predicted 
genome size of 34 Mb. This software uses an Overlap-Layout-Consensus algorithm 
to generate a polished de novo assembly of large genomes. Other assembling 
softwares are available for this purpose, but HGAP3 is recommended by the 
sequencer manufacturer PacBio and is implemented within the SMRT Portal. The 
polished assembly contained 536 contigs (n50 = 421,740 bp), assembled from 
201,878 reads of 14,594 bp on average. The genome has been deposited in 
ENA/GenBank under the accession number NHOR01000000.
The IL3000 genome was produced at the Centre for Genomic Research (University 
of Liverpool) on the PacBio SMRT sequencer and given to us as a draft genome 
containing 1,415 contigs (n50 = 156,211 bp) for the sole purpose of VSG ES 
analysis.
4.2.5 Genome annotation
For both strains, assembled contigs were annotated using the web server 
Companion (Steinbiss et al. 2016), using RATT (Otto et al. 2011) on species mode 
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to transfer relevant annotation from T. brucei 927, with ab initio gene finding using 
AUGUSTUS (Stanke et al. 2004) with a score threshold of 0.7 to make gene 
prediction more sensitive.
4.2.6 Contig selection 
Identification of telomere-containing contigs
The first step in the investigation of the telomeric context of T. congolense was to 
identify and retrieve genomic contigs containing a string of 3 or more telomeric 
repeats at their ends. This was performed using Repeat Masker 
(http://repeatmasker.org) on the polished assembly, which searches DNA 
sequences for repeats and low complexity DNA sequences and provides detailed 
annotation on their location and composition. Thus, all the contigs with identifiable 
strings of telomeric repeats were selected and manually curated. Contigs with 
telomeric repeats not located at the ends were discarded and considered 
sequencing or assembly errors. 
Identification of Contigs Containing IL3000 telomeric features
To check that the features identified in the IL3000 telomeric contigs from John 
Donelson and the sequencing project (Jackson et al. 2012) were specific to 
telomere-associated contigs, the polished assemblies were screened by sequence 
similarity search [BLASTn and tBLASTx (Altschul et al. 1990)]. BLAST was also 
used to search for conserved regulatory regions and ESAGs. The conserved non-
coding regions (CNR) described in section 4.3 (‘Results’), were identified from the 
preliminary data (369 bp repeat, CNR1 and CNR2) and from repeated observations 
of conserved open reading frames (CNR3 and CNR4) in the BLAST output. A 
significance threshold (E-value) of 10-4 was applied and all regions manually 
checked by ACT (Carver et al. 2005) and multiple sequence alignment.
4.2.7 Contig annotation
The features identified by the sequence similarity searches were annotated into the 
respective contigs using Artemis (Rutherford et al. 2000).
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4.2.8 Multiple Sequence Alignment
Nucleotide sequences of conserved non-coding regions of T. congolense Tc1/148 
were aligned with ClustalW (Larkin et al. 2007) and manually curated. The 126 
CNR1 sequences produced an alignment of 3632 nucleotides. The conserved Non-
Coding Region 2 (CNR2) produced an alignment of 37 sequences and 176 
nucleotides. The conserved Non-Coding Region 3 (CNR3) produced an alignment 
of 15 sequences and 199 nucleotides. The conserved Non-Coding Region 4 (CNR4) 
produced an alignment of 21 sequences and 148 nucleotides. Amino acid 
sequences of conserved coding regions found in multiple telomere-containing 
contigs (Fam15, Fam53, DEAH-box RNA helicase, cathepsin B) were aligned with 
ClustalW (Larkin et al. 2007). The Fam15 alignment was comprised of 217 
sequences from T. brucei and T. congolense IL3000 and Tc1/148 of 435 amino 
acids. The Fam53 protein alignment consists of 173 sequences from T. brucei, T. 
congolense IL3000 and Tc1/148, T. vivax and T. cruzi and has 294 amino acids. 
The DEAH-box RNA helicase alignment contains 50 sequences from T. brucei and 
T. congolense IL3000 and Tc1/148 of 1089 amino acids. The cathepsin B alignment 
has 23 sequences from T. brucei and T. congolense IL3000 and Tc1/148 of 347 
amino acids.
4.2.9 Phylogenetic estimation
To investigate orthology between T. brucei and T. congolense ESAGs and their 
relationship with family members outside the ES context, phylogenies were 
estimated for each of the ESAGs using protein sequences. Phylogenies were 
estimated from protein sequence alignments with maximum likelihood following 
automatic model selection (Lefort et al. 2017) using PHYML v3.0 (Guindon & 
Gascuel 2003) and RaXML (Stamatakis 2014). Robustness was assessed with 100 
bootstrap replicates. 
4.2.10 Comparison of tree topology
When the T. brucei telomeric ES were described by Hertz-Fowler et al. (2008), it 
was found that the tree topologies of different loci were distinct across the ES. This 
showed that the phylogenetic signal along the ES was variable, and thus indicated 
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that sequence recombination was a driver of ES evolution. To evaluate whether the 
same applied to T. congolense, the differences in phylogenetic signal between 
different loci of the ES were calculated by evaluating the significance of the 
differences in likelihood values between the optimal tree and the constrained tree. 
ML phylogenetic trees were estimated for each CNR1 and CNR2-4 using the 
Tamura-Nei model (Tamura & Nei 1993) in MEGA7 (Kumar et al. 2016), resulting in 
4 phylogenies. Under the same methods, phylogenetic topologies were constrained 
to the topology of the optimal CNR1 tree, resulting in 3 phylogenies. Likelihood 
values recorded for the phylogenies of CNR2-4 and the differences between 
constrained and unconstrained topologies were calculated. The significance of such 
differences was evaluated using the Shimodaira-Hasegawa test (Shimodaira & 
Hasegawa 1999) in RaxML (Stamatakis 2014). Likelihood comparisons require 
comparable trees to have equal taxon sets, thus only contigs containing both of the 
features being compared were included (i.e. CNR1 and CNR2; CNR1 and CNR3; 
CNR1 and CNR4; CNR3 and CNR4). Because the number of contigs containing 
CNR2 and CNR3 or CNR2 and CNR4 was below the minimum threshold for 
phylogenetic estimation (N = 4), the phylogenetic signal between them was not 
measured. 
4.2.11 Recombination and selection tests
To understand whether the DEAH-box RNA helicase family expansion was a 
telomeric-unique phenomenon (and therefore linked to their transposition to that 
genomic context), the role of recombination in the expansion was investigated. This 
was performed by predicting breakpoints with the Genetic Algorithm for 
Recombination Detection (GARD) (Kosakovsky Pond et al. 2006). GARD was run 
using the REV model, under the AICc information criterion. The Kishinoi-Hasegawa 
(KH) test was applied to test for rate heterogeneity to account for the effect of 
significant topological incongruences. The role of selection in sequence evolution 
was assessed with three site-level selection tests. These were the Fixed Effects 
Likelihood (FEL) to directly estimate dN/dS ratios (Pond & Frost 2005); the Random 
Effects Likelihood (REL) to infer selection pressures using an empirical Bayes 
approach and model (dN/dS) ratios at individual sites based on a pre-defined 
distribution; and the Fast Unbiased Bayesian Approximation (FUBAR) to estimate 
 based on Bayesian Inference using a MCMC routine (Murrell et al. 2013). One 
branch-level test (BRL) based on an empirical Bayes approach was also applied to 
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infer selection pressures in individual phylogenetic lineages (Kosakovsky Pond et al. 
2011). 
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4.3 Results
To investigate whether T. congolense has conserved telomere-associated 
structures, as observed in T. brucei, long-read SMRT sequencing of two strains, 
Tc1/148 and IL3000, was performed to allow detection of contigs containing 
telomeric repeats at the ends. This approach also allowed the description of non-
VSG genes found in the telomeres and the investigation of the role of recombination 
in telomeric sequence evolution. As the context identified in both genome 
sequences were consistent with the sequences from the clones of the IL3000 of the 
actively-transcribed VSG, I will treat the telomere-containing contigs and their 
structure as T. congolense VSG ES.
4.3.1 The telomere-containing contigs
In my Tc1/148 genome sequence, 153 contigs contained a string of telomeric 
repeats at their end. These included 25 complete mini-chromosomes, containing 
one telomeric repeat at each end and a long complex 369 bp repeat in the middle. A 
complex repeat homologous to the 369 bp repeat previously described in T. 
congolense mini-chromosomes (Moser et al. 1989) was found in 80 % of the contigs 
and 66 % had a non-coding region that resembles a transcription promoter. 
The 369 bp complex repeat was considered the proximal boundary of the ES 
because it occupies the centre of complete mini-chromosomes, being flanked by 
CNR1 at each end. This suggests the presence of two identical ES, one at each 
telomere. Furthermore, when the 369 bp complex repeat is found in the megabase 
chromosomes, it is the most proximal conserved region identified, separating the ES 
from the subtelomere.
Three other conserved non-coding regions were identified: CNR2 was found in 31 % 
of the contigs and also in the ‘IL3000 ES’. CNR3 and CNR4 were found in 8 and 12 
% of the contigs, respectively. Full-length VSGs were found in 50 % of contigs, 
occasionally adjacent to other VSGs and VSG pseudogenes. Coding sequences 
found in the telomeres included 2 contigs with a cathepsin B (1 %), 7 contigs (5 %) 
with transferrin receptors (Fam15), 3 contigs (3 %) with ESAG3-like genes (Fam53), 
17 (11 %) with a DEAH-box RNA helicase, 16 contigs (10 %) with RHS genes, and 
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a range of low-copy number hypothetical proteins. The transposable element Ingi 
was found inside the ES in 15 contigs (2 %).
In the IL3000 genome, the scenario was very similar. Six complete mini-
chromosomes were identified, with a structure identical to those in Tc1/148, and two 
contigs were assigned to megabase chromosomes 9 and 11. Of the 128 contigs 
with a string of telomeric repeats at their end, 127 contained the 369 bp repeat (99 
%) and 122 the CNR1 (95 %). The CNR2-4 were found in 77 (60 %), 25 (20 %), and 
30 (23 %) contigs, respectively, and VSGs in 51 contigs (40 %). Cathepsin B was 
found in one contig (1 %), Fam15 was found in 5 contigs (4 %), and 7 contigs (5 %) 
contained DEAH-box RNA helicases. 
4.3.2 T. congolense has canonical telomeric structures
Taking into account both strains, a consensus canonical telomeric structure was 
inferred and shown in Figure 31. This consists of the 369 bp repeat, CNR1, the 
VSG and CNR2-4. These are the features that are more abundant and exist always 
in the same relative position. 
Figure 31 The consensus structure of the telomere-associated structures in T. 
congolense. Conserved structures are colour-coded and named and their frequency in the 
telomere-containing contigs given by the bar chart. 
The 369 bp repeat
The 369 bp repeat was found in 80 and 99 % of contigs, respectively, always close 
to the telomere and exclusively in the context of the ES. This repeat is highly 
repetitive and has an AT-rich complex sequence (66.71 %±0.37). Figure 32 shows 
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a multiple sequence alignment of the 369 bp repeat from the Tc1/148 and IL3000 
genome sequences. For clarity, only 50 sequences from each strain were used. The 
figure highlights the high nucleotide conservation, mostly greater than 95 %, across 
contigs and between strains. In Tc1/148 and some sporadic contigs of IL3000, the 
repeat is 359 bp rather than 369 bp, due to an insertion between nucleotides 241 
and 250 in IL3000 (marked in Figure 32 by dashed box). Occasionally, and in 
IL3000 only, the repeat is palindromic. 
The 369 bp repeat has been previously described as a feature of mini-
chromosomes, analogous to the 177 bp repeats in T. brucei (Moser et al. 1989; 
Sloof et al. 1983). This is consistent with our results in both strains. A southern blot 
gel run by Simon D’Archivio at the University of Nottingham confirms that the repeat 
is present in the mini-chromosomes (Figure 33), but it does not show evidence for 
the 369 bp repeat presence in megabase chromosomes. This contradicts the finding 
of the 369 bp repeat in the megabase chromosome 5 of Tc1/148 (1.57 bp in length, 
spanning the subtelomere and the core), and its presence in the IL3000 original 
genome sequencing project (which was a back-end library of the megabase 
chromosomes) (Jackson et al. 2012). Both these studies associate the 369 bp 
repeat with megabase chromosomes and suggest it is not exclusive to the small 
chromosomes, but rather to the telomeric context.
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Figure 32 Multiple sequence alignment of the 369 bp repeat in IL3000 and Tc1/148. Strain identity is marked on the left. IL3000-specific insertion is 
denoted by dashed box. Shade represents nucleotide conservation ≥ 95 %.
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Figure 33 The karyotype of T. brucei spp. and T. congolense. Southern Blot gel shows 
staining with ethidium bromide, hybridization to labeled mini-chromosome satellite repeats 
(177 bp in T. brucei spp. and 369 bp in T. congolense, and hybridization to labeled telomeres 
(D’Archivio, S., unpublished).
CNR1 
CNR1 is a conserved non-coding region of a variable size up to 3584 bp, but with a 
consistent conserved region common to all contigs (65 % sequence identity) and an 
ultra-conserved core of 302 nucleotides between residue 1893 and 2195 sharing 87 
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% identity. Figure 34 shows the nucleotide variation (entropy) and the frequency of 
each residue across the alignment of all CNR1 sequences. The graph shows 
nucleotide conservation is highest (i.e. lowest entropy) around residue 2129; the 
most variable regions locate just before residue 1445 and around residue 1813. In 
terms of residue frequency  across all sequences, the core part of the alignment (i.e. 
between nucleotides 1445 and 2813) is present in most sequences, whereas the 
beginning and end of the alignment are less common, suggesting a high length 
variation in the region. This structure is only found within the ES context. 
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Figure 34 CNR1 sequence variation and frequency in Tc1/148. Graph shows the Shannon 
entropy of the multiple sequence alignment of the CNR1 region in grey (left axis) and the 
frequency of each residue across the multiple contigs in green (right axis). Top percentages 
represent sequence identity at each region. 
VSG
In Tc1/148, VSGs were found in a telomeric context in 90 contigs. In the vast 
majority, they represented the most telomere-proximal coding sequence. To 
determine whether VSGs were randomly assigned to the telomeres or whether 
particular phylotypes were consistently absent, all VSG from the telomeres were 
retrieved and analysed. Results show that they derive from both Fam13 and Fam16 
and that most, but not all, phylotypes are represented (Table 9). Phylotypes 6 and 9 
were not found at the telomeres in either Tc1/148 or IL3000. The genomic and ES 
VSG profiles of each strain correlate very poorly (IL3000 R2 = 0.07; Tc1/148 R2 = 
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0.002). Additionally, whilst the genomic VSG profiles of IL3000 and Tc1/148 
somewhat correlate (R2 = 0.59), their ES profiles do not (R2 = 0.11). Nonetheless, 
the difference between profiles was not significant either between individual 
phylotypes (student t-test, p > 0.05 for all phylotypes) or between complete VAPs 
(Poisson regression model, p > 0.05). Therefore, it is still possible that the 
differences in repertoire observed between the genome and the ES are due to 
chance alone.
Table 9 Variant antigen profiles of the genomic VSG and the telomeric VSG (ES) from 
IL3000 and Tc1/148. Values are shaded according to key. Blue represents low frequency 
and red represents high frequency of a given phylotype.
CNR2
CNR2 is conserved non-coding region composed of 180 bp repeats found 
exclusively in a telomere-associated context. It is always located between the CNR1 
and the VSG at conserved distances. In Tc1/148, CNR2 is associated with a 
telomere in 36 contigs. In those, in 75 % of the cases (27), it is located an average 
of 4,229 (± 770) bp upstream of the telomere. In the remaining 25 % of the cases (N 
+-
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= 9) it is located it is further away, i.e. 20,500 (± 3,347) bp upstream of the telomere. 
The region is also associated with a VSG in 20 contigs: in 16 of those it locates 
2,498 (±944) bp upstream of it and in 4 of them is positioned 16,023 (± 2,784) bp 
upstream. Whilst the overall nucleotide similarity can be as low as 40 %, CNR2 is 
compositionally consistent and various blocks of highly conserved nucleotides (> 70 
%) are visible (Figure 35), such as a 5’-GTTGATT-3’ string between residues 78 
and 85 and a 5’-GCTCTCT-3’ string between positions 102 and 108 of the 
alignment. Furthermore, its relative positioning to the telomere and the VSG is 
conserved in both strains. 
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Figure 35 Multiple sequence nucleotide alignment of CNR2. Top sequence is from 
IL3000 active ES; remaining sequences were retrieved from the Tc1/148 ES. Shade 
represents nucleotide conservation ≥ 70 %.
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CNR3
CNR3 is a highly conserved 200-nucleotide sequence present exclusively in the 
context of the VSG ES (). CNR3 can be found in 12 contigs in Tc1/148 always 
downstream of the VSG. On average, CNR3 locates 1,047 (± 280) bp downstream 
of the VSG and 536 (± 174) bp upstream of the telomere. CNR3 was identified in 
IL3000 as the pseudogene TcIL3000_04880, but it is most likely a conserved non-
coding region. There is no evidence for gene expression in any of the available 
datasets for T. congolense [EST library data (Helm et al. 2009), the bloodstream 
form IL3000 transcriptome (Wellcome Trust Sanger Institute pre-release 
(https://www.ebi.ac.uk/arrayexpress/experiments/E-ERAD-440/), and all the 
epimastigote/metacyclic transcriptomes produced for chapter 3]. It is a T. 
congolense-specific sequence with no other gene orthologue anywhere in the 
reference genome, the GC content is higher than the average for T. congolense 
coding sequences, and there are multiple internal stop codons in the sequence. 
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Figure 36 Multiple sequence nucleotide alignment of CNR3. Top sequence is from 
IL3000 genome (TcIL3000_0_04880); remaining sequences were retrieved from the 
Tc1/148 ES. Shade represents nucleotide conservation ≥ 70 %.
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CNR4
CNR4 is a 148 bp region highly conserved towards the 3’ end (Figure 37). In 
Tc1/148, it was found in 18 contigs, two of which have two CNR1 sequences and 
thus were not used for positioning analysis. Of the 16 contigs with a single CNR1, 
CNR4 was always found associated with both a VSG and a telomere. In all 
instances, it locates 1,386 (± 483) bp downstream of the VSG and in 15/16 
instances 458 (±207) bp upstream of the telomere. In the only exception, it locates 
12,234 bp upstream of the telomere, but still within the same distance from the VSG 
as the others. CNR4 was first identified in the IL3000 genome as the pseudogene 
TcIL3000_0_12610, but when putting it in the context of the remaining copies, it 
becomes more likely to be a non-coding region. Compositionally, CNR4 does not 
resemble a coding sequence, its translation in any frame results in heavily 
pseudogenic sequences, there is no orthologue in the IL3000 genome, there is no 
evidence for its expression in any of the available datasets [EST library data (Helm 
et al. 2009), the bloodstream form IL3000 transcriptome (Wellcome Trust Sanger 
Institute pre-release (https://www.ebi.ac.uk/arrayexpress/experiments/E-ERAD-
440/), and all the epimastigote/metacyclic transcriptomes produced for chapter 3], 
and the GC content is higher than average for T. congolense coding sequences (60 
% vs. 51 %).
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Figure 37 Multiple sequence nucleotide alignment of CNR4. Top sequence is from 
IL3000 genome (TcIL3000_0_12610); remaining sequences were retrieved from the 
Tc1/148 ES. Shade represents nucleotide conservation ≥ 70 %.
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4.3.3 T. congolense telomere-associated genes lack evidence for 
sequence adaptation to the telomere
Although not all ESAGs are essential for ES activation, the T. brucei ESAG 
repertoire, as a whole, is a necessary and constitutive feature of the BES (Becker et 
al. 2004; Hertz-Fowler et al. 2008). To understand whether the same principle 
applied to T. congolense, the coding sequences found within the telomeric context 
were analysed. The first striking difference between species is that the non-VSG 
coding sequences are not part of the canonical structure, but rather scarce and 
variable in position. There are coding regions that resemble those present in the T. 
brucei ES, such as the transposable element ingi, Fam15, and Fam53, yet they are 
not orthologous to those T. brucei ESAGs. 
Fam15
Fam15 is a transferrin-receptor gene family present in T. congolense and T. brucei, 
but not in T. vivax. In 2013, Jackson et al showed that this family evolved from 
VSGs after the separation of T. vivax from the remaining African trypanosomes. 
Fam15 in T. brucei is comprised of ESAG6 (GPI+), ESAG7 (GPI-) and a single 
GPI+/GPI- tandem pair (Tb927.7.3250/3260) at a strand-switch region on 
chromosome 7. Therefore, ESAG6/7 are almost exclusively located at the BES and 
always in tandem pairs. In T. congolense IL3000, Fam15 has expanded (45 genes 
compared to 23 in T. brucei) and most copies of both GPI-positive and GPI-negative 
versions of the gene are found throughout the subtelomeres. In the telomeric 
context, Fam15 was found in 7 contigs in Tc1/148 and in 5 contigs in IL3000 
(Figure 38). These genes are homologous to the copies found in the subtelomeres, 
but they are not necessarily arranged in tandem pairs. The phylogeny of Fam15 
shows that although homologous, ESAG6/7 and T. congolense TFR genes are 
paraphyletic and therefore not orthologous to each other. This corroborates the 
findings of Jackson et al. (2013) that ESAG6/7 are a T. brucei specific innovation for 
the BES.
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Figure 38 Consensus maximum likelihood phylogeny of the transferrin receptors 
protein sequences from Trypanosoma congolense and Trypanosoma brucei. The 
phylogeny was estimated with PHYML with a JTT+ model and 100 bootstrap replicates. 
Terminal nodes are coloured by species according to key; bootstraps higher than 70 % are 
shown in the internal nodes. Green arrows show the position of T. congolense telomeric 
genes. Dashed line separates Fam14 (Procyclic-associated genes (PAG) and PAG-like 
genes) from Fam15 (ESAG6/7 and ESAG6-like genes).
Fam53
Fam53 encodes ESAG3 and ESAG3-like proteins in all trypanosomatids. However, 
in T. brucei, this family has expanded considerably in the subtelomeres; some 
members have transposed to the BES to become involved in VSG expression. 
ESAG3 is the only gene with flexible positioning within the ES and is often 
associated with recombination breakpoints, which might indicate a role of this gene 
family in BES recombination and/or VSG switching (Hertz-Fowler et al. 2008). 
Despite this expansion, T. brucei retains further subtelomeric copies, divergent in 
sequence to telomeric ESAG3-like genes (‘GRESAG3’). These genes have co-
orthologues in T. congolense, T. vivax and T. cruzi  (Figure 39).
 In T. congolense, only 5 copies of ESAG3-like genes were found at the telomeres, 
all homologous to the genes located at the subtelomeres. In IL3000, 19 telomere-
associated contigs contained Fam53 members; all of these genes clustered with the 
Tc1/148 ESAG3-like genes from both the subtelomere and the telomere. However, 
in the subtelomere, two distinct genes were found to cluster separately from this 
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clade. The amino acid sequence of these genes is more similar to those of 
GRESAG3. Together, these findings suggest that, like T. brucei, T. congolense has 
also expanded ESAG3-like sequences. Despite this analogous situation, T. 
congolense and T. brucei are not orthologous, forming two distinct clades in the 
phylogeny (Figure 39).
Figure 39 Consensus maximum likelihood phylogeny of Fam53 protein sequences from 
African Trypanosomes. The phylogeny was estimated with PHYML with a WAG+ model 
and 100 bootstrap replicates. Clades are colour-coloured by species; internal nodes are 
labelled with bootstrap percentages higher than 70 %. Green arrows show the position of T. 
congolense telomeric genes. Dashed line separates ESAG3 and ESAG3-like genes from 
GRESAGs.
Whilst the data suggest that there are no orthologues to T. brucei ESAGs in T. 
congolense, there may be T. congolense specific genes that fulfil the criteria of an 
expression site associated gene. Such ESAGs could have originated from the same 
process, but recruited from different gene families. The other non-VSG coding 
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regions found distributed in the ES were cathepsin B, DEAH-box RNA helicases, 
and a range of hypothetical proteins. 
Cathepsin-B
Cathepsin-B is a family of cysteine proteases that is single-copy in T. brucei and T. 
vivax, but has expanded in T. congolense (Mendoza-Palomares et al. 2008). 
Cathepsin-B is essential for T. congolense survival, being implicated in lysosomal 
protein degradation and immunogenicity (Mendoza-Palomares et al. 2008). One 
copy of cathepsin-B was found in the IL3000 actively transcribed VSG ES. This 
copy was also found in the new IL3000 assembly in a similar context. In Tc1/148, 
two telomeric contigs harbour cathepsin-B, all containing the canonical structures 
described above and the flanking genes present in the active ES of IL3000 (i.e. 
RNase A, zinc-finger protein). These four cathepsin-B copies are all part of a known 
derivation of proteins where the catalytic cysteine has been replaced by a serine 
residue (Figure 40) (Mendoza-Palomares et al. 2008). Despite this peculiarity, they 
are homologous to the cathepsin-B genes found in the core chromosomes, showing 
no evidence for a T. congolense-specific adaptation of cathepsin-B to the telomeres. 
Figure 40 Consensus maximum likelihood phylogeny of cathepsin B protein sequences 
from African Trypanosomes. The phylogeny was estimated with PHYML with a 
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WAG+ model and 100 bootstrap replicates. Bootstrap percentages higher than 70 % are 
shown in the internal nodes. Green arrows show the position of telomeric genes. The amino 
acid substitution cysteine to serine is shown in pink. Tree is mid-rooted.
DEAH-box RNA helicase
DEAH-box RNA helicases were found inside the ES in 17 telomere-containing 
contigs from Tc1/148 and 7 from IL3000. These genes were occasionally arranged 
in tandem pairs. Phylogenetic analysis showed that ES copies cluster with 
subtelomeric copies, but have likely derived from a specific helicase from 
chromosome 6 (Figure 41). This helicase exists in all trypanosomatids in a similar 
genomic context; its locus is characterised by a strand-switch region at the 5’ end, 
followed by a conserved serine/threonine protein phosphatase that has been lost in 
T. congolense, only. At the 3’ end, it is flanked by several conserved genes, 
including a dephospho-CoA kinase (TcIL3000_6_260). 
The phylogeny suggests that T. congolense expanded this particular copy of DEAH-
box RNA helicases from the core into the subtelomere. Often, these genes can be 
transposed to the telomeres, by unknown mechanisms. To test the contribution of 
selection to the expansion of this gene family, we searched for evidence of 
recombination using GARD (Pond et al. 2006) and subsequently performed three 
tests of site-level selection [FEL, FUBAR, and REL (Pond & Frost 2005; Murrell et 
al. 2013)] and one test of branch-level selection (BSR) on non-recombinant 
sequences. Two significant breakpoints were found at nucleotide 873 and 1522, but 
inspection of the sequence alignment did not reveal an obvious recombination point. 
Regarding the role of selection, all tests agreed on one site being under diversifying 
selection, whilst the remaining sites showed evidence for purifying selection, 
suggesting that the DEAH/box RNA helicase expansion in T. congolense is not 
driven by positive selection or gene conversion. Together, these results indicate that 
the DEAH-box RNA helicase expansion in T. congolense is not a telomeric-unique 
phenomenon. 
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Figure 41 Consensus maximum likelihood phylogeny of DEAH-box RNA helicase 
protein sequences from Trypanosoma congolense and Trypanosoma brucei. The 
phylogeny was estimated with PHYML with a VT++F model and 100 bootstrap replicates. 
Branches are labelled with bootstrap percentages higher than 70 %. Green arrows show the 
position of telomeric genes.
Retroposon hot spot protein pseudogenes were found inside the ES in fifteen 
contigs. One is found within or in the boundary of the ES in 6 contigs (i.e. 
TcIL3000_0_56340) and expression data suggest it is expressed in both metacyclic 
and bloodstream form life stages, and three seem to be preferentially expressed in 
the metacyclic stage (TcIL3000_0_32470, TcIL3000_0_32480, TcIL3000_0_32490) 
(Helm et al. 2009, The Wellcome Sanger Institute, ENA sample accession number 
SAMEA3629513). The latter belong to a subtelomeric tandem array and they exist 
in at least eight more instances throughout the subtelomeres. Due to their short 
length, it is likely that the expression data refers to the subtelomeric copy of the 
genes. Their role, if any, in VSG expression, remains unclear, but their absence 
from the IL3000 ES suggests they may result from sporadic, arbitrary translocations 
to the Tc1/148 ES. 
Six other coding sequences were found inside the Tc1/148 ES. These corresponded 
to four predicted hypothetical proteins in the IL3000 genome (Table 10). Three 
genes have been shown to be expressed, either by EST library (Helm et al. 2009), 
metacyclic/epimastigote transcriptomes (chapter 3) or bloodstream form 
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transcriptome (The Wellcome Sanger Institute, ENA sample accession number 
SAMEA3629513). 
Table 10 Hypothetical proteins found inside the ES of Tc1/148 and their available 
expression data. IDs are given for the IL3000 best hits obtained by sequence similarity 
search.
Together, these results indicate that whilst there are T. congolense ESAGs, they are 
either paralogous or analogous, but not orthologous to T. brucei ESAGs and none 
approach their exclusivity, as they are not functionally distinct isoforms found 
uniquely in the ES.
4.3.4 Tree Topology
To explore the role of recombination in the T. congolense telomere evolution, 
phylogenetic relationships between different CNRs were investigated by likelihood 
comparisons of optimal and constrained trees (Figure 42). In the absence of 
recombination, the phylogenetic relationships between features along the telomeric 
structure should be constant, only reflecting the pattern of telomere duplication. 
However, if homologous recombination plays a role in sequence evolution, as 
observed in T. brucei ES, the optimal topology for each feature will be distinct to 
reflect the pattern of sequence exchange and telomeric reorganisation. 
The phylogenetic signal varies along the T. congolense ES as suggested by the 
visible differences in between the optimal phylogenies of the CNR1 and CNR2-4. 
These differences are evident at the topological level and the comparison of their 
log-likelihood scores reveals they are statistically significant (p<0.01). For all four 
combinations, comparing the likelihood score of the optimal topology with the 
constrained topology score resulted in a decrease, although a linear relationship 
with physical distance could not be established. The highest topological dissimilarity 
occurs between the CNR1 and CNR2, suggesting that a recombination point might 
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exist between these loci. However, further analysis of recombination using GARD 
did not reveal any significant breakpoints within the conserved sequences.
Figure 42 The difference in phylogenetic signal along the conserved non-coding regions 
of the ES. The first three tanglegrams relate the CNR1 phylogeny with those of CNR2-4 and 
the last relates CNR3 with CNR4. Black lines link corresponding contigs. Incongruence is 
highest in CNR2 and lowest in CNR3, although still significant. 
4.3.5 The chromosomal location of the telomere-associated structures
From the Tc1/148 genome assembly, three contigs undoubtedly belong to the 
megabase chromosomes due to their length (1.78Mb, 1.57Mb, and 1.16Mb) and 
polycistronic gene organisation (Figure 43). The 1.78Mb contig belongs to 
chromosome 10 and does not contain the canonical structure described in this 
chapter. Instead, it is comprised of multiple VSGs and one partial copy of CNR3. At 
the subtelomeres, multiple copies of VSG and DEAH-box RNA helicase also exist. 
Additionally, at the core end of the 1.78 Mb contig, there is the only evidence of 
CNR4 outside the telomeric context. The 1.57 Mb contig belongs to chromosome 11 
and contains a canonical structure: the 369 bp repeat, preceded by ingi; CNR1 in 
the same strand; one frameshifted VSG in the complementary DNA strand; and 
CNR4 immediately upstream of the telomere. In the core and subtelomere of the 
1.57Mb contig, multiple VSG copies and one DEAH-box RNA helicase were found. 
The 1.16Mb contig belongs to chromosome 6 and also lacks a complete canonical 
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telomeric structure. However, it does have a VSG pseudogene and two adjacent 
copies of CNR3 and CNR4 in the leading DNA strand as the last features upstream 
the telomere. VSGs were not identified anywhere else in the contig, but two copies 
of DEAH-box RNA helicases, two copies of cathepsin-B, and one ESAG8-like gene 
were found dispersed along the subtelomere and core. In IL3000, contigs were not 
long enough to be undoubtedly assigned to the megabase chromosomes, although 
the scaffolded assembly has allocated two telomere-containing contigs to 
chromosomes 9 and 11, both of which contain the full canonical structure described 
here. 
The Tc1/148 genome assembly also resulted in 25 complete mini-chromosomes 
with sizes ranging from 20,914 to 37,974 bp. The general structure of the mini-
chromosomes includes a long string of the 369 bp repeat in the centre, flanked by 
CNR1, VSGs, CNR2-4 and other coding regions. Figure 44 shows all the structural 
combinations found. Nineteen out of twenty structures have VSGs, always as the 
most telomere-proximal coding region. In two instances, the transferrin receptor is in 
this position. All but two of the full mini-chromosomes recovered have at least one 
CNR1, always adjacent to the 369 bp repeat. The CNR2 is present in 4 of the 20 
topologies and is always located adjacent to the CNR1. Conversely, CNR3 and 
CNR4 were only found in 2 topologies, always after the VSG but immediately 
preceding the telomere. The IL3000 genome assembly resulted in 6 complete mini-
chromosomes with sizes ranging from 21,075 to 37,994 bp. The general structure is 
identical to that described for Tc1/148 with the only exception that the 369 bp repeat 
is occasionally palindromic. These results indicate that the telomere-associated 
canonical structures are commonly present in the mini-chromosome ends. 
In summary, this chapter presents more than one hundred telomere-associated 
structures in each strain (150 in Tc1/148 and 128 in IL3000). It shows that this is a 
canonical structure conserved across telomeres and strains, composed of one 
complex repeat, the VSG, and at least four conserved non-coding regions. 
Additionally, these structures may contain non-VSG coding regions of variable 
functions, including cathepsin B, DEAH-box RNA helicase, Fam53, and conserved 
hypothetical proteins. Finally, it suggests that the telomere-associated structures are 
subject to homologous recombination and sequence reorganisation. Together, these 
results show that, like T. brucei, T. congolense has canonical telomeric structures 
that are likely to be VSG ES. However, they are analogous and not homologous to 
the T. brucei ES. 
147
Figure 43 Structure of the telomere-containing contigs from the Tc1/148 megabase 
chromosomes. Contigs 1-3 belong to chromosome 10, 11, and 6, respectively, according to 
sequence similarity searches. Contigs are drawn to scale and have been aligned at their 
telomeric end. Conserved features are shown according to key.
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Figure 44 The non-redundant structure of the T. congolense mini-chromosomes in 
Tc1/148 and IL3000. A. Artemis plot of a complete mini-chromosome with a GC content 
graph. B. Mini-chromosomes are drawn to scale and have been aligned at their 5’ end. 
Conserved features are shown according to key.
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4.4 Discussion 
This chapter identified and described VSG-rich structures at the telomeres of T. 
congolense using SMRT sequencing technology. The data presented shows that 
the T. congolense telomeres in multiple strains are associated with a repetitive 
domain, that has a canonical structure consisting of a complex repeat region, the 
VSG gene and four conserved non-coding regions, here named CNR1-4. In 
addition, they were shown to contain sporadic non-VSG genes, predominantly a 
specific lineage of DEAH-box RNA helicases, Fam53 and Fam15. These results 
were consistent in both Tc1/148 and IL3000. 
Second-generation sequencing technologies (e.g. Illumina Sequencing) have been 
exceedingly useful, but they rely on short read lengths, which makes genome 
assembly difficult. This is particularly challenging for repetitive regions such as the 
telomeres and the mini-chromosomes, (Rhoads & Au 2015). For trypanosomes, 
short-read sequencing has resulted in genome assemblies containing large ‘bins’. 
From an expression site point of view, these may potentially contain useful data. 
Long-read sequencing, such as SMRT sequencing (Pacific BioSciences, USA), may 
resolve this issue. Initially developed mainly for bacterial genomes, SMRT 
sequencing has improved to be applicable to large genomes. SMRT sequencing 
offers read lengths up to 60 kb, facilitating assembly of repetitive regions. As 
genomes get fragmented less often, they potentially conserve unique flanking 
sequences that can determine the origin of the read. The on-going improvements in 
the technology have also allowed for the polymerase read quality to be generally 
higher than 84 % and thus resolve the initial issue of higher error rate (Rhoads & Au 
2015). Moreover, although SMRT cells are less efficient than short-read sequencing 
technologies both in terms of number of successful reads and number of reads 
yielded (e.g. 3.5–7.5x104 reads, compared to 1.2x109 paired reads per run in 250 bp 
Illumina HiSeq 2500 ; Rhoads & Au 2015), this issue can be partially overcome by 
using multiple SMRT cells. In this chapter, I have shown that SMRT sequencing can 
be helpful in describing the sequence diversity of telomeres and mini-chromosomes 
of African trypanosomes.
When the 369 bp repeat was discovered, it was proposed as a feature of the T. 
congolense mini-chromosomes (Kukla et al. 1987; Gibson et al. 1988; Moser et al. 
1989), analogous to the 177 bp repeat in T. brucei (Sloof et al. 1983; Gibson et al. 
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1988), the 170 bp repeat in T. vivax (Dickin & Gibson 1989), the 550 bp repeat in T. 
simiae (Majiwa & Webster 1987) and the 195 bp repeat satellite DNA in T. cruzi 
(Gonzalez et al. 1984). All these repeats correspond to 5-10 % of the total nuclear 
genome and, with the exception of T. vivax, are AT-rich (29-35 % GC) (Gonzalez et 
al. 1984; Dickin & Gibson 1989; Moser et al. 1989). Indeed, the majority of contigs 
containing the 369 bp repeat described in this chapter belong to mini-chromosomes. 
However, I show that it can also be associated with megabase chromosomes. The 
conservation of the telomeric structures described in this study, the abundance of 
VSGs found, and the fact that the active VSG in IL3000 was found in a similar 
genomic context, suggest that these structures are T. congolense VSG expression 
sites. On this basis, a striking difference between T. congolense and T. brucei is that 
the majority of ES containing VSGs are found at the ends of mini-chromosomes. 
T. brucei mini-chromosomes are rich in VSGs (Marcello & Barry 2007a; Cross et al. 
2014). In T. brucei, mini-chromosomes are thought to be transcriptionally silent 
(Wickstead et al. 2003; Wickstead et al. 2004). The first instance of evidence 
supporting this conclusion comes from the observation that the 177 bp repeat is not 
transcribed (Sloof et al. 1983). Subsequently, members of the Cross and Borst 
laboratories showed that VSGs from mini-chromosomes must be converted to one 
of the ES in the megabase chromosomes to become active (de Lange et al. 1983; 
Van der Ploeg et al. 1984; Borst 1986; Cross 1990). More recent evidence 
corroborating the previous studies includes experiments of ectopic gene expression 
from the mini-chromosomes (Wickstead et al. 2002) and the transcriptomic analysis 
of T. brucei Lister 427, where very few reads map to sequences from the mini-
chromosomal DNA (Siegel et al. 2010). Furthermore, the canonical features of the 
T. brucei ES, i.e. the ESAGs, are absent from the mini-chromosomes (Wickstead et 
al. 2004). In contrast, in T. congolense the same canonical structure is found 
throughout the mini-chromosomes and the megabase chromosomes. This might 
indicate that the ES of both chromosome types can become active. However, it 
could also be that all mini-chromosome and megabase chromosome ES captured in 
this analysis are silent, like they are in T. brucei. 
Another difference in the mini-chromosomes between T. congolense and T. brucei 
is their number. The T. brucei TREU 927 genome contains approximately 100 mini-
chromosomes of 30-150 kb and 5 intermediate chromosomes of 200-900 kb (Hertz-
Fowler et al. 2007). In contrast, the Southern blot gel presented in this chapter 
(Figure 33) indicates that mini-chromosomes represent 7-10 Mb of DNA in T. 
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congolense IL3000, thus suggesting that a diploid T. congolense cell may have 240-
320 individual mini-chromosomes (assuming an average mini-chromosome size of 
~30 kb). Furthermore, the molecular karyotype of T. congolense has been shown to 
vary in different serodemes (Majiwa et al. 1986), a feature attributed to the 
aneuploidy of the mini-chromosomes and their non-Mendelian inheritance mode 
(Wells et al. 1987; Alsford et al. 2001). In this chapter, I describe more than 100 ES 
structures, all sharing a canonical structure and very low length and composition 
variation. The data suggest that T. congolense has more ES than T. brucei. How 
this relates to antigenic switching, VSG gene conversion from the subtelomeres to 
the ES, and to VSG sequence diversity generation remains unknown. 
Structurally, the main differences between T. congolense and T. brucei ES are the 
nature and number of coding regions in the polycistronic transcription unit, and the 
existence of defined anchor points for sequence exchange. In T. brucei, ESAGs are 
a canonical feature of the BES (Becker et al. 2004; Hertz-Fowler et al. 2008). This 
species has thirteen characterised ESAGs, most of which are essential for activation 
and retain their order throughout the generic BES structure (Hertz-Fowler et al. 
2008). With the exception of the facultative ESAG10, all T. brucei ESAGs were 
specifically recruited from the core and subtelomeres and independently diversified 
in the ES (Jackson et al. 2013). In contrast, T. congolense has few non-VSG coding 
regions and none showing the exclusivity and ES adaptation of T. brucei ESAGs. 
Although Fam15, Fam53, and cathepsin have been found in a small percentage of 
contigs, they lack the intrinsic features of an ESAG as defined here: i.e. they are 
indistinguishable from subtelomeric homologs, and found beyond the ES more often 
than within it. Therefore, these genes cannot represent a distinct telomere-
associated adaptation in the manner of T. brucei ESAGs.
Among the non-VSG genes found in the ES, the DEAH-box RNA helicases could 
potentially be a T. congolense ESAG as it derives from a single-copy core 
chromosomal lineage. DEAH-box RNA helicases are remodelling enzymes that use 
ATP to catalyse the separation of double stranded RNA. They are conserved in 
most living organisms, including eukaryotes, bacteria and viruses (Marchat et al. 
2015). In parasitic genomes, DEAH-box RNA helicases can be involved in many 
RNA-related processes, including pre-mRNA splicing in Entamoeba histolytica 
(Valdés et al. 2014); RNA silencing in trypanosomatids (Kramer et al. 2010; Holetz 
et al. 2010; Zinoviev et al. 2011), Plasmodium falciparum (Tarique et al. 2013), and 
Giardia (Adam 2000); and translation regulation in nematodes (Marchat et al. 2015). 
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However, the particular lineage of DEAH-box RNA helicases found in the T. 
congolense ES has not yet been functionally characterised.
When asking whether this helicase is an ESAG, it is worth noting that they are 
present in only in 5-11 % of the described ES and that they do not show any 
evidence for sequence divergence relative to their homologue (and presumed 
precursor) in the core genome. Although they have expanded in T. congolense from 
a single-copy core chromosomal lineage present in other trypanosomes, the 
sequences of the isoforms found in the ES are indistinguishable from the 
subtelomeric copies. This is unlike the specialization in sequence that we observe 
for the majority of T. brucei ESAGs. 
T. congolense telomeric structure is consistent with the hypothesis that T. brucei 
ESAGs were independently recruited to the ES as T. brucei-specific innovations, 
and further suggests that T. congolense has not undergone this same process. 
Perhaps, this is because T. congolense has evolved different survival mechanisms 
that do not require them. The role of all ESAGs in T. brucei is not completely clear, 
but for example, T. brucei ESAG6 and 7, the transferrin receptors, are exclusive to 
the ES (with the exception of a single locus at a strand switch region) (Salmon et al. 
1994; Schell et al. 1991; Jackson et al. 2013). Thus, all transcription of transferrin 
receptors must occur from the ES. In contrast, T. congolense has evolved a large 
repertoire of subtelomeric transferrin receptors (Jackson et al. 2013), therefore 
transcription from the ES may not be essential. 
In terms of conserved non-coding regions, T. brucei has only two that are known: 
the promoter as the most upstream feature of the BES and the 70 bp repeat, which 
separates the VSG from the rest of the BES and often works as a recombination 
anchor point (Hertz-Fowler et al. 2008). Here I show that T. congolense has at least 
five conserved non-coding regions (the 369 bp repeat and CNR1-4). Though they 
do not exist in all telomeres, they maintain both the general order within the context 
and the relative distances to the VSG and the telomere. This suggests that CNR2-4 
might play a role in gene regulation within the ES or, following the example in T. 
brucei, sequence transposition. The phylogenetic signal along the telomeric 
structure of T. congolense is not consistent. In fact, phylogenetic comparison of the 
cohort of CNR1 and CNR2-4 sequences shows differences in tree topology that is 
statistically significant, suggesting that these ES features are uncoupled through 
time, and indicating frequent sequence exchange between telomeres. Although the 
low number of telomeres containing all the conserved coding regions precludes an 
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exhaustive recombination analysis, the evidence suggests that, like T. brucei, the T. 
congolense ES also undergo frequent recombination. 
Where and how recombination is happening remains unanswered. In T. brucei, 
quantifying the difference in phylogenetic signal along the BES revealed that 
sequence exchange occurs using various breakpoints, including at ESAG3, 
between ESAG5 and ESAG4/8, between ESAGs1/2 and 11, and at the 70 bp repeat 
(Hertz-Fowler et al. 2008). ESAG3 has been proposed as an important intervening 
feature in ES rearrangement, being the only ESAG appearing at multiple locations in 
the ES and not clustering by position (Hertz-Fowler et al. 2008). VSG switching is 
known to be facilitated by the 70 bp repeat upstream of the VSG and the VSG C-
terminal domain (Hovel-Miner et al. 2016). These two structures act as 
recombination anchor points to enable VSG recruitment from the subtelomeres to 
the ES and VSG movement and conversion between ES (Marcello & Barry 2007a; 
Hovel-Miner et al. 2016). T. congolense VSGs lack homologous CTDs that would 
play such a role, having instead 15 distinct CTDs (Jackson et al. 2012). 
Furthermore, a structure analogous to the 70 bp repeat adjacent to T. congolense 
VSGs has not been found so far. It is tempting to speculate that the existing 
conserved non-coding regions might act as annealing regions to facilitate telomeric 
exchange and gene conversion between telomeres. CNR2 could work as the 5’ 
recombination anchor point and CNR3/4 as the 3’ recombination anchor point. 
However, as they are not found in the subtelomeres, it is unclear how the same 
regions might facilitate exchange with the vast majority of VSG loci. 
If CNR2-4 are not involved in gene conversion and sequence transposition, they 
could be involved in the regulation of ES activation. In fact, non-coding regions are 
often associated with regulation of expression or chromosomal localisation of variant 
gene families. For instance, the var genes, which are linked to virulence and 
antigenic variation in Plasmodium falciparum, have a canonical structure in the 
subtelomeres and show a conserved gene organisation that is driven by their 5’ 
noncoding sequences (Kyes et al. 2007). Moreover, their monoexpression is 
controlled by the variant silencing gene PfSETvs, which silences var gene 
transcription by methylating histone H3 Lysine 36. The methylated version of this 
histone coats not only the coding region of the var gene, but also its promoter, 
completely blocking transcription. To transcribe the active var gene, a long coding 
RNA, generated from the transcription initiation site in the antisense direction, 
inhibits PfSETvs, allowing transcription initiation (Jiang et al. 2013). 
155
In eukaryotes, post-translational modifications of histones have been proposed to 
affect transcription activation, chromatin condensation and signalling for DNA repair 
(Strahl & Allis 2000). In T. brucei and T. cruzi, histone acetylation and methylation 
have indeed been described as mechanisms of epigenetic control (Figueiredo et al. 
2008; Respuela et al. 2008; Daniell 2012). However, as gene transcription is mostly 
post-transcriptionally regulated, the repertoire of chromatin-modifying and 
chromatin-remodelling enzymes and the extent of histone post-translational 
modifications is considerably smaller than in most eukaryotes (reviewed in 
Figueiredo et al. 2009). Thus, only one histone-modifying enzyme (DOT1B) has 
been recognised to be directly involved in VSG transcriptional regulation and ES 
switching through trimethylation of H3K76 for rapid antigenic switching (Figueiredo 
et al. 2008). 
In the bovine haemoparasite Babesia bovis, antigenic variation involves the variant 
erythrocyte surface antigen-1 (VESA1), which exists in quasi-palindromic loci 
comprised of a bidirectional promoter and non-coding regulatory regions flanking the 
variant antigens (Al-Khedery & Allred 2006; X. Wang et al. 2012). These non-coding 
sequences directly affect the levels of activity of the promoter and can drive 
expression from transcriptionally silent loci, suggesting their role in in situ 
transcriptional switching (X. Wang et al. 2012). Therefore, it would not be 
unprecedented for conserved non-coding regions to hold important functions in 
regulation of the VSG expression. 
The VSGs found in the telomeres derive from most, but not all phylotypes. In 
particular, phylotype 6 and 9 were not observed in the telomeres of either Tc1/148 
or IL3000. This is further emphasised by the observation from chapter 3 that 
phylotype 6 is barely expressed by metacyclic parasites. The low expression could 
be explained simply by developmental regulation, but its paucity in the ES of two 
distinct strains and the IL3000 bloodstream transcriptome suggest that these genes 
might have evolved a function unrelated to antigenic variation.
4.4.1 Future directions
The work presented in this chapter raises many important questions, but perhaps 
the most important ones for VSG biology are, first, to experimentally confirm that the 
structures I described here are VSG expression sites. Second is to understand 
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whether phylotype 6 and 9 encode functional VSG proteins, or if they have an 
invariant role. Identifying the active VSG through proteomics and identifying the 
genomic position of the cognate VSG gene can answer the first question, whilst 
chIP-sequencing can be used to identify the expression site promoter by detecting 
its interaction with RNA polymerase I. 
Discovering whether phylotype 6 and 9 encode non-VSG proteins could be 
achieved by following adapting the approach used for the characterisation of T. 
brucei VR genes by Marcello & Barry (2007). If they are not variant antigens, 
sequence homogenization might bring negative fitness consequences, therefore 
these genes are likely to exist in fewer numbers and be more conserved across the 
species. This hypothesis can be tested through the comparison of their repertoires 
in terms of sequence conservation, size, and phylogenetic relationships amongst 
strains. Particularly for phylotype 9, which is the smallest of the T. congolense VSG-
like sequence repertoire, PCR primers could be designed to test their presence and 
sequence conservation across additional field isolates without the need for genome 
sequencing. Another aspect that could differentiate phylotypes 6 and 9 from the 
variant antigens is their expression level in the various parasite forms, which could 
be detected by RT-PCR in an inexpensive manner. When a similar experiment was 
conducted for the VR genes, the evidence for expression of VR genes by procyclic 
parasites strongly indicated their non-VSG role (Marcello & Barry 2007a), and the 
same is possible in this context. Beyond this, gene knockout studies and functional 
in vitro assays could elucidate their specific function. 
Answering either question would require an investment in molecular biology studies 
applied to T. congolense. Molecular biology techniques have been mostly applied to 
T. brucei. The few studies performed in T. congolense have focused on establishing 
basic (but crucial) premises, such as PCR diagnosis, molecular karyotype 
characterisation, and cell culture establishment. Recently, more complex work is 
being performed, such as the characterisation of quorum-sensing signal responses 
in high-parasitaemia T. congolense infections and the inter-communication with T. 
brucei in mixed infections (Silvester et al. 2017). However, there is a need to 
establish models of infection and genetic engineering in T. congolense to fully 
understand the functional consequences of the VSG ES structure and characterise 
the VSG expression machinery in this parasite.
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4.4.2 Conclusion 
This chapter shows that T. congolense telomeric VSGs typically occur in a specific 
and conserved genomic context. These conserved structures are widely present in 
both strains analysed and are primarily associated with mini-chromosome 
telomeres, although we have also observed them on megabase chromosomes. 
These VSG-rich structures resemble T. brucei VSG ES in their location and 
conservation, but they lack abundant and conserved non-VSG coding regions (i.e. 
ESAGs). Instead, they are characterised by several conserved non-coding regions, 
and sporadic non-VSG genes, which do not show any unique sequence derivation 
specific to the telomeric environment. This indicates that T. congolense telomere-
associated structures are analogous, rather than orthologous, to T. brucei ES. The 
most parsimonious explanation for such observation is that their common ancestor 
also had a telomeric ES structure, though any sequence homology has been lost 
through parasite divergence. The components of the ancestral structure will remain 
unknown, erased by large sequence diversification, but would likely have had an 
analogous expression site structure composed of a repeat, a promoter, the VSG, 
and the telomere.
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Chapter 5. The Variant Antigen Profile to quantify 
antigen diversity in Trypanosoma vivax
5.1 Introduction
Trypanosoma vivax is an exclusively animal pathogen with a dixenic life cycle. 
Unlike T. congolense and T. brucei, it lacks a procyclic stage, colonising the 
proventriculus and foregut in the first day of infection and then migrating to the 
mouthparts (Ooi et al. 2016). Although Glossina sp. is the only vector species where 
T. vivax can grow and multiply, mechanical transmission is possible between other 
hematophagous flies, which has led to its introduction into South America, likely 
from West Africa (Osório et al. 2008). T. vivax transmission is solely mechanical in 
tsetse-free areas, but both cyclical and mechanical in Sub-Saharan Africa (Osório et 
al. 2008). In both areas, T. vivax can be mechanically transmitted by tabanids 
(Cryptotylus and Tabanus spp.) and Stomoxys spp. (Hoare 1972; Levine 1973). 
Since T. vivax cannot complete its life cycle outside the tsetse belt, South American 
T. vivax isolates remain genetically very close to West African isolates, whilst a 
large genetic distance separates them both from East African parasites (Osório et 
al. 2008). 
T. vivax is the least studied of the three African trypanosomes species mainly due to 
the inability to maintain the different life stages of the parasite in culture until very 
recently (D’Archivio et al. 2011). However, major differences in gene expression and 
VSG evolution in this species (Jackson et al. 2012; Jackson et al. 2015), and its 
presence in South America, make it a critical object of research in the 
trypanosomiasis field. One reason why I want to know more about T. vivax VSG is 
the phenotypic variability of T. vivax infections. In West Africa T. vivax often causes 
an acute, rapidly fatal disease. In East Africa, most disease is mild and chronic, but 
sporadically it can occasionally result in haemorrhagic syndrome (Wellde et al. 
1983). As VSG play an essential role in host-parasite interactions, they may be 
involved in clinical outcome.
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A surface coat of 12-15 nm is visible by electron microscopy in all African 
trypanosome bloodstream forms (Vickerman 1969). However, in T. vivax this coat 
appears to be thinner, suggesting a less abundant VSG coat (Vickerman 1969). 
Indeed, VSG comprise only 56 % of the total gene transcripts (Greif et al. 2013), as 
opposed to 98 % in T. brucei. The transcriptome analysis of the T.vivax isolates 
IL1392 further shows that the parasite surface contains several non-VSG, species-
specific proteins (Jackson et al. 2015). So far, 23 parasite-specific gene families 
encoding putative cell-surface proteins have been described (Jackson et al. 2013). 
Whilst they have not been experimentally shown to localise at the surface, they 
encode the necessary diagnostic motifs (e.g. signal peptide, GPI-anchor) and they 
are abundantly expressed in the bloodstream stage of the parasite (Jackson et al. 
2013; Jackson et al. 2015). 
The VSG-like gene repertoire in T. vivax is comprised of four structurally different 
families (Fam23-26), of which Fam23 and 24 are homologous to T. brucei a- and b-
type VSG, respectively (Jackson et al. 2012). Whether Fam25 and 26 encode 
functional variant antigens or if they have acquired alternative functions remains 
unresolved. As discussed in the previous chapters, functional differentiation of VSG-
like sequences is well documented in both T. brucei and T. congolense (e.g. the 
transferrin receptors of T. brucei and T. congolense (Jackson et al. 2012); the SRA 
gene in T. brucei rhodesiense (De Greef & Hamers 1994; Van Xong et al. 1998); 
and the TgsGP gene in T. brucei gambiense (Uzureau et al. 2013; Capewell et al. 
2013). So far, there is no evidence for the expression of Fam25/26 as variant 
antigens. In the study of T. vivax global gene expression, the identified 
superabundant BSF VSG belonged to Fam24 and two Fam25 members were 
preferentially expressed in the epimastigote stage, where VSG expression is 
repressed in other species (Jackson et al. 2015). Whilst the function of Fam25 and 
Fam26 remains undetermined, their role as variant antigens would be established if 
they were shown to provide the major surface glycoprotein in bloodstream 
infections.
At publication, the TvY486 reference genome included 721 VSGs. However, in the 
on-going re-sequencing project this has increased to 1920 (unpublished data 
produced by the Darby lab at the Institute of Integrative Biology of the University of 
Liverpool). In both cases, the relative sizes of each VSG-like subfamily remain 
constant. Fam23 is the largest, accounting for 50 % of the total repertoire, followed 
by Fam24 and Fam25, which account for 22 % and 18 % of the VSG pool, 
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respectively. Fam26 is the smallest family, contributing with 9 % of the genes. The 
phylogenetic distances between gene clades within each family are even more 
remarkable than in T. congolense, suggesting scarce recombination and explaining 
the why it has the lowest percentage of pseudogenes in African trypanosomes (15.5 
% and 27.2 % of Fam23 and Fam24, respectively, compared to 21.1 % and 29.7 % 
of Fam13 and Fam16 in T. congolense, and 69.2 % and 72.2 % of a- and b-type 
VSG in T. brucei) (Berriman et al. 2005; Jackson et al. 2012). However, unlike T. 
congolense, intra-phylotype recombination is thought to be infrequent (Jackson et 
al. 2012).
The reference strain Y486, firstly isolated in Zaria, Nigeria, is a representative of 
West African and most South American T.vivax strains (Gibson 2012), but they are 
genetically distinct from East African strains (Cortez et al. 2006; Rodrigues et al. 
2008; Adams et al. 2010). This may relate to the distinct pathological characteristics 
of East and West African T. vivax trypanosomiasis (Stephen 1986). 
Overall, research into T. vivax molecular diversity supports the identification of East 
African T.vivax as a separate subspecies to West African and South American 
strains, mainly due to its distinctiveness in molecular diagnostic tests based on 
single molecular markers, e.g. T. vivax-specific antigen, SSU rRNA, and gGAPDH 
genes (Masake et al. 1997; Morlais et al. 2001; Njiru et al. 2004; Malele et al. 2003; 
Ventura et al. 2001; Adams et al. 2010). Furthermore, these studies also indicate 
greater diversity in East Africa compared to West Africa and South America 
(Rodrigues et al. 2017). However, considering that all of these studies were 
conducted with few isolates, they are not definitive, especially given that 
divergences at the SSU rRNA sequences amongst T. congolense subgroups are 
greater than those of the Duttonella subgenus (Rodrigues et al. 2008). 
At first glance, I would expect the T. vivax VSG repertoire to be distinct between 
West and East African isolates, reflecting their genomic signature. However, given 
the ancestral origin of VSG lineages (Jackson et al. 2012), the evidence for low 
recombination within the T. vivax VSG repertoire, and the fact that the VSG 
repertoires of T. congolense ‘savannah’ and forest sub-types comprise identical 
VSG phylotypes (as observed in chapter 2), I would predict that the T. vivax VSG 
repertoire is conserved across the species.
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Past research reports cases of T. vivax infections in cattle with undetectable 
parasitaemia and symptom recovery after 100 days post-infection (Barry 1986; 
Fidelis Jr et al. 2016). This suggests that protective immunity can occur naturally, 
perhaps a sign of antigenic exhaustion (Barry 1986). Research also shows that the 
VSGs expressed in early infection often belong to the same serodeme, depending 
on a combination of host species and size and pathogenicity of the parasite isolate, 
which suggest that VSG expression in T. vivax may be partially predictable (Barry 
1986). To appreciate the scope of VSG diversity and recognise relationships 
between particular VSGs or VSG combinations and disease course can help to 
understand why T. vivax infections have major differences in morphology, host 
susceptibility, virulence, and pathology (Hoare 1972; Stephen 1986; Murray & 
Clarkson 1982).
The development of a VAP methodology universal for the T. vivax group would not 
only aid epidemiological mapping of AT, but also contribute to diagnostics and 
taxonomy by providing the largest comparison of continental-wide T. vivax isolates 
to date. As introduced in Chapter 2, the ultimate aim of the VAP is to be applicable 
to any organism employing antigenic variation for immune evasion, being sensitive 
enough to dissect diversity to the sequence level. Following the method 
development for T. congolense VSG, the first part of this chapter attempts to 
develop a methodology to characterise VSG diversity in T. vivax using a historical 
collection of 19 field strains. 
In the second part, the methodology is applied to TvLins, a Brazilian strain of T. 
vivax isolated from an epidemic in dairy cows in the TvLins municipality of São 
Paulo, Brazil (Cadioli et al. 2012). South American T. vivax has expanded via 
mechanical transmission in non-tsetse vectors. All South American strains reported 
so far were closely related the reference TvY486, firstly isolated in Nigeria, West 
Africa (Cortez et al. 2006; Rodrigues et al. 2008). Whilst the majority of T. vivax 
infections in South America remain asymptomatic in endemic areas, when T. vivax 
escapes to non-endemic regions, it causes very acute disease with severe 
symptoms and rapid death. Likewise, TvLins infections caused acute disease with 
general symptoms, such as fever, jaundice, decreased milk production, weight loss, 
profuse diarrhoea, abortion, anaemia, leucocytosis, elevated plasma fibrinogen, and 
neurological symptoms, such as dysmetria, ataxia, muscle weakness, ptyalism, 
lymph node enlargement and submandibular oedema (Cadioli et al. 2012). Despite 
the reasons behind such virulence remaining unknown, the parasite coat is of 
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particular interest due to its key role in host: parasite interactions. By applying an 
automated VAP methodology on genomic and transcriptomic reads, this chapter 
presents a detailed description of the TvLins VSG repertoire. 
Specifically, this chapter aims to:
1. Investigate the universality of the VSG phylotypes identified in the reference 
strain using phylogenetic analysis;
2. Present a novel method to dissect antigenic diversity in T. vivax based on 
presence and absence of diagnostic VSGs using a collection of 19 historical 
field isolates; 
3. Apply the method to quantify and describe antigenic diversity of the TvLins 
isolate in the context of the collection of historical isolates.
163
5.2 Methods 
5.2.1 Sample identification and storage
Samples were collected between 1966 and 1990 by ILRI staff from cattle and tsetse 
flies as part of various experiments (Table 11). They were passaged into a naïve 
host (rodent, goat, or bovine) to increase parasitaemia. At peak parasitaemia, 
animals were bled and multiple 35 to 50 µl blood stabilates in 10-30 % glycerol were 
prepared and stored at -80 °C. Samples were subsequently transferred to liquid 
nitrogen. Samples for this project were chosen from the ILRI Biobank (Kenya) based 
on availability of at least 150μl of blood and number of passages. All samples used 
had had a maximum of 4 passages, as passaging through multiple hosts may affect 
the VSG repertoire. DNA was extracted from the blood stabilates in ILRI (Kenya) in 
January 2016 and imported immediately to the United Kingdom on dry ice.
The Brazilian sample T. vivax Lins used as an example application of the VAP 
method was first isolated from a dairy cow in the municipality of Lins, São Paulo, 
Brazil (Cadioli et al. 2012). Parasites were recovered from experimental infections of 
goats (Capra aegagrus) in the Federal University of São Paulo, Brazil. Two goats 
were experimentally infected with 1.25x105 parasites collected from a naturally 
infected cattle and cryopreserved in 8 % glycerol and 10 % EDTA. Parasitaemia 
was determined daily by haematocrit centrifugation technique as described by Woo 
(1970). When parasitaemia reached ~3x106 trypanosomes/ml, 100 ml of goat blood 
was collected from the jugular vein into tubes without anticoagulant. After blood 
clotting, the blood was left at 27 ºC for 1 hour to allow for parasites to move from the 
buffy coat into the serum. The serum with trypanosomes was collected into 1.5 
centrifuge tubes (Eppendorf, USA) and centrifuged at 10,000 g for 30 min at 10°C. 
The pellet was mixed with 1 ml of Percoll (Sigma) containing 8.55 % sucrose, 2.0 % 
glucose, and the pH was adjusted to 7.4. The mixture was centrifuged at 17,500g 
for 20 min at 4 °C. Parasites were recovered from both the top and the middle layer 
of the Percoll gradient and resuspended 1:3 with PBS containing 0,5 % glucose 
(sodium phosphate 40 mM, pH 7.5, NaCl 150 mM) (PBSG). The solution was 
centrifuged at 4,500 g for 30 min at 4 °C to recover a parasite pellet. The pellet was 
washed twice in 40 ml of PBS with glucose to remove residual Percoll. The 
parasites were resuspended in 2 ml of PBS with glucose and used for DNA or RNA 
extraction. 
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Table 11 Sample ID, date and location of collection, host, and species used for 
passaging.
5.2.2 Cell lysis and nucleic acid extraction
DNA was extracted from the blood using a magnetic bead protocol adjusted to 
increase recovery of fractioned DNA. 200 l blood stabilates were transferred to 2.0 
ml Lo-Bind tubes (Eppendorf, UK). 1.5 ml ACK lysing buffer (0.15 M NH4Cl, 10 mM 
KHCO3, 0.1 mM EDTA) were added and the solution was incubated 3 min at room 
temperature, followed by a 10-min centrifugation at 650 g. The supernatant was 
discarded and the pellet washed in 500 l MACS buffer (2 mM EDTA, 5xBSA in 
PBS pH7.2). The samples were centrifuged for 10 min at 650 g. The supernatant 
was discarded and cells were washed a second time in 750 ml MACS buffer and 
centrifuged for 15 min at 650 g. The supernatant was discarded and pellet 
resuspended in 100 μl lysis buffer (aqueous solution of 1 M Tris-HCl pH8.0, 0.1 mM 
NaCl, 10 M EDTA, 5 % SDS, 0.14 M Proteinase K). Samples were incubated at 
room temperature for 1 hour and DNA was extracted with the magnetic Sera-Mag 
Speedbeads protocol used for T. congolense. Recovered DNA was quantified with 
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Qubit® fluorometric dsDNA quantitation (dsDNA HS Assay Kit) (Life Technologies, 
UK) and sent for sequencing. 
For TvLins, DNA was extracted with the phenol-chloroform method by Brazilian 
collaborators. One parasite sample for each infected goat was used to extract RNA. 
The two RNA replicates (S3 and S4) were obtained using the Dynabeads® mRNA 
DIRECT™ Kit (Thermo Fisher Scientific) according to the manufacturer’s protocol. 
5.2.3 Next-Generation Sequencing (NGS)
Genomic libraries were prepared at the Wellcome Trust Sanger Institute 
(Cambridgeshire, UK) using the NEBNext® Ultra™ DNA Library Prep Kit according 
to the manufacturer’s protocol (New England Biolabs, UK). The protocol consists of 
mechanical shearing of DNA in 500 bp fragments using the Covaris ADA process 
(Covaris, UK), enzymatic DNA end repair and adapter ligation, size selection using 
magnetic Sera-Mag Speedbeads, and PCR Enrichment of Adaptor Ligated DNA. 
Genomic libraries were sequenced multiplexed in one lane over ten runs in a MiSeq 
platform (Illumina Inc, USA) as 150 bp paired-end (PE) reads. 
For TvLins, gDNA was used to prepare 550 bp insert libraries using the TruSeq 
Nano DNA LT Library Preparation Kit, and sequenced on an Illumina MiSeq 
platform with paired-end reads (2 x 300 bp) obtained using a MiSeq Reagent Kits v3 
(600 cycles). RNA samples were used to prepare a double-stranded cDNA library 
using the TruSeq Stranded mRNA LT Sample Preparation Kit (Illumina, San Diego, 
CA, USA) and sequenced on an Illumina MiSeq platform with paired-end reads 
(2x75 bp) obtained using a MiSeq Reagent Kits v3 (150 cycles).
Analysis of NGS data
Paired reads from the host species were removed by mapping all reads to the host 
genome (version 9.0) and keeping only unmapped reads for downstream analysis, 
using Bowtie2 under sensitive settings. Recovered reads were used to produce de 
novo assemblies of each strain. 
Recovered reads were also mapped against the T. vivax Y486 reference genome. 
Mapping results were used to calculate per base coverage of sequenced strains 
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against the reference genome. Per base coverage was calculated from a sorted 
bam file using the genomecov option of the bedtools package. Total coverage was 
calculated with an in-house script counting the percentage of bases with sequencing 
coverage of at least 1. 
To check that all samples derived from single infections, allele frequencies were 
calculated with vcftools. This allowed inference of haplotypes and detection of 
fluctuating allele frequencies inconsistent with diploidy. All frequencies from all 
samples were 0, 0.5, or 1, thus reflecting single infections. 
De novo assembly
Recovered reads were used to produce de novo assemblies of each strain using 
velvet version 1.2.07 (Zerbino & Birney 2008). For the historical isolates, the 
following settings were applied: kmer of 65, insert length adjusted for 400 base pairs 
with standard deviation of 50, minimum pair count of 20, and coverage cutoff 
between 0 and 5, depending on sample quality. For TvLins the kmer was 99, 
producing an assembly of 178,079 contigs with n50 of 1,837.
The methodological process from contig assembly to VAP development is shown in 
Figure 45 and consists of three main steps: identification of VSG-like sequences, 
VSG phylotype analysis, and VAP development. 
5.2.4 VSG-like sequence recovery
Assembled contigs were examined for VSG-like sequences by sequence similarity 
search with tBLASTx using a database of T. vivax Y486 VSG genes as query 
(Figure 45). A threshold of p-value > 0.001, contig length > 150 amino acids, and % 
identity ≥ 75 was applied to select significant results. Sequences with 40 to 75 % 
similarity to the reference were manually inspected and its inclusion in the analysis 
empirically decided. The closest relative of each sequence query retrieved was used 
to assign recovered VSG-like sequences to a family and phylotype.
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Objective
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26
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individual phylotypes
- Identification of VSG orthologs
- Read Mapping (reads vs. COG
database)
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search of contigs vs. COG database
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phylotype
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(COGs)
- Presence/Absence MatrixOutput
- Are Fam23-26 conserved?
- Are TvY486 phylotypes
conserved?
- Are there any novel phylotypes?
- Is the T. vivax VSG repertoire
conserved across the population?
- Are there strain-specific or region-
specific COGs?
- How does the T. vivax VAP relate
to population history and geography?
- Can the VAP be applied to
expression data?
Questions
Figure 45 Methodology followed for the T. vivax VAP development. VSG-like sequences were recovered from the assembled contigs of each strain by 
sequence similarity search (tBLASTx). Translated nucleotide sequences were separated into Fam23 to Fam26, joined to the TvY486 VSG sequences and used 
to estimate 4 T. vivax VSG phylogenies. After each phylogeny was analysed, I concluded that phylotypes were widespread, but that universality could not be 
inferred due to missing data. Therefore, individual phylotypes were separately analysed to identify VSG orthologues that could be used as diagnostic 
sequences in the VAP. This resulted in 1081 COGs that were used to develop the VAP. The VAP methodology was developed using two different approaches: 
the first by mapping genomic reads to the COG database; the second by performing sequence similarity searches of the COG database in assembled contigs. 
Both approaches resulted in a presence/absence binary matrix that identifies location-specific COGs and provides the VSG repertoire relationships among 
strains.
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5.2.5 Multiple Sequence Alignment
To investigate VSG family structure and phylotype universality, VSG-like sequences 
were aligned by family into four multiple sequence alignments (Figure 45). VSG-like 
nucleotide sequences were manually retrieved from the assembled contigs files and 
translated with BioEdit 7.2.5 (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). 
Translated nucleotide sequences were aligned with ClustalW (Larkin et al. 2007), 
producing a nucleotide alignment for each of 96 phylotypes. Phylotypes belonging to 
the same family in the reference were manually joined and curated to produce an 
amino acid alignment for each family after partial sequence removal. The Fam23 
alignment contained 1223 protein sequences of 120 to 272 amino acids; the Fam24 
alignment contained 454 protein sequences of 110 to 336 amino acids, the Fam25 
alignment contained 388 protein sequences of 149 to 325 amino acids, and the 
Fam26 alignment contained 165 protein sequences of 115 to 196 amino acids.
5.2.6 Phylogenetic estimation
VSG-like gene phylogenies were inspected to check whether all sequences 
clustered with co-orthologues from the reference genome and to detect new VSG 
clades not present in the reference genome (Figure 45). VSG phylogenies were 
estimated for each family from protein sequence alignments of recovered VSG-like 
sequences and TvY486 VSG sequences. Four ML phylogenies were built with the 
WAG+ substitution model (Whelan and Goldman 2001) after model selection in 
MEGA7 (Kumar et al. 2016). Robustness was assessed with 100 bootstrap 
replicates, using RaxML (Stamatakis 2014). Bayesian inference failed to converge 
on a consensus phylogeny for all four families.
To dissect further the phylogenetic structure of each phylotype, I searched for VSG 
co-orthologues (Figure 45). ML VSG phylogenies of each phylotype containing 
more than 4 sequences were estimated from a translated nucleotide sequence 
alignment of recovered VSG-like sequences and Y486 VSG sequences using the 
Tamura-Nei substitution model (Tamura & Nei 1993) in MEGA7 (Kumar et al. 2016). 
5.2.7 Clusters of Orthologous Groups (COGs) identification 
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Each phylotype phylogeny was inspected to separate each member of each 
phylotype into defined groups based of their sequence identity (Figure 45). In the 
context of this chapter, VSG sequences of the same phylotype with more than 98 % 
nucleotide identity were considered co-orthologous and analysed as a single gene. 
VSG sequences with no orthologues in the sample set were included as individual 
orthologue groups. This approach resulted in a non-redundant gene database that 
allowed screening of genomes for specific VSG. In total, 1081 COGs were 
identified.
5.2.8 Binary matrices
Binary matrices were produced based on presence or absence of COGs using read 
mapping or contig similarity search (Figure 45). Mapping was performed using 
bowtie2 version 2.2.5 (Langmead & Salzberg 2012) under very sensitive and 
sensitive settings. COGs with at least one read mapped were considered to be 
present in the strain. Similarity search was performed with BLASTn (Altschul et al. 
1990) with a 95 or 98 % identity, 0.001 E-value and 100 nucleotide length 
thresholds. The search and processing of the output to produce the binary matrix 
was done with an in-house script. 
5.2.9 Strain variation 
MiSeq reads were retrieved and mapped against the T. vivax Y486 genome using 
BWA mem (Li 2013), converted to bam format, and sorted and indexed with 
Samtools (Li et al. 2009). Sorted bam files were cleaned, and duplicates marked 
and indexed with Picard (http://broadinstitute.github.io/picard/). SNPs were called 
and filtered with Genome Analysis Toolkit suite according to the recommended 
protocol for multi-sample variant calling (Van der Auwera et al. 2013). Reads were 
realigned and loci called with GATK (Van der Auwera et al. 2013). SNPs were called 
for individual samples with HaplotypeCaller, and then the genotypes were called 
simultaneously for all samples. Finally, SNPs were extracted as a multi-sample file 
and filtered using default parameters using GATK (Van der Auwera et al. 2013). The 
multi-sample vcf file obtained from GATK was converted to fasta format using 
vcftools v0.1.14 (Danecek et al. 2011) and a maximum likelihood phylogeny was 
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estimated with RAxML, using the JTT+ model of nucleotide substitution, following 
nucleotide model selection on MEGA7 (Kumar et al. 2016).
5.2.10 T. vivax Lins transcriptome analysis
TvLins transcriptomic reads were mapped to the reference TvY486 with Bowtie2 
version 2.2.5 (Langmead & Salzberg 2012) under default settings. Mapping 
percentages of 90.35 % and 89.24 % were obtained for S3 and S4, respectively. 
Transcript abundances for both replicates were estimated using cufflinks version 
2.2.1 (Trapnell et al. 2010), under default settings. 
5.2.11 Ethics Statement
The animal work performed to obtain the genome and transcriptomes of TvLins was 
performed in accordance with the guidelines of the Brazilian College of Animal 
Experimentation (CONCEA), following the Brazilian law for “Procedures for the 
Scientific Use of Animals” (11.794/ 2008 and decree 6.899/2009). Ethical approval 
was obtained from the Ethical Committee to the Use of Animals (CEUA) of the 
Veterinary and Agrarian Sciences Faculty (FCAV) of the State University of São 
Paulo (Jaboticabal campus) (São Paulo, Brazil).
171
5.3 Results
In this chapter I present VAPs of 19 T. vivax isolates. Through the analysis of these 
VSG repertoires, I have investigated the level of conservation of Fam23-26 across 
the T. vivax species and I have dissected the TvY486 VSG repertoire into 96 
phylotypes. I have investigated whether these phylotypes were universal, whether 
there are novel phylotypes, and whether they could be used to develop a T. vivax 
VAP methodology. The results show that a T. vivax-specific methodology is 
necessary, based on VSG orthologues rather than individual phylotypes. In the 
second part of this chapter, I apply the VAP to the analysis of the TvLins 
transcriptome to show that the VAP can be used to measure and compare VSG 
expression across infections. 
5.3.1 Genome completion of sequenced field strains
Nineteen T.vivax isolates from four African countries were successfully sequenced 
(Table 11). To understand how deep the sequencing process was, the depth of 
coverage per base for each isolate was calculated (Table 12). This metric shows 
the completeness of the sequencing data, and therefore estimates data reliability. 
The majority of samples (15/19) had a genome coverage higher than 70 %; four 
samples, Tv319, Tv2005, TvILV-21 and Tv3171, were 51 % to 70 % complete. 
These were still included in the analysis, but flagged.
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Table 12 Sequencing coverage and mapping results of field strains compared to the 
reference strain. Genome coverage was calculated as number of reference nucleotide bases 
present in at least one read over the total number of nucleotide bases. Mapping proportion 
was calculated as the proportion of paired reads mapping to the reference genome with 
Bowtie2 (Langmead & Salzberg 2012).
5.3.2 Sampling test 
Another metric to assess quality of data, in the context of this study, is the size and 
composition of the VSG repertoire that can be recovered by sequence similarity 
searches, using the previously defined length and identity thresholds (≥ 150 amino 
acids and ≥ 40 % ID). The number of VSGs recovered in the field strains ranged 
from 40 to 303, representing 6 to 42 % of the reference VSG genomic repertoire 
(Table 13). The low number of recovered VSGs might be due to the quality of the 
initial data, which affects the quality of the genome assembly, leading to short 
contigs. Due to the length thresholds applied to the sequence similarity search 
(≥150 amino acids), only contigs longer than 450 nucleotides were considered. The 
average full length of the reference VSGs is 404 amino acids, whilst the average 
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length of the VSG recovered per strain ranges from 190 to 340 amino acids, 
corresponding to 47 % to 86 % of the VSG average full length. 
To assess whether the VSGs were sufficient to produce reliable VAPs through the 
same methodology as T. congolense VSG profiling, a sampling exercise was 
performed on the reference full repertoire. The original VSG repertoire of TvY486 
has 723 VSG-like sequences. These VSGs were divided into 96 phylotypes based 
on their genetic distances. To achieve this, the TvY486 VSG phylogenies were 
inspected and each clade was assigned a phylotype number. Consecutively smaller 
percentages of the repertoire were sampled and VAPs produced to observe whether 
all 96 phylotypes in the reference repertoire were recovered. Random sampling 
revealed that to obtain all phylotypes, the VSG repertoire had to be complete. This 
is because 69 of the 96 phylotypes (72 %) contain less than 10 genes. Therefore, 
the chance of recovering any particular phylotype is low because they are 
infrequent. This, coupled with the large number of phylotypes relative to T. 
congolense, means that 100 % of genome coverage is necessary to capture all 
VSG sequences. This contrasts with the situation in T. congolense, where only 15 % 
of the VSG repertoire was sufficient to provide an accurate profile. 
Sampling a small part of the VSG repertoire only gives a robust estimate of sub-
familial proportions (Table 13). When looking at the percentage of Fam23-26 
compared to the reference, no significant difference between the reference full 
repertoire and the field isolates repertoires was found (Figure 46), suggesting that 
the abundance of each family is both highly conserved and different enough to be 
detected even at low sequencing depth. 
This means that the VAPs cannot be accurately estimated from the data simply 
using the same sequence similarity-based methodology as T. congolense. 
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Table 13 Number of VSG recovered from each strain by sequence similarity search and their proportion compared to the reference full repertoire.
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Figure 46 Proportion of VSG belonging to families 23-26 from all field strains 
compared to the proportions of the reference full VSG repertoire given as mean ± . 
Bars are colour coded according to key.
Due to the high number of phylotypes and their low frequency, the genomes are 
never complete enough to produce accurate VAPs based on the phylotype 
frequencies, as done in chapter 2 for T. congolense. Low abundance phylotypes 
would be represented by frequencies too low to measure variation. Therefore, I 
have adopted an approach based on the presence of diagnostic COGs. Whilst in T. 
congolense, the VAP relies on shared patterns within the VSG sequences; in T. 
vivax it identifies VSG sequences that are characteristic of particular locations.
To pursue this method, family phylogenies were estimated using all recovered 
VSGs and the reference full repertoire to identify new phylotypes, absent in the 
reference genome. Figure 47 shows ML phylogenies for Fam23-26. The reference 
nodes are highlighted in red, showing that sequences from the field isolates cluster 
amongst the reference sequences within each phylotype. This indicates that the 
cladistic structure of all four families is conserved across the strain cohort. No novel 
phylotypes were identified. Furthermore, 95 out of the 96 phylotypes identified in the 
reference genome were present in at least two other isolates. These results indicate 
that the majority of phylotypes are widespread. In contrast to T. congolense, in T. 
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vivax the data cannot confirm universality because of the low numbers of VSGs 
recovered and the smaller geographic distribution of the sample cohort. 
Figure 47 Phylogenies of the VSG families. Reference strain sequences highlighted in red, 
field strain sequences are shown in black. The phylogenies show that the reference cladistic 
structure is maintained in the remaining isolates. Unrooted trees were estimated with 
maximum likelihood method and the WAG+ model using RaxML (Stamatakis 2014).
5.3.3 Intra-phylotype variation
To identify VSG orthologs, phylogenies were built for each phylotype with 4 or more 
sequences (all except phylotypes 29, 30, 69 and 83); COGs were identified based 
on their phylogenetic position and their sequence identity (>98 %). The longest 
genes of each of the COGs were compiled in a database. Genes belonging to 
177
phylotypes with less than 4 sequences were subsequently added to the database as 
individual entries. 
The purpose of the COG database is to screen VSG contigs or VSG reads and 
identify shared sequences. Whilst this approach is efficient at associating VSG 
sequences that are present in the database, it fails to identify novel VSGs that were 
not detected in the sample cohort. Therefore, until the T. vivax genome diversity has 
been extensively sampled, new genomes may have to be searched for novel, strain-
specific VSG to update the database. 
The COG database was used to screen VSG using two different approaches: first, 
by searching contigs based in sequence similarity with 95 % and 98 % identity 
thresholds and, second, by read mapping under two sensitivity thresholds (Table 
14). In both approaches, the number of COGs recovered depends on the mapping 
or identity threshold. The most stringent approach is contig search at 98 % identity 
(463 ± 269 COGs recovered), whilst the most flexible is read mapping under “very 
sensitive” settings (710 ± 244 COGs recovered) (Table 14). This difference results 
from size of compared sequences and data availability. First, the shorter size of 
reads compared to contigs means that a smaller matching sequence is required for 
a positive identification. Second, read mapping considers more data than contigs, 
because of data lost during the genome assembly process. 
Table 14 Distribution of COGs recovered by the two approaches under different 
sensitivity thresholds. Contigs refers to results from sequence similarity searches with 98 % 
and 95 % sequence identity thresholds. Reads refers to read mapping with Bowtie2 using the 
sensitive or very sensitive options. 
In the contig similarity search with 98 % identity threshold, 48 COGs were found in 
all isolates from all locations (Table 14). These correspond to VSG that are 
conserved across the species. A total of 52 COGs were found in isolates from all 
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locations except from The Gambia. The sample cohort only has one isolate from 
The Gambia (IL3171), which has low genome coverage (55 %, shown in Table 12. 
Therefore, it is possible that some or all of these 52 COGs are present in Gambian 
isolates, but have been missed in this dataset. Seventy-one of COGs were found in 
isolates from all locations except in any of the four Ugandan isolates. Although only 
6 to 20 % of the VSG repertoire of these isolates has been analysed, it is possible 
that they also represent missing data. However, these 71 COGs are absent from all 
four isolates, not just one as in the previous example from The Gambia. This 
approach also identified 416 COGs apparently specific to Nigeria, 69 to Ivory Coast, 
and 8 to The Gambia. The high number of Nigeria-specific COGs may reflect the 
high number of Nigerian samples included in the dataset (N = 11) and the fact that 
their sequencing output was generally better [77 to 80 % of genome coverage 
(Table 12) and up to 42 % of the VSG repertoire recovered (Table 13)]. As there 
are more sequences from Nigerian samples than the other locations, it is possible 
that there is a bias in the sequence search. Furthermore, this is supported by the 
fact that when the sequence similarity search identity threshold is reduced to 95 %, 
the number of Nigeria-specific COGs reduces by 74 % to 110 (Table 14). 
In the read mapping approach, more COGs are recovered from the genomes in both 
sensitive and very sensitive settings than with the contig sequence similarity search
(463 ± 269 COGs recovered with contig search at 98 % identity; 710 ± 244 COGs 
recovered with read mapping under very sensitive settings) (Table 14). As the 
difference in the number of VSG recovered between sensitive and very sensitive 
settings is not statistically significant (p-value = 0.43) and the latter increases the run 
time, the sensitive option is preferred. With read mapping (sensitive), 246 COGs 
were found in isolates from all countries. No COGs were found to be specific for 
Ivory Coast, The Gambia or Uganda, whilst 138 COGs were found exclusively in 
Nigerian isolates.
COG analysis is useful to identify diagnostic markers for geography and disease 
phenotype, but also to discriminate amongst antigens of different isolates. With the 
available data, it is possible to select region-specific genes. However, their nature 
depends on the approach taken. Choosing the most stringent method (contig 
mapping, 98 % ID), results in a large cohort of country-specific COGs (N(Nigeria) = 
416, N(Ivory Coast) = 69, N(The Gambia) = 8). Together they represent 45.6 % of 
the COG database. Taking into account multiple-country combinations, the data 
suggest that only 2.3 % of the VSG pool is common to all African T. vivax. Even if 
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the Gambian isolate is disregarded due to the reasons discussed above, this 
number only increases to 9.2 %. However, if a more relaxed approach is taken (read 
mapping, sensitive settings), the percentage of widespread COGs increases to 44.9 
% (N = 486), representing the majority of phylotypes (84/96). The phylotypes not 
represented are mostly of single-copy genes (7/12), and thus their absence could 
relate to incomplete sampling as noted in section 5.3.2. 
Together, these observations suggest that at most 84 phylotypes are universal to 
the T. vivax strains used in this study. Furthermore, when comparing the COG 
database to the PacBio genome of TvY486 by read mapping, all COGs can be 
found, including those that were not described in the original TvY486 genome 
produced by Sanger sequencing. Therefore, the read mapping approach using the 
new genome as reference reduces number of country-specific genes to only 138 (all 
from Nigeria – the original location of TvY486). Nevertheless, using either approach, 
a large part of the VSG repertoire (27.6 % to 49.1 %) is conserved across multiple 
locations at a very high sequence identity (> 98 %), suggesting that the T. vivax 
VSG repertoire is stable, remaining conserved across isolates in the same manner 
as the core genes. Better genome coverage and further sampling are likely to 
reinforce this argument by reducing the effect of genome fragmentation and 
incomplete geographical coverage. 
5.3.4 Genetic relationship between strains
To understand the genetic relationship between strains, a minimum evolution 
phylogeny was estimated based on whole-genome SNPs (Figure 48A). All isolates 
grouped according to geographic region of collection. Cluster analysis of the 
recovered COGs as a binary matrix also showed a similar relationship between 
strains with the exception of isolate Tv3651 from Ivory Coast (Figure 48B). In the 
cladogram estimated from the COG matrix, Tv3651 clusters with the Ugandan 
strains. The direct correlation between the COG matrix and the whole genome 
variation also support the hypothesis that the T. vivax VSG repertoire diverges 
similarly to the core genome. 
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Figure 48 The relationship between T. vivax SNPs and COGs. A. Maximum likelihood phylogeny of T. vivax whole genome SNPs. Tree was estimated 
with RAxML, mid-rooted. 0.07 nucleotide substitutions per site. B. Dendrogram of T.vivax strains based on presence and absence of 1081 COGs. Colour-
coded by country of collection according to key.
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5.3.5 The genomic VSG repertoire of T. vivax Lins
To show how the VAP can be applied to characterise clinical isolates, the VSG 
repertoire of the Brazilian strain T. vivax Lins was analysed. For such study, 
genomic reads were screened for a collection of VSG orthologues retrieved from the 
population genomics analysis of African T. vivax presented in the previous section. 
A heatmap and a cladogram were produced based on presence and absence of 
these orthologues (Figure 49). TvLins clusters within 3 Ugandan samples, being 
each other’s closest relatives.
To corroborate whether the genetic affinity of TvLins to the Ugandan isolates was a 
feature of the whole genome or just the VSG repertoire, a whole genome SNP 
phylogeny was estimated. This showed a defined geographical signature across 
Africa and verifies that the Ugandan strains are TvLins’ closest relatives in this 
sample cohort (Figure 50). This situation contrasts with the previously published 
Venezuelan isolate TvLIEM (Greif et al. 2013), which is closer to the Gambian 
isolate Tv3171. 
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Figure 49 Heatmap and cladogram showing presence and absence of 1081 VSG 
orthologues across our sample dataset. In the heatmap, presence of COGs is indicated in 
red, and absence indicated in yellow. In the dendrogram, strains are coloured by their 
geographic location. Positioning of TvLins is indicated by the black rectangle.
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Figure 50 Maximum likelihood phylogeny of T. vivax strains based on whole genome 
SNPs estimated with GATK (N = 1,011,378). SNPs called from the transcriptome of the 
Venezuelan isolate TvLIEM were added posteriorly to the analysis (N = 7,848 SNPs) to 
include an independent representative of South American T. vivax (Greif et al. 2013). Tree is 
mid-rooted. Strains are colour coded according to geographical location. Arrows indicate 
samples from South America (TvLIEM and TvLins).
As noted earlier, the COG database cannot find novel VSGs. Therefore, to check 
whether TvLins contained specific VSG, VSG contigs were retrieved by sequence 
similarity search, using a database of TvY486 VSGs. A total of 409 VSGs were 
recovered. All 4 VSG families (Fam23-Fam26) were represented in similar 
proportions as to both the reference and the historical isolates (Figure 51). The 
recovered VSGs were aligned with all the VSGs from TvY486 and the four Ugandan 
strains (Figure 52). The Ugandan samples were included because they are closer 
to TvLins than TvY486. Therefore, they can be used to identify VSGs absent in the 
reference but not specific to this Brazilian strain. In all families, all VSG nodes are 
closely related to the Ugandan samples and/or TvY486 and no novel VSGs were 
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detected. Clusters of TvLins-specific sequences were never observed, suggesting 
that the COG database is sufficient to describe the VSG repertoire of this isolate. 
Figure 51 Relative Frequency of each VSG family in our strain dataset, TvY486, and 
TvLins. Values for all strains are mean ± . Bars are colour-coded according to key.
In summary, the VSG repertoire in TvLins reflects the repertoire of the African T. 
vivax samples. However, unlike previous reports in literature and the Venezuelan 
TvLIEM (Cortez et al. 2006; Greif et al. 2013), it suggests that this strain is closer to 
Ugandan strains (East Africa) than to West African strains, including the reference 
TvY486. 
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Figure 52 Maximum likelihood phylogeny of amino acid sequences of VSG families 23-
26 using WAG+F model of amino acid substitution. Nodes in black correspond to 
sequences of the reference Y486, blue of Ugandan samples, while red shows sequences from 
T. vivax Lins. The green labels identify the most abundant VSG transcripts seen in the 
transcriptome replicates S3 and S4.
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5.3.6 The expressed VSGs in T. vivax Lins
The VSG database can also be applied to transcriptomic data to compare VSG 
expression between isolates or different time points. Two transcriptomes were 
produced from replicate experimental infections in goats, named S3 and S4. Reads 
were mapped to the reference TvY486 with Bowtie2 (Langmead & Salzberg 2012). 
Subsequently, cufflinks (Trapnell et al. 2012) was used to estimate transcript 
abundances. The transcriptomic profile showed that the most abundant transcripts 
were VSGs, ribosomal proteins and cytoskeleton-associated proteins. A total of 94 
and 89 VSG transcripts were recovered from S3 and S4, respectively. The FPKM 
values ranged from 0.1 to 25073. 
The transcriptome results were compared to the bloodstream transcriptome of 
IL1392, previously published by Jackson et al. (2015) (Table 15). The IL1392 
transcriptome was produced from parasites maintained in vivo by mouse passage. 
The three transcriptomes were produced from RNA extracted from parasites purified 
from blood by differential centrifugation as described in Jackson et al. (2015). 
Although the IL1392 transcriptome has more read pairs, the percentage of 
transcripts mapped to the reference genome are comparable [89.77 %, 90.35 %, 
and 84.24 % for IL1392, S3 and S4, respectively (Table 15)].
Table 15 Summary of VSG transcripts in S3 and S4 compared to the IL1392 
transcriptome previously published by Jackson et al. (2015).
The average FPKM for the 1000 most abundant transcripts of S3 and S4 is lower 
than for IL1392 (Mean: S3 = 247, S4 = 282, IL1392 = 547; Median: S3 = 145, S4 = 
165, IL1392 = 224). The differences in transcript abundance between both S3 and 
S4 and IL1392 are statistically different (Independent t-test, p < 0.001), but the 
differences between S3 and S4 are not (Independent t-test, p = 0.65). To further 
understand the differences in transcript abundance between samples, FPKM 
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correlations were calculated. In the first panel, Figure 53 shows the positive 
correlation of FPKM values between S3 and S4 (R2 = 0.99), indicating that the 
samples are good replicates. The second and third panels show the correlation 
between the IL1392 transcript abundances and the ratio of the abundances of 
TvLins and IL1392 (R2(S3) = 0.88, R2(S4) = 0.92). The data was transformed to 
show the exponential correlation between S3/S4 and IL1392. These results indicate 
that transcripts of higher abundance in IL1392 have a weaker correlation with both 
S3 and S4. Such differences are likely to be a reflection of the different sequencing 
effort because read coverage affects high abundance transcripts more than low 
abundance transcripts. This is corroborated by the higher number of reads in IL1392 
compared to S3 and S4 as observed in Table 15.
Regarding the VSG repertoire, despite the higher number of reads, more VSG 
transcripts were recovered from S3 and S4 than from IL1392 (94 and 89) (Table 
15). However, only in S3 was a super abundant VSG found (FPKM = 25,073.7). It is 
a co-orthologue of the reference gene TvY486_0025610, and belongs to Fam25. 
This shows for the first time that Fam25 encodes functional VSGs. In sample S4, a 
super abundant VSG could not be identified, but two VSGs from Fam23 were the 
most abundant (co-orthologous to TvY486_0014340 and TvY486_0034650; FPKM 
values of 932.2 and 732.3, respectively). The phylogenetic positions of the three 
most abundant VSGs are indicated in green in Figure 52. The six VSGs with 
highest FPKM for each sample were compared to the IL1392 T. vivax transcriptome 
and are shown in Figure 54. This highlights the difference in magnitude between 
the super-abundant VSG and the others, and indicates that VSGs can be 
characterised using the VAP. Here, it is shown that within the 6 most abundant 
VSGs of each sample, there are members of Fam23, Fam24 and Fam25. 
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Figure 53 Correlation of transcript abundances based on the 1000 most abundant 
transcripts between S3, S4, and IL1392. The superabundant VSGs of S3 and IL1392 were 
removed. The first graph shows the linear correlation between S3 and S4 transcript 
abundance values, expressed as fragments per kilobase of transcript per million mapped 
reads (FPKM). The second and third graphs show the exponential correlation between the 
ratio of FPKM values of S3/S4 and IL1392 respectively. R2 values are shown in red 
(p<0.05).
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Figure 54 FPKM values of top 6 transcripts and correspondent VSG families for S3. Transcripts belonging to Fam23 are shaded in black, Fam24 in red 
and Fam25 in blue.
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5.4 Discussion 
This chapter presented the first study of T. vivax VSG diversity on a population 
scale. I developed a VAP methodology suitable for the peculiarities of the T. vivax 
VSG repertoire, based on the presence or absence of diagnostic VSG orthologs. As 
in chapter 5, 13 of the 20 isolates used here were passaged into naïve rodents 
previous to DNA extraction, which may have reduced the diversity of the study. This 
is particularly pertinent in T. vivax, as the majority of isolates is thought not to grow 
in rodents (Morrison et al. 2016). However, this could not be avoided, not only 
because of the barely undetectable parasitaemia characteristic of T. vivax infections 
in endemic areas, but also of the challenges of finding cryopreserved T. vivax blood 
stabilates. In the second part of this chapter, I have applied the VAP to the 
bloodstream stage transcriptome of TvLins to show that the VAP can successfully 
describe VSG expression. 
In chapter 2, I developed the VAP based on conserved protein structural motifs that 
successfully differentiate the 15 phylotypes that comprise the T. congolense VSG 
repertoire. Here, I had to adopt a different methodological approach because the T. 
vivax VSG repertoire is structurally very distinct from T. congolense. First, the T. 
vivax VSG repertoire is comprised of 96 low-abundance phylotypes, which 
precludes accurate comparisons of phylotype relative frequencies. Since all 
phylotypes are a small proportion of total VSGs, this diversity also means that a 
genome sequence must be almost complete for all phylotypes to be detected. 
Recovering the full VSG repertoire is challenging when sequencing field isolates 
due to the low parasitaemia of natural infections, but even in experimental 
infections, the sequencing depth and coverage would have to be very high to 
recover every phylotype frequency and be sure that unrecorded phylotypes were 
genuinely absent. Second, whilst in T. congolense the 15 VSG phylotypes are 
universal and exhaustive, in T. vivax I could not establish universality. Whilst the 
evidence supports that most VSGs are conserved in the population, I found VSGs 
specific to particular countries. Whether they are all real or result from incomplete 
sampling remains unresolved. With these data, I presented a novel VAP approach 
that, rather than measuring conservation across the repertoire as is done for T. 
congolense, detects and relates diagnostic VSGs. At present, these VSGs are 
associated with the isolate geographical location. In future, I envisage these 
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markers to relate to other aspects of epidemiology, particularly host use, disease 
outcome, and virulence.
5.4.1 Antigenic diversity in T. vivax
In this chapter, I have shown that the T. vivax VSG repertoire has 96 lineages, 
distributed by four structurally distinct families that are conserved in the population 
in stable proportions. I further showed that, whilst there are examples of 
geographically restricted VSGs, these lineages are conserved in the twenty 
genomes from Africa and South America analysed here. This contrasts with both T. 
brucei and T. congolense. The VSG repertoire of T. brucei is very dynamic, resulting 
in the development of antigenically distinct ‘mosaic’ VSGs even during the course of 
a single infection (Hall et al. 2013). In T. congolense, the phylotype proportions are 
stable across isolates, but there are significant fluctuations that allow differentiation 
among isolates. For example, I showed in chapter 2 that the Gambian T. 
congolense isolates had a discrete signature of larger phylotypes 5 and 6 (page 64). 
Moreover, in T. congolense the VSG repertoire stability is reflected in the phylotypes 
proportions alone, whilst in T. vivax, the repertoire conservation can be detected to 
the level of individual genes or orthologue groups. 
The conservation in the T. vivax VSG repertoire may reflect clonality. In the whole 
genome SNP analysis, I show little overlap between populations of different 
countries and little evidence for genetic exchange. This is consistent with the 
evidence for asexual reproduction in this species suggested by Duffy et al. (2009). 
In their paper, 531 samples were collected from The Gambia between March 2006 
and January 2007 from donkeys, horses and cattle and analysed by multi-locus 
genotyping. The T. vivax genome encodes meiosis-associated genes, but its 
population structure is consistent with clonal expansion, showing reduced genetic 
diversity, clonal expansion of particular genotypes, and significant levels of linkage 
disequilibrium (Duffy et al. 2009). Together, these data suggest the parasite has lost 
the ability to mate after separating from the T. brucei/T. congolense ancestor (Duffy 
et al. 2009).
Clonal expansion may also explain the direct relationship between VAP, population 
structure and geography. The sample cohort retains a strong geographic signal at 
the genomic level that is reflected by the VSG repertoire (Figure 48). In contrast, in 
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T. congolense, the correlation between the VAP and the population structure is 
weak. In T. brucei, there is a marked genetic difference between West African T. 
brucei gambiense and East African T. brucei rhodesiense (Gibson 2001). Even 
within T. brucei rhodesiense and T. brucei gambiense populations, geography is 
often a main source of genetic variation (Duffy et al. 2013; Echodu et al. 2015). For 
example, long phylogenetic branches separate isolates from Ivory Coast, Guinea 
and Cameroon, even when more than one focus exists in the country and collection 
was spread over 50 years (Weir et al. 2016). However, mating frequency was still 
shown to influence population structure. This is evidenced by the heterogeneity of T. 
brucei rhodesiense populations in Malawi, where mating was recurrent, as opposed 
to the lower genetic diversity of Uganda, where evidence for genetic exchange is 
scarce (Duffy et al. 2013). 
The high number of conserved phylotypes is unprecedented in organisms 
employing antigenic variation. In T. brucei, VSGs have only been divided into a and 
b-type, although the N-termini can be split into 3 groups (A-C) and the C-termini into 
six groups (1-6) (Carrington et al. 1991; Marcello & Barry 2007a). Similarly, in T. 
congolense, VSGs can be divided into 15 lineages (Jackson et al. 2012). In 
Plasmodium falciparum, antigenic variation occurs mainly through the var genes, a 
family of variant surface antigens encoding PfEMP1 (Baruch et al. 1995). PfEMP1 is 
involved in virulence, including but not exclusively through the mediation of parasite 
adhesion to host endothelial receptors (Lavstsen et al. 2003). Although vast, the var 
repertoire of P. falciparum is divided into only three major groups (group A, B and C) 
and two intermediate groups B/A and B/C representing transitions (Lavstsen et al. 
2003; Kraemer & Smith 2003). The three major groups are comparable to the VSG 
families Fam23-26 of T. vivax, which raises an important distinction in gene 
repertoire: whilst var groups A-C can interchange genes, giving rise to intermediate 
groups B/A and B/C, the four VSG families in T. vivax are too structurally distinct for 
recurrent gene conversion. Thus, T. vivax is not only conserving structurally distinct 
families, but also conserving numerous phylotypes within these families and a 
defined cladistic structure within those phylotypes. 
Similarly to T. congolense, phylotype conservation may have functional reasons. For 
example, different phylotypes, or even individual VSGs, may determine clinical 
outcome. As the VAP also delivers a method to analyse transcriptomes, it is now 
possible to examine VSG expression in isolates and conditions. This is evidenced 
by the analysis of the TvLins transcriptome. The VSG repertoire of TvLins is not 
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atypical and all four families are represented in similar proportions as the African 
strain collection. However, the profiling of the two transcriptome replicates, S3 and 
S4, does reveal novel results, since a member of Fam25 has for the first time been 
reported as the superabundant VSG. Fam25 and Fam26 were first described in the 
African trypanosome phylome study as VSG-like families not belonging to either a-
type or b-type VSG and with no co-orthologues in either T. brucei or T. congolense 
genomes, which introduced doubt about their function as variant antigens (Jackson 
et al. 2013). The TvLins transcriptome results support the hypothesis that Fam23, 
Fam24 and, at least, Fam25 encode functional variant antigens.
Understanding the diversity of the T. vivax VSG repertoire may help explaining the 
phenotypic variability of T. vivax infections. For example, in Brazil, parasite 
genotypes circulating in five farms from two municipalities in Pantanal were found to 
cause mild, chronic disease, causing symptoms exclusively as a secondary 
pathogen (Paiva et al. 2000). However, in Pernambuco, T. vivax has led to 
symptomatic disease, characterised by reduced milk production, premature 
offspring and miscarriages (de Souza Pimentel et al. 2012). In the first T. vivax 
outbreak in the state of São Paulo, caused by the TvLins isolate, disease was very 
acute, triggering a wide range of haematological and neurological symptoms 
(Cadioli et al. 2012). Similarly, in Paraíba, a T. vivax outbreak has caused the loss 
of 71 % of a sheep herd, even though cattle and buffalos of the same farm had only 
mild or asymptomatic disease (Galiza et al. 2011). These studies suggest that the 
clinical outcome of T. vivax infections is diverse and unpredictable in Brazil, 
something that has long been observed in Africa (Hornby 1921; Hudson 1944; 
Losos & Ikede 1972). It is possible that the different disease outcomes reflect 
different host-parasite interactions. Thus, as the main surface proteins interacting 
with the host’s immune system, the VSGs may play a role in infection phenotype. 
The VAP provides a method to start investigating such associations. 
If particular VSGs can be linked to disease outcome, geographical location, or host 
susceptibility, the VAP becomes an epidemiological and diagnostic tool. Diagnosis 
of HAT and surra based on variant antigens already exists. For instance, T. brucei 
rhodesiense infections can be diagnosed by a SRA-specific PCR (Radwanska et al. 
2002). For T. brucei gambiense, there are two rapid diagnostic tests targeting a 
combination of VSGs (HAT Sero-K-SeT and HAT Sero-Strip) (Buscher et al. 2013). 
Additionally, for T. brucei evansi there is a rapid diagnostic test targeting a 
recombinant VSG produced in yeast (Birhanu et al. 2015). However, the VAP may 
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allow the development of diagnostics that not only screen for disease, but also 
predict its outcome, virulence and distribution. Epidemiological mapping based on 
variant antigens has been successfully achieved for other infectious diseases. In 
malaria, analysis of var gene diversity and expression patterns has revealed 
associations of particular genes to disease outcome. For example, there are var 
gene expression patterns characteristic from cerebral malaria (Kyriacou et al. 2006), 
whereas particular var gene groups have been associated with severe disease in 
Brazil and Africa (Kirchgatter & Del Portillo 2002; Chen et al. 2011; C. W. Wang et 
al. 2012). Therefore, if, as seems reasonable, the same happens for AAT, research 
on VSG expression may result in an increased understanding of clinical outcome.
The ability to compare and contrast VSG expression during infections and between 
isolates may also help vaccine design. Unlike T. brucei, the stability of the T. vivax 
VSG repertoire and the lack of recombination suggest that T. vivax could be 
amenable to vaccination. The literature reports that T. vivax infections can be ‘self-
limiting’ in trypanotolerant cattle. Analyses of disease progression in experimentally 
infected cattle in Kenya suggested that the VSG repertoire of a single isolate could 
be exhausted, resulting in self-cure (Barry 1986). They also show cross-protection 
between isolates belonging to the same serodeme, suggesting that natural 
protective immunity is possible (Nantulya et al. 1986). Furthermore, in the early 
stages of T. vivax infection, the expressed VSGs of distinct isolates often belong to 
the same serodeme, perhaps reflecting some predictability of the expressed VSG 
sequences (Barry 1986). These results, coupled with my observation that variation 
among the T. vivax VSG repertoire is much lower that in T. congolense and T. 
brucei, offer the hope that there may be VSGs constitutively expressed in T. vivax 
infections, or else substantially lower antigenic diversity. As the VAP provides a way 
to study VSG diversity and expression patterns in T. vivax, it may help identifying 
potential VSG-based vaccine candidates for AAT. 
5.4.2 The COG matrix methodology
The COG matrix was built using read mapping or sequence similarity searches. 
When doing read mapping with Bowtie2 (Langmead & Salzberg 2012), results are 
better under sensitive settings to account for strain diversity. The three most 
common DNA-seq aligners [i.e. Bowtie2 (Langmead & Salzberg 2012), BWA-Mem 
(Li 2013), and STAR (Dobin et al. 2013)] and the most recent segemehl (Otto et al. 
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2014) have similar accuracy rates (98.6-99.9 %), but Bowtie2 has the second to 
lowest user time and the lowest memory requirements (Otto et al. 2014). This is 
particularly important when building a method to handle multiple samples. 
Additionally, with the use of long-read genome sequencing increasing, these 
software are, or have been, updated to accept long reads, thus ensuring the 
adaptability of the VAP. This tool successfully avoids the need for annotation and 
genome assembly, which greatly enhances its speed and sensitivity, as genome 
assembly remains a significant problem for computational biologists (Henson et al. 
2012). 
It is difficult at this point to decide which screening approach is best. The sequence 
similarity approach is more stringent and is dependent on the assembly quality; 
therefore it finds fewer COGs in the dataset. However, since it relies on the similarity 
of the whole VSG contig, it is more accurate. The read mapping approach is more 
sensitive because, first, it bypasses genome assembly, and second, it is dependent 
on the read length rather than contig length. This results in more COGs being 
recovered, partly because the definition of COG becomes more relaxed. This can be 
partially overcome by increasing the genome read length, but will always be less 
strict than the comparison of two full VSG contigs. The presence of recombination is 
an issue that impacts both approaches, yet in different manners. While recombinant 
VSGs would not pass the rigorous requirements of the first approach, they might be 
considered in the second. In fact, in the latter, a mosaic VSG with two parents 
belonging to two distinct COGs would be seen as evidence for the presence of both 
parents, whilst in the former, it would be discarded and seen as a novel variant 
absent from the database. 
Although strictness is often ideal, the ability to simultaneously deal with large fast-
evolving gene families and incomplete genomes can become compromised. For 
example, if taking the most stringent parameters (contig search, 98 %), many COGs 
appear geographically-defined and the widespread VSG repertoire becomes as low 
as 5 % of the total VSG pool. Thus, the question becomes where to draw the line. In 
reality, it comes down to three aspects: the definition of ortholog, or how similar two 
VSGs must be to be considered true orthologs; whether VSGs are subject to the 
same degree of genetic variation as the rest of the genome; and how complete the 
genomes are. At this point, the solution is to invest in more sampling to produce an 
exhaustive COG database. In future, as the database becomes larger, it might be 
possible to refer to the T. vivax VSG repertoire as a finite number of individual 
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genes. In that case, as all expected variation is contained within the database, it 
would be easier to define orthologues and therefore identify the real location-specific 
VSGs. 
5.4.3 Conclusion and Future directions
This work proposes the VAP as a new method to analyse antigenic diversity in T. 
vivax on a population scale and characterise VSG expression in vivo, overcoming 
the computational challenge of studying antigenic diversity on genomic and 
population scales. The particular nature of the T. vivax VSG repertoire revealed the 
importance of genome completeness and comprehensive sampling for an accurate 
VAP estimation. Despite the need for further sampling and deeper sequencing, this 
study showed that the T. vivax VSG repertoire is substantially more stable than that 
of T. brucei and T. congolense, raising the possibility of a finite number of antigens. 
However, I also identified a panel of location-specific VSGs that can be used as 
diagnostic markers in epidemiological studies. In future, we will link antigens to 
disease phenotypes, host susceptibility, and parasite virulence, allowing the VAP to 
deliver a better understanding of disease outcomes. 
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Chapter 6. The molecular evolution of VSGs in 
African trypanosomes
6.1 Introduction
In 2012, Jackson et al. showed that the VSG repertoires of T. brucei, T. congolense, 
and T. vivax produced quite distinct phylogenetic patterns, indicative of distinct 
underlying evolutionary mechanisms. By comparing the probability of phylogenetic 
incompatibility in the VSG repertoire of each species, they inferred that 
recombination played a variable role in diversity, since phylogenetic incompatibility 
probabilities are thought to reflect distinct recombination rates. In this chapter, I 
tested this hypothesis from a population perspective. By offering multiple viewing 
points of the same historical recombination event, a population analysis is more 
powerful than the examination of an individual reference genome for the historical 
signature of recombination past. Therefore, this chapter aims to understand the 
balance of evolutionary forces affecting VSG evolution in African trypanosomes, 
whether this is recombination, mutation rate, or population history. 
Most of the T. brucei and T. congolense VSG genes are located in the 
subtelomeres, the regions between the interstitial regions of the chromosomes and 
their ends (Callejas et al. 2006). These regions are rich in species-specific genes 
and diverse sequence repeats due to high levels of transcription and recombination, 
and low levels of negative selection. In African trypanosomes, subtelomeres are 
larger and more variable than in other trypanosomatids probably due to the VSG 
system (Callejas et al. 2006). Here, recombination is thought to occur ectopically, is 
not restricted to homologous cross-over at cell division (Horn & Barry 2005) and 
there is affinity towards heterologous sequences, which greatly enhances gene 
diversification and expansion of gene families (Ricchetti et al. 2003). Pérez-Morga et 
al. (2001) also showed telomere clustering in T. brucei through in-situ hybridization 
analysis, which further facilitates recombination by bringing telomeres and 
subtelomeres into physical proximity, and makes subtelomeres the ideal regions for 
the VSG archive. 
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Homologous recombination also allows VSG mosaicism. VSG mosaic gene 
formation has long been recognised as a key aspect of infection chronicity in T. 
brucei (Kamper & Barbet 1992; Barbet & Kamper 1993). Gene conversion among 
VSG genes contributes to wide amplification of the available antigenic repertoire 
and increasing antigenic diversity. Homologous recombination affects T. brucei 
VSGs. However, species differences in sequence composition and variation suggest 
that T. congolense and T. vivax have evolved distinct mechanisms for generating 
antigenic diversity (Jackson et al. 2012). Despite antigenic variation being a 
phenotype common to all African trypanosomes, the genomic organisation and 
evolutionary mechanisms of the VSG repertoire seem to vary with the species and 
so might the role of homologous recombination. 
While T. congolense VSG are structurally heterogeneous, T. brucei b-type VSG 
have passed through bottleneck evolution that resulted in the loss of all but one b-
type VSG lineage, generating the single lineage phenotype observed today 
(Jackson et al. 2012). Phylogenetic analysis of the VSG repertoires of the three 
species shows clear differences in sequence organisation and variation. While T. 
brucei phylogenies are very “tree-like” with multiple long terminal nodes, consistent 
with frequent recombination, the phylogenies of T. congolense and T. vivax have 
longer basal nodes, creating long, separate clusters containing multiple, closely 
related sequences, structures that could only be maintained if recombinatorial 
pressures were low. 
Evidence for recombination accounting for differences in VSG variation is 
strengthened by the frequency of VSG pseudogenes in the genomes. As 
pseudogenes are often the result of gene conversion and sequence reorganisation, 
their abundance in the genome is positively correlated with the frequency of 
recombination (Thon et al. 1989; Purandare & Patel 1997). Indeed, the number of 
pseudogenes in T. brucei is much higher than in T. congolense or T. vivax (69.2 % 
for a-type VSG, 72.2 % for b-type VSG, 21.1 % for Fam13, 29.7 % for Fam16, 15.5 
% for Fam23, and 27.2 % for Fam24) (Jackson et al. 2012; Hall et al. 2013; Cross et 
al. 2014). The analysis of the phylogenetic incompatibility (PI) probability performed 
by Jackson et al. (2012) supports the same argument. PI is low amongst T. vivax 
VSG of the same family, regardless of their sequence identity (0.138 and 0.126 for 
Fam23 and Fam24, respectively), suggesting that recombination is scarce amongst 
this species VSG (Jackson et al. 2012). However, results for T. congolense support 
a different conclusion. Whilst phylogenetic incompatibilities are lower when 
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comparing random sequences of the VSG repertoire (0.125 for Fam13 and 0.43 for 
Fam16), they increase drastically when analysing sequences of the same phylotype 
(0.466 and 0.823 for Fam13 and Fam16, respectively) (Jackson et al. 2012). 
Furthermore, these probabilities can be increased if the CTDs are removed from the 
analysis, suggesting that recombination amongst T. congolense VSG occurs mostly 
within the same phylotype and that the CTD is a constraint for recombination 
(Jackson et al. 2012). The latter is a major difference with T. brucei, whose CTD is 
known to facilitate recombination by providing a sequence anchor point and 
containing a defined breakpoint. In fact, exchange of CTDs between VSG with 
distinct NTDs has been shown multiple times (Hutchinson et al. 2003). The analysis 
of PI in T. brucei VSG completes the argument by showing a generally high 
probability of recombination, but higher within the closely related sequences and a 
significant decrease when the CTD is removed (Jackson et al. 2012).
Homologous recombination is relevant for pathogenesis because it directly relates 
to antigenic switching. Antigenic switching requires the movement of a silent VSG 
from the subtelomeres or other telomeric expression sites to the active expression 
site, which is achieved by sequence recombination. However, homologous 
recombination is dependent on sequence homology and substrate length (Bell & 
McCulloch 2003; Barnes & McCulloch 2007), as well as the efficiency of base 
mismatch repair. T. brucei has at least three pathways of homologous 
recombination contributing to VSG recombination: the RAD51-dependent pathway, 
which has been well characterised in the literature and accounts for the majority of 
switching events (McCulloch & Barry 1999; Proudfoot & McCulloch 2005); RAD51-
independent, microhomology-mediated end-joining (Glover et al. 2011); and the 
MSH2-independent pathway, which accounts for the residual VSG switching events 
observed in RAD51 mutants (Barnes & McCulloch 2007). Whilst the 
microhomology-mediated end-joining  pathway is more efficient for substrates of 
200 bp, the MSH2-independent pathway favours mostly short homology substrates 
of 5-15 bp (Barnes & McCulloch 2007). 
As homologous recombination relies on DNA repair mechanisms, it has been 
proposed that DNA double-strand breaks (DSB) are triggers of VSG recombination 
(Glover et al. 2013). The frequency of natural DSB increases with the proximity to 
the telomere, suggesting that the subtelomeres are inherently fragile sites prone to 
recombination. However, not all DSB result in recombination and antigenic 
switching. Instead, the likelihood of a successful VSG recombination event is 
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dependent on the location of the DSB and the degree of homology of the flanking 
regions. Specifically, DSB occurring in the expression site downstream of the VSG 
and closer to the telomere are less efficient in triggering antigenic switching because 
the distance to the 70 bp repeat, which provides sequence homology to facilitate 
VSG recombination, is larger. Glover et al. (2013) presented a comprehensive 
model of antigenic variation that brings together all these aspects. In the event of a 
DSB at the expression site, which is frequent due to the fragile nature of the 
subtelomeres, the 70 bp repeats in the expression site associate with the 70 bp 
repeats of the subtelomeres to facilitate conversion of the active VSG as part of the 
DNA repair mechanism. Importantly, not all DSB occuring in the expression sites 
result in antigenic variation, which agrees with the experimental observation that 
antigenic switching occurs at much lower rates than subtelomeric DSB (Glover et al. 
2013). 
In this chapter, I directly compare the VSG repertoires of T. brucei, T. congolense, 
and T. vivax, at the population level, using a combination of read mapping and 
homologous recombination estimations. The specific aims are:
1. To give an interspecies perspective of VSG variability, which will allow VSG 
variability prediction for population genomic studies.
2. To quantify expected orthology among VSG repertoires to reveal the 
species-specific signature of gene hypervariability. 
3. To investigate the role of recombination in generating VSG diversity across 
African trypanosome populations to understand what is the balance of 
evolutionary forces affecting VSG diversity.
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6.2 Methods
6.2.1 Genomes 
To evaluate VSG diversity on a population level, I have used twenty-six T. 
congolense genomes of those presented in chapter 2, all T. vivax genomes from 
chapter 5, twenty-one T. brucei and three T. brucei evansi genomes that were 
retrieved from the ENA (Table 16).
Table 16 Description of samples used in this chapter. Isolates are organised by species 
and include country of collection, host species, date of collection and previous publication 
details.
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6.2.2 VSG mapping
To indirectly test the hypothesis that mosaicism rates are higher in T. brucei than 
the remaining species, I have compared VSG read mapping percentages across 
different strains. Specifically, VSG read mapping with Bowtie2 (Langmead & 
Salzberg 2012) was used to investigate the frequency of VSG conservation between 
the field strains and the reference. To retrieve VSG reads from the field strains, 
sequencing reads were mapped against a database of full length VSG and the 
number of mapped paired reads noted (Figure 55). The mapped reads were 
subsequently mapped against the database of full length VSG from the reference 
strain of each species and the number of mapped paired reads noted again (Figure 
55). The percentage of reads from the field strain remaining paired in the reference 
strain was calculated and compared between species. The same procedure was 
applied to adenylate cyclases, which worked as a negative control for the baseline 
background variation (Alexandre et al. 1996; Bridges et al. 2008; Salmon et al. 
2012).
Figure 55 Reference VSG mapping strategy. Field strain VSG reads were retrieved by 
read mapping using Bowtie2 (Langmead & Salzberg 2012). These reads were mapped 
against a database of full-length VSG from the same strain and mapped paired reads were 
quantified (1). The same VSG reads were subsequently mapped to a database of full length 
VSGs from the reference genome (2). Mapped paired reads were quantified and compared to 
(1). This procedure was applied for all strains of T. brucei, T. congolense, and T. vivax
6.2.3 VSG characterisation
The variability in VSG conservation according to strain and species suggested that 
VSG mosaicism exists in different proportions between species. However, to 
understand how mosaicism is happening and the players involved, an approach 
inverse to the first one was used. Rather than using field strain reads, reference 
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VSG were fragmented into 150 nucleotide pseudo-reads and mapped against the 
full-length strain VSG (Figure 56). This was necessary because the field strain VSG 
repertoires are incomplete and of variable sizes, which would introduce greater 
variability and error when quantifying mapped and unmapped reads. 
The original identifiers of the reference VSGs were kept in the pseudo-reads so that 
the frequency of reference reads remaining paired in the field VSG could be 
estimated. This procedure was applied to all strains and compared between 
species. VSG mapping was performed with Bowtie2 under sensitive settings 
(Langmead & Salzberg 2012). Using the mapping results, all VSG from the field 
strains were characterised into uncoupled, multi-coupled and fully coupled, 
according to how many reference VSG contributed to them (Figure 56). The 
reference VSGs contributing to a strain VSG were called ‘donors’. Fully coupled 
VSG were those with at least one donor contributing to more than 84 % of the 
sequence. Multi-coupled VSG were those with one or more donors contributing with 
more than 1 pseudo-read (≥ 300 nucleotides), whereas uncoupled VSG were those 
remaining [i.e. one or more donors contributing with 1 read only (i.e. ≤ 150 
nucleotides]. The reference VSG that were not mapped at least once to the strain 
VSG were considered reference-specific variants. Under these definitions, I would 
expect that T. vivax presented the highest percentage of fully coupled VSG, and T. 
brucei the highest percentages of multi-coupled and unmapped VSG.
Figure 56 VSG characterisation strategy. Reference VSG sequences were split into 
pseudo-reads of 150 nucleotides. These pseudo-reads were mapped against a database of 
field strain full-length VSGs. Each field strain VSG was then defined as fully coupled, multi-
coupled, uncoupled, or unmapped, according to how many and how much of the VSG 
pseudo-reads were mapped to it.
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6.2.4 VSG donor analysis
To further understand how mosaicism is happening, the reference sequences 
contributing to each multi-coupled VSG (i.e. donors) were retrieved and analysed 
(Figure 57). For each VSG, the number of donors and their coverage (i.e. how 
many base pairs each donor contributed to the VSG) were calculated from the 
mapping output using a customised script. This approach allowed me to test the 
hypothesis that the level of mosaicism is lower for T. vivax, even within mosaic 
VSGs.
Figure 57 VSG donor analysis strategy. The VSG pseudo-reads mapped to multi-coupled 
VSG were retrieved and analysed. The number and contribution of pseudo-reads mapping to 
each VSG were quantified. 
Subsequently, I performed a specific VSG donor analysis for T. congolense to 
understand whether closely related VSG sequences were more likely to recombine. 
The CTD is an anchor for recombination in T. brucei and has been proposed to 
have the same role in T. congolense. As each phylotype has a different CTD, intra-
phylotype recombination has been shown to be the most frequent in the reference 
strain IL3000. To test whether the same was observed at the population level, T. 
congolense multi-coupled VSGs and their reference donors were profiled using the 
Variant Antigen Profiling tool presented in chapter 2. Intra- and inter-phylotype 
recombination were calculated and compared on a data matrix. 
I have also tested whether particular regions of the T. congolense VSG sequence 
were more likely to be shared across the sample cohort. In chapter 2, I showed that 
the T. congolense 15 VSG phylotypes were mainly defined by conserved CTDs. 
This suggests that T. congolense uncoupled VSGs would most likely be mapped at 
the CTD. To test this hypothesis, the reference pseudo-reads mapping to T. 
congolense uncoupled VSGs were localised in the VSG secondary structure using 
their sequence identifier.
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6.2.5 Recombination analysis 
Whilst all the previous methodological approaches have measured recombination 
indirectly, the likelihood of recombination can be directly quantified by measuring PI. 
Alignments with recombinant sequences have multiple phylogenetic signals, i.e. 
different PI, whose probability can be estimated using the pair-wise homoplasy 
index (PHI) (Bruen et al. 2006). 
To test whether multi-coupled VSGs were more likely to be recombinant than fully 
coupled VSGs, I calculated PI for each VSG group. PI was also calculated for 
adenylate cyclases as a control for the background genome recombination level and 
for two sets of simulated data (250 replicates, 16 sequences per replicate) with and 
without recombination. Simulated data was generated with NetRecodon (Arenas & 
Posada 2010), under diploid settings, a population mutation rate () of 160, a 
heterogeneity rate of 0.05, and an expected population size of 1000. The population 
recombination rate () was set to 0 and 96 for the non-recombinant dataset and 
recombinant datasets, respectively. Both experimental and simulated sequences 
were divided into subsets of 4 sequences (quartets) and aligned using clustalW 
(Larkin et al. 2007). PHI was run iteratively (Bruen et al. 2006) on each quartet and 
the probability of PI recorded. The percentage of quartets with significant PI was 
compared between sequence types and species. The multi-coupled VSG group 
resulted in 909, 513, and 878 quartets for T. brucei, T. congolense, and T. vivax, 
respectively. The fully coupled VSG produced 115, 25, and 159 quartets, and the 
adenylate cyclases group yielded 910, 155, and 269 quartets, respectively. The 
simulated data resulted in 1000 quartets per condition.
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6.3 Results
6.3.1 VSG mapping
To indirectly evaluate how much of the VSG repertoire was mosaic in the 
population, I quantified the proportion of VSG reads from the different strains 
remaining paired in the reference full repertoire. To test the hypothesis that the 
different species had different degrees of VSG repertoire conservation, I calculated 
the percentage of paired reads shared between the reference and the field strains. 
This showed that T. brucei had the lowest percentage of shared paired reads (79 
%), whilst T. congolense and T. vivax had 87 % and 94 %, respectively (Figure 58). 
The same approach was used with adenylate cyclases as a negative control for the 
background genetic variation. In contrast with VSG, the percentage of adenylate 
cyclases shared paired reads was 94 %, 98 %, and 97 % for T. brucei, T. 
congolense and T. vivax. For each species, the difference in shared paired reads 
between VSG and adenylate cyclases was significantly different (Independent t-test, 
p<0.001). Within the VSG group, the species differences are also significant  
(Figure 58). 
Furthermore, Figure 58 shows that the averages presented above are the result of 
very distinct dynamics. T. vivax shows a pattern where the percentage of shared 
reads between the strains and the reference is always higher than 90 %. The 
majority of T. brucei only share between 70 and 79 %, whilst a minority shares 80-
89 %, and T. congolense presents an intermediate scenario where the percentage 
of shared reads increases from 60-69 % (N = 2 strains) to more than 89 % (N = 12). 
A lower percentage of shared paired reads indicates that, in different strains, VSG 
reads map to distinct regions, which is a likely result of lower conservation between 
VSGs. Therefore, these data suggest that T. brucei has the most variable VSG 
repertoire and T. vivax occupies the opposite end of the spectrum with the highest 
degree of conservation among strains.
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Figure 58 Proportion of field strain paired VSG reads remaining paired when mapped 
to full-length VSG for each African trypanosome species. Adenylate cyclases (AC) were 
included as a negative control for background mapping variation. African trypanosome 
species are colour-coded according to key. Stars indicate statistical significant differences 
between species (Independent t-test, ** = p < 0.01; *** = p < 0.001). The percentage of 
shared reads between VSGs and adenylate cyclases was significantly different for all species 
(Independent t-test, p < 0.001).
6.3.2 VSG characterisation
Analysis of read mapping indicates that species differ in VSG rearrangement, but is 
not sensitive enough to show the scale of mosaicism. To achieve this, the reference 
VSGs were segmented into non-overlapping pseudo reads of 150 nucleotides and 
iteratively mapped against each strain full-length VSGs. The reference VSG pseudo 
reads were named based on their original VSG and their positioning in the original 
sequence so they could be tracked after mapping. The mapping outputs were used 
to calculate read coverage and to classify strain VSGs accordingly into three 
groups: fully coupled, or those strain VSGs whose reference VSG pseudo reads 
aligned to more than 84 % of sequences; uncoupled, or those strain VSGs to which 
only one pseudo read per reference VSG mapped; and multi-coupled, or those 
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strain VSGs which have had multiple pseudo reads from the same reference VSGs 
mapped to them, but which cover less than 85 % of the full-length VSG sequence 
(Figure 59). Additionally, those reference VSGs that did not map to any of the strain 
VSGs were considered unmapped and therefore unique to the reference in the 
context of the population being analysed.
Figure 59 Example representation of fully coupled and multi-coupled VSGs with their 
respective topology probability. Topologies were estimated with Topali v2 (Milne et al. 
2009). Breaks in topology significance reflect evidence for recombination. In fully coupled 
sequences, only one topology is significant across the whole nucleotide sequence. In 
contrast, in a multi-coupled sequence, three different topologies account for different parts of 
the nucleotide sequence, reflecting at least three VSG donors. Dashed line shows 
significance threshold of 95 %. 
This approach showed that T. vivax has a significantly higher percentage of fully 
coupled VSGs than both T. congolense and T. brucei (59 ± 4 %, Independent t-test, 
p<0.0001). In contrast, the percentages of fully coupled VSGs in T. brucei and T. 
congolense are not significantly different. T. congolense has similar percentages of 
multi-coupled and uncoupled VSGs (33 ± 2 % and 31 ± 4 %). The percentage of T. 
congolense multi-coupled VSGs is significantly higher than that of T. vivax 
(Independent t-test, p < 0.01), but significantly lower than T. brucei (Independent t-
test, p < 0.05). Therefore, T. brucei has the highest percentage of multi-coupled 
VSGs (39 ± 1 %) and T. vivax the lowest (25 ± 2 %). In contrast, the percentage of 
T. congolense uncoupled VSG is significantly higher than both T. vivax (8 ± 1 %) 
and T. brucei (12 ± 1 %) (Independent t-test, p < 0.001).
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A high percentage of fully coupled VSGs suggests high repertoire conservation in 
the population. In contrast, multi-coupled and uncoupled VSGs are mosaics. These 
results suggest higher VSG conservation among T. vivax strains. Hence, this 
confirms the hypothesis that T. vivax has the most conserved VSG repertoire 
among the sample cohort.
T. brucei has a significantly higher percentage of unmapped VSGs (29±2 %) than 
both T. vivax (8 ± 2 %) and T. congolense (16 ± 1 %) (Independent t-test, p<0.0001) 
(Figure 60). Unmapped VSGs reflect strain-specific VSGs, which can result from 
gene turnover high enough to erase evidence of ancestral sequences. Therefore, 
the results also suggest that T. brucei VSG repertoire is the most variable across 
strains.
Figure 60 The composition of the VSG repertoire for each African trypanosome species 
(mean ± SEM). Field strain VSGs were characterised according to the number of reference 
pseudo-reads that mapped to them into fully coupled, multi-coupled, uncoupled, or 
unmapped. Graph represents the percentage of each category per strain, per species. Stars 
indicate statistically significant differences (Independent t-test, * = p < 0.05; ** = p < 0.01; 
*** = p < 0.001). Species are colour-coded according to key.
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Genomic novelty is mostly generated by recombination. In fact, in T. brucei, 
segmental gene conversion has already been showed to be crucial for new VSG 
variant generation (Marcello & Barry 2007a). So far read mapping results show that 
multi-coupled VSGs are mosaics. However, to test whether mosaicism is caused by 
recombination, I compared the probability of PI in fully coupled and multi-coupled 
sequences for each species. PI was calculated with PHI (Bruen et al. 2006) (Figure 
61). This measure provided a statistical basis to link multi-coupling with 
recombination and thus validates the mapping-based methodology used in this 
chapter. The majority of multi-coupled VSG from all three species showed evidence 
for recombination (67 %, 65 %, and 41 %, for T. brucei, T. congolense, and T. vivax, 
respectively), whilst the evidence for recombination within the fully coupled VSGs is 
within the same level of both the background recombination level expressed by the 
arbitrarily selected adenylate cyclases quartets and the negative recombination 
simulations. 
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Figure 61 Phylogenetic incompatibility among VSG genes using PhiPack (Bruen et al. 
2006). The percentage of sub-alignments showing significant phylogenetic incompatibility 
(Ppi) in in multi-coupled and fully coupled VSG is shown for T. vivax [N(MC) = 878; N(FC) 
= 444], T. congolense [N(MC) = 513; N(FC) = 213], and T. brucei [N(MC) = 909; N(FC) = 
597], with bars shaded by species according to key. Adenylate cyclases were included as the 
experimental negative control [N(T. vivax) = 269 , N(T. congolense) = 155, N(T. brucei) = 
910]. The same metric for 1000 quartets of simulated data in the presence and absence of 
recombination, obtained with NetRecodon (Arenas & Posada 2010), is shown in black. The 
population mutation rate () was kept constant at 160; r represents the population 
recombination rate used to produce the sequences. African trypanosome species are colour-
coded according to key.
The high percentage of uncoupled VSGs in T. congolense shown in Figure 60 was 
surprising unless they represented alignments to the well-conserved CTDs. The T. 
congolense VSG repertoire is divided into 15 universal and exhaustive phylotypes 
characterised by distinctive conserved CTDs and therefore such a high percentage 
of uncoupled VSG should reflect this. This hypothesis was tested by tracking the 
reference pseudo-reads in the mapping output of each strain and localising the 
region of the strain VSG they matched. The results presented in Figure 62 
corroborate the predictions, showing that, in 58 % of the events, the reference 
pseudo read mapped to the CTD (Figure 62).
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Figure 62 Donor VSG sequence localisation within T. congolense uncoupled VSGs. 
NTD = N-terminal domain, CXC = the central CXC VSG domain, CTD = C-terminal 
domain, Pre CTD = the regions immediately upstream the CTD.
Another unusual observation was that, on average, 8 % of the T. vivax reference 
VSG pseudo reads remained unmapped (Figure 60). If the T. vivax VSG repertoire 
is as conserved as suggested by chapter 5 and Figure 58, then all reads should 
map to all strains. However, as shown in chapter 5, the T. vivax VSG repertoire 
contains a subset of region-specific VSG that are not found in all strains. Therefore, 
and given that the reference strain is Nigerian, it would be expected that the majority 
(if not all) of the unmapped reads should come from the non-Nigerian strains. To 
test this, the percentage of unmapped reads per strains was analysed. This 
revealed that among the Nigerian isolates the average percentage of unmapped 
reads was only 2 % ± 1.44, whilst the for non-Nigerian strains this increases to 16 % 
± 6.94. These results suggest that whilst the majority of T. vivax VSGs are 
conserved across isolates, there is a small number of location-specific VSGs. These 
findings corroborate those presented in chapter 5. 
6.3.3 Donor analysis
To further dissect the differences in VSG repertoire for the three African 
trypanosome species and to understand the reasons and mechanisms behind such 
differences, the number and contribution of the reference VSG (‘donor’) to each 
strain VSG was analysed. A lower number of donors per VSG would indicate that 
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not all VSG were free to recombine with each other, suggesting more constraints for 
VSG recombination. Although the three species have VSG with multiple donors, T. 
brucei has the highest number (up to 58), whereas T. vivax has the lowest (up to 
29). These results support previous observations that mosaicism plays a large role 
in antigenic variation in T. brucei (Marcello & Barry 2007a; Hall et al. 2013). In fact, it 
has been shown to accumulate rapidly, contributing to a large sequence turnover, 
where sequence identity does not seem to constrain gene conversion (Hall et al. 
2013). Our data also supports this view: we see that the total nucleotide identity 
between donors and their recipient VSG varies (Figure 63). Whilst the T. vivax 
donors share 86 % ± 0.1 sequence similarity, the T. brucei donors and their 
correspondent VSG only share 47 % ± 0.06, which indicates a higher repertoire 
conservation and greater orthology amongst VSGs in T. vivax, and consequently 
higher sequence diversity and fewer recombination constraints in T. brucei. 
Whilst the number of donors in certain T. vivax VSGs is higher than expected for 
such recombination scarcity, it reflects the repetitive nature of the repertoire, 
populated by multiple VSG tandem arrays originated by duplicative gene conversion 
events. On the other hand, in T. congolense, the sequence identity required for 
recombination is high, closer to T. vivax at 71 % ± 0.13, which likely reflects the 
recombination constraints between different VSG phylotypes. In fact, 88 % of T. 
congolense multi-coupled VSGs have donors of the same phylotype. This is shown 
in Figure 64, a heat map representing the relative frequency of phylotype 
combinations between the reference donor VSG and the strain VSG, confirming the 
hypothesis that recombination between sequences of different phylotypes is rare 
(Jackson et al. 2012). Further to this analysis, I looked at the contribution of each 
individual donor to the VSG in terms of sequence coverage and show that despite 
the large range (i.e. 8 to 84 %), lower coverages are more frequent in T. congolense 
and T. brucei than in T. vivax (Figure 65), suggesting a clear difference in repertoire 
conservation across the species among the three African trypanosomes.
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Figure 63 Nucleotide sequence identity amongst all sequences involved in MC VSG 
formation (donors and recipients) (mean ± 95 % CI). Stars indicate statistical significant 
differences (Independent t-test, *** = p < 0.001). African trypanosome species are colour-
coded as previously.
Figure 64 T. congolense VSG recombination distribution by phylotype. Data is 
expressed as a proportion of total recombination and colour-coded by number of events. 
Green represents lower and red represents higher frequency.
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Figure 65 The sequence coverage of VSG donors expressed as a percentage of the full 
multi-coupled VSG repertoire. African trypanosome species are colour-coded as 
previously.
In all three species, the number of VSGs with a single donor was remarkably high. 
When these events are analysed further, they reveal that the majority of T. vivax 
single donors account for over 75 % of the sequence. This contrasts with T. brucei 
and T. congolense, where those instances are a minority, once again suggesting a 
clear difference in repertoire conservation across the species among the three 
African trypanosomes (Figure 66). The relative frequency of single donor coverage 
in T. congolense and T. brucei follows a normal distribution. The T. congolense 
maximum frequency donor coverage is between 25 and 44 %, and in T. brucei is 35 
to 54 %. 
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Figure 66 The sequence coverage of VSGs with a single donor, represented as a 
percentage of VSG. African trypanosome species are colour-coded as previously.
What remains unresolved is the degree of conservation that can be expected in the 
VSG repertoire across the population for each trypanosome species. In principle, 
orthology can be easily extrapolated from the percentage of fully coupled VSGs 
observed in each species (59 % ± 4; 22 % ± 4; 20 ± 1, for T. vivax, T. congolense, 
and T. brucei, respectively). Here, we have used the reference genomes as fixed 
points for pairwise comparisons with the remaining strains. If such analysis were 
repeated using a distinct genome as reference, it is highly likely that the specific set 
of FC VSG would change. As such, it is our view that the majority, if not all, VSGs 
are mosaic sequences, depending on which strains are being compared. Therefore, 
estimating orthology based exclusively on the set of FC VSG would result in a large 
underestimation of sequence conservation and in the overall interpretation that VSG 
orthology across the population is scarce. Thus, we propose that a more accurate 
way to calculate orthology amongst VSGs is to include the orthologous VSG sub-
sequences that constitute mosaic VSGs and assess the number of shared base 
pairs in the context of the full VSG repertoire of each strain. This way, sequence 
orthology in the T. brucei VSG population repertoire can be estimated at 40 %, in T. 
congolense at 41 % and in T. vivax at 74 % (Figure 67). 
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Figure 67 Total sequence orthology amongst VSG repertoires of the same species. 
Orthology was calculated as the proportion of shared nucleotides between each strain and the 
reference. Stars indicate statistical significant differences (Independent t-test, NS = non-
significant; *** = p < 0.001). African trypanosome species are colour-coded as previously.
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6.4 Discussion
Gene conversion has been previously proposed to play distinct roles in diversity 
generation in African trypanosomes (Jackson et al. 2012), but this hypothesis was 
based exclusively on the reference genomes of T. brucei, T. vivax, and T. 
congolense. In this study, I have analysed the conservation of the VSG repertoire 
across a population sample (N = 69) with a continental distribution. This has allowed 
me to compare the quantitative contribution of recombination to VSG diversity among 
the different African trypanosome species. I have shown that the rate of gene 
conversion in the VSG repertoire is highest among T. brucei isolates and lowest in T. 
vivax, whilst T. congolense occupies an intermediate position characterised by 
frequent recombination within specific gene cohorts. The novelty of this work lies in 
the overall picture of the role of recombination in sequence evolution afforded by 
population analysis, which is more accurate than the analysis of single isolates, 
especially when dealing with variant gene families undergoing extensive gene 
turnover. 
Segmental gene conversion, or VSG mosaicism, has the main function of generating 
novel variants, utilising the vast repertoire of silent and/or pseudogenic VSG 
(Marcello & Barry 2007a). Furthermore, mosaicism allows infection chronicity by 
providing an endless pool of variant antigens. In Anaplasma marginale, mosaicism 
has been proposed as driver of super infections of partially immune hosts (Brayton et 
al. 2002). If that applies to African trypanosomes, then mosaicism adds complexity to 
the already vast phenotypic potential of trypanosomes (Barry et al. 2005).
The accepted hypothesis for the formation of mosaic VSGs in T. brucei is a pathway 
of sequential, independent steps of segmental conversion, enabled by a restricted 
set of donor VSG sequences (Marcello & Barry 2007a). This is consistent with 
sequence homology between sequence donor and recipient being a major 
determinant of recombination (Bell & McCulloch 2003). The T. brucei VSG repertoire 
is very rich in mosaic VSGs. For instance, unique VSG comprise 60 % of the T. 
brucei TREU927 VSG repertoire; the remaining 40 % relate to clusters of 
orthologues of 2-4 members with over 50 % identity (Marcello & Barry 2007a). In this 
chapter, I have shown that 50 % of T. brucei VSGs are mosaics (i.e. 39 % MC and 
11 % UC) (Figure 60), of which 67 % have a recombination signature measurable by 
PI (Figure 61). These estimations are likely to be under-represented, because 29 % 
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of T. brucei VSGs lack any orthology within the population sample (i.e. the 
unmapped VSGs) and therefore were not analysed for evidence of recombination. 
These data suggest that the T. brucei VSG repertoire is highly dynamic and heavily 
influenced by ectopic recombination, which actively contributes to VSG diversity 
generation within the population.
Recombination is also a major generator of antigenic diversity in other organisms. In 
P. falciparum, the chromosomal ends are populated by var genes. Like in T. brucei, 
these telomere-associated structures are well conserved across chromosomes, 
favouring sequence recombination. Indeed, ectopic recombination is a major driver of 
new var genes formation (Freitas-Junior et al. 2000; Taylor et al. 2000). Likewise, in 
Anaplasma marginale, msp2 gene expression is often preceded by multiple levels of 
recombination to convert pseudogene segments into a fully functional gene at the 
expression site (Brayton et al. 2002).
The results of this chapter indicate that recombination within the T. congolense VSG 
repertoire is dependent on sequence diversity. The analysis of T. congolense 
phylotype recombination showed that sequence exchange between sequences of 
different phylotypes is rare. The majority of VSG recombination events in T. 
congolense occur between sequences of the same phylotype, most likely due 
sequence homology constraints: the large disparities in sequence composition 
between Fam13 and Fam16 and amongst the CTDs of each phylotype appear to 
limit recombination. This agrees with the previous analysis of the IL3000 VSG 
repertoire (Jackson et al. 2012) and also with evidence presented in chapter 2 that 
the different phylotypes are under purifying selection. In T. brucei, such constraints 
do not exist, as the VSG CTDs are homogeneous, apparently facilitating homologous 
recombination between diverse sequences (Marcello & Barry 2007a; Jackson et al. 
2012).
The presence of recombination constraints is even more evident in T. vivax than in T. 
congolense. The high number of fully coupled genes across the species and the 
scarce evidence of recombination are all indicators of high repertoire conservation. 
Yet, T. vivax seems to have the tools necessary for recombination, at least regarding 
the processes linked to sequence repair in T. brucei, such as the RAD51-dependent 
pathway double-strand breakpoint repair mechanism (for example, the DNA repair 
protein RAD51, the meiotic recombination protein DMC1, and the replication factor A 
protein RPA1), and the DNA mismatch repair protein MSH2 (Bell & McCulloch 2003; 
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Barnes & McCulloch 2007; Glover et al. 2011; Glover et al. 2013). Therefore, the low 
levels of recombination observed in T. vivax do not seem to relate to any loss in 
sequence repair ability. Although it is possible that these mechanisms are less 
efficient in T. vivax, therefore resulting in lower recombination levels, it is perhaps 
more likely that recombination constraints relate to differences in sequence 
homology as observed for T. congolense. As described in chapter 5, the T. vivax 
VSG repertoire is composed of 96 phylotypes. These lineages are separated by long 
evolutionary distances, but composed of a small number of very similar genes. As 
sequence homology strongly affects efficiency of ectopic recombination, it is possible 
that recombination is rare amongst T. vivax because the number of genes between 
which conversion is possible is limited and so is the number of pseudogenes. In fact, 
in this species the sequences involved in mosaic VSG formation usually share high 
nucleotide sequence identity (multi-coupled VSG, 86 % ± 0.1), whilst T. brucei 
sequences are only 47 % ± 0.06 similar (Figure 63).
If sequence homology is the major recombination constraint affecting T. congolense 
and T. vivax, it brings back the question of why and when the different lineages were 
formed. The lineages of T. congolense were likely present in the T. congolense/T. 
brucei ancestor because T. brucei ESAG2 closest relatives are members of 
phylotype 3 in T. congolense. Yet, these lineages are not in T. vivax, suggesting that 
they were developed after T. vivax speciation. This leaves the origin of the many T. 
vivax lineages unsolved. VSG families Fam23 and Fam24 are a- and b-type VSG, 
hence they were present before T. vivax speciation and have shared origin with T. 
brucei and T. congolense VSGs (Jackson et al. 2012). However, Fam25 and Fam26 
are apparently T. vivax-specific (Jackson et al. 2012). They could be an innovation, 
which has arisen after the origin of T. vivax, or they could have been present in the 
African trypanosome ancestor and lost by the T. congolense/T. brucei ancestor. 
In other antigenically variant organisms, recombination constraints within variant 
antigen gene repertoires are less evident. An analysis of P. falciparum var gene 
diversity from three distinct isolates has demonstrated that parasite isolates share 
little of their var gene repertoire, a sign of extensive segmental gene conversion 
(Kraemer et al. 2007). The var gene repertoire is divided into three major groups (A, 
B, and C) (Gardner et al. 2002; Kraemer & Smith 2003; Lavstsen et al. 2003). 
However, unlike in T. congolense, hybridisation between groups is possible and 
frequent, being described by the intermediate groups B/A and B/C (Lavstsen et al. 
2003). This categorisation, which is based on both 5' upstream sequence similarities 
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and chromosomal location, was subsequently updated to groups A1-2, B1-B4, C1-2, 
and E, as a means to include ‘atypical’ variants generated by the frequent 
recombination and chromosomal loci movement (Kraemer et al. 2007). 
In P. falciparum, telomeric clustering is thought to be stochastic, thus allowing var 
genes to recombine with a multitude of other potentially unrelated var genes, and 
exponentially increasing the potential for variant formation (Freitas-Junior et al. 
2000). However, particular chromosomal end combinations may be more efficient 
than others at driving recombination due to higher sequence homology and/or 
peculiarities of chromatin structure (Freitas-Junior et al. 2000). In fact, Kraemer et al. 
(2007) observed that recombination preferentially occurs within var groups, except 
amongst the var groups B and C of the core chromomes (central var clusters). These 
two groups are more similar to each other, therefore chimaeric genes are more 
common within these clades, suggesting that group B and C recombine more often 
with each other than with var group A (Kraemer et al. 2007). These differences in 
recombination probability observed amongst different var groups are referred to as 
gene recombination hierarchy (Kraemer et al. 2007). Such a concept can be 
transposed to T. congolense as we too see high prevalence of recombination within 
groups (i.e. phylotypes), followed by scarce recombination between groups of higher-
similarity (e.g. phylotypes 8 and 4) (Figure 64). The formation of distinct antigen 
groups in the genome has been considered a response to immune selection 
pressures (Gupta et al. 1996). If that applies to T. congolense, then the presence of 
inter-phylotype recombination would not be advantageous because it would 
counteract such process.
With such key differences in repertoire diversity generation, it might be expected that 
the VSG repertoires of the three species diverge at different rates. In T. brucei, the 
VSG repertoires change rapidly over time, even within the same isolate. For 
example, one of the genomes used in this study, 427var3, is an uncultured variant of 
the strain Lister 427, used as reference here. Yet, only 34.62 % of their VSG 
repertoire is fully coupled, suggesting that over time Lister 427 has drastically 
changed its VSG repertoire. Furthermore, whilst in T. congolense the percentage of 
fully coupled VSGs between the reference and a field strain can have a wide range 
(5 % to 69 %), in T. brucei, even closely related strains have dissimilar VSG 
repertoires up to a limit of 12 % identity (12 % to 37 %). This suggests that gene 
turnover is occurring at a rate fast enough to homogenize the VSG gene pool. These 
results corroborate the view of Hall et al (2013) that T. brucei antigenic variation is 
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built continuously by many variants, rather than in a tightly regulated, intermittent 
manner. In T. vivax, we observe the opposite situation; with the exception of three 
isolates, at least 50 % of VSGs are conserved in the full extent of the gene, clearly 
confirming that ectopic recombination amongst T. vivax VSGs is much less frequent 
than in its relatives.
Recombination in T. brucei and T. congolense may also be occurring at meiosis. 
Mating and meiosis as mechanisms of gene exchange have been well characterised 
in T. brucei (Turner et al. 1990; Tait et al. 2007; Peacock et al. 2011; Peacock, 
Bailey, et al. 2014). In T. congolense, mating has been shown amongst T. 
congolense savannah in two distinct occasions (Morrison, Tweedie, et al. 2009; 
Tihon et al. 2017). T. vivax, however, despite having the machinery for sexual 
recombination and therefore the potential to mate, appears to be clonal (Duffy et al. 
2009). Clonality may have further implications for the VSG repertoire. For example, 
the T. vivax VSG repertoire presents a strong geographic signature that directly 
mirrors population structure (chapter 5). Such strong signal may reflect both the 
clonal nature of the parasite and the scarcity of ectopic recombination within the VSG 
repertoire. In African trypanosomes undergoing sexual exchange, VSG repertoire not 
always replicates the population structure. For instance, in T. congolense the VSG 
repertoire appears uncoupled from the rest of the genome (chapter 2), most likely as 
a result of a combination of non-Mendelian inheritance of subtelomeres, gene flow 
and ectopic recombination. 
The key aspect is why the genes within these families diverged so much that 
recombination stopped being possible between lineages. Perhaps it is linked to T. 
vivax losing sexual replication. The presence of meiotic machinery in T. vivax 
suggests it is ancestral in nature, being therefore more likely that clonality reflects a 
T. vivax loss of function rather than a T. congolense/T. brucei gain (Duffy et al. 
2009). Hypothetically, the ancestor maintained a diverse VSG repertoire, driven by 
sexual recombination and ectopic gene conversion, which originated a multitude of 
distinct VSG. As T. vivax diverged and became asexual, VSG recombination ceased, 
and VSG repertoire evolved through changes in gene copy number rather than 
mosaicism. Conversely, the sexual nature of T. brucei and T. congolense are likely to 
have contributed to greater recombination levels, albeit in different ways. After 
speciation, T. brucei seems to have devised strategies to accelerate recombination, 
possibly for the purpose of infection chronicity and efficient transmission, whilst T. 
congolense devised different fitness strategies potentially involving deceleration of 
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diversifying selection for the preservation of the distinct lineages. Such an approach 
would be beneficial for example if these were functional differentiated or 
developmentally regulated lineages.
6.4.1 Conclusion
This chapter described the differences in VSG diversity generation in the different 
African trypanosome species from a population perspective. The work presented 
here shows species-specific signatures of gene hypervariability, represented by clear 
differences in the average recombination trait of T. brucei, T. congolense and T. 
vivax of VSG sequences. The T. vivax VSG repertoire is for the most part conserved 
across the species, preserving high sequence orthology even between distantly 
related isolates. In contrast, the T. brucei VSG repertoire is dynamic, highly 
recombinant, even within isolates of shared backgrounds. T. congolense is in 
between, preserving high levels of recombination, but keeping it restricted to VSGs of 
the same phylotype, perhaps reflecting its intermediate positioning in the 
trypanosome phylogeny. In conclusion, I expect the overall levels of VSG orthology 
among strains of each species to be alike for T. brucei and T. congolense (40 % and 
41 %, respectively), but much higher for T. vivax (74 %). 
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Chapter 7. General Discussion 
It is the view in some quarters that HAT will be eradicated in the very near future. 
The success of continental-wide control programmes enforced in the past 18 years 
predicts that elimination of HAT by 2020 will be possible (Holmes 2014; Holmes 
2015). These programmes were based on detailed surveillance, investment on 
diagnostics and treatment availability, as well as improved epidemiological mapping 
of the disease (Holmes 2014). Needless to say, efforts to achieve eradication must 
continue, to prevent re-emergence of the disease, as observed at the end of the 20th 
century (Holmes 2014). Nonetheless, this position reflects a considerable effort to 
understand and combat the human-infecting trypanosomes over the last few 
decades. The focus on HAT by African governments, the WHO, and research 
funders has resulted in outstanding models of disease and deep understanding of 
the T. brucei gambiense and T. brucei rhodesiense biology, distribution and diversity. 
In stark contrast, AAT remains poorly measured, coarsely described and largely 
unstudied in research laboratories. It follows that innovations in prevention and 
treatment of AAT are rare, and the situation in the field has barely progressed, even 
while the effort against HAT has increased. 
Whilst AAT is often seen as a veterinary extension of HAT and treated as a single 
disease, the reality is that AAT is a spectrum of diseases, caused by multiple species 
and strains of African trypanosomes (Morrison et al. 2016). This results in large 
variability in pathogenesis, epidemiology, and clinical outcome. This is shown by the 
differences in virulence within T. congolense as sub-type ‘savannah’ is more 
pathogenic than sub-types ‘forest’ and ‘kilifi’ (Gibson 2007; Auty et al. 2015), or by 
the differences in clinical outcome in T. vivax infections. In East Africa, T. vivax, 
which usually causes mild, chronic disease, can sporadically result in acute 
haemorrhagic syndromes (Wellde et al. 1983). In Brazil, whilst most T. vivax 
infections in endemic areas result in chronic disease of low parasitaemia, localised 
epidemics causing high mortality rates have been associated with particular isolates, 
such as the ‘Lins’ strain described in chapter 5 and also by Cadioli et al. (2012) and 
Fidelis Jr et al. (2016). Although anecdotal evidence associating particular disease 
symptoms and geographical foci with disease pathology is plentiful among local 
veterinarians and farmers, a real understanding of the association between disease 
genotypes and phenotypes is still lacking. 
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As the main surface protein interacting with the host immune system, it would be 
naïve to think that VSGs have the sole purpose of providing raw material for 
antigenic variation. In fact, VSGs have been shown to have other roles in 
pathogenesis, particularly in the modulation of the host’s cellular responses 
(Stijlemans et al. 2016). For instance, VSGs specifically inhibit activation of the 
alternative pathway in T. brucei gambiense, preventing trypanosome lysis (Devine et 
al. 1986). VSGs also induce the pro-inflammatory response, which causes many of 
the disease symptoms. For example, as a response to stress, GPI-Phospholipase C 
(GPI-PLC), an endogenous phospholipase, is activated to cleave the VSG off the 
GPI anchor, resulting in the release of soluble VSGs (De Almeida & Turner 1983; 
Bulow & Overath 1986; Ferguson et al. 1988). Both the cleaved GPI anchor and the 
soluble VSGs trigger the activation of the pro-inflammatory cascade and the 
expression of pro-inflammatory genes (Leppert et al. 2007). The soluble VSGs also 
trigger receptors that prime macrophages and induce an IFN- response (Magez et 
al. 1998; Magez et al. 2002; Leppert et al. 2007; Mansfield & Paulnock 2005). This is 
further exacerbated by increased MHC-II presentation and activation of CD4+ T-cells 
(Schleifer et al. 1993). The excessive IFN- production triggers the acute 
inflammatory response responsible for acute anaemia development (Stijlemans et al. 
2007; Stijlemans et al. 2008; Stijlemans et al. 2010).
Here I have shown multiple times how the three major African trypanosome species 
differ in terms of their VSG repertoire. Whilst it was traditionally assumed that the 
VSG machinery is one and the same between African trypanosomes, this work 
challenges such dogma. Every aspect investigated here [and in other studies 
(Marcello & Barry 2007a; Jackson et al. 2012; Jackson et al. 2013; Hall et al. 2013; 
Cross et al. 2014; Jackson et al. 2015; Mugnier et al. 2015)] reveals major 
differences, be it in repertoire composition, gene expression, sequence diversity or 
diversity generation. With such diversity among the VSG family, it is at least possible 
that not all VSGs have the same effect. 
Studying diversity may help understanding clinical outcome, but for this, a robust 
molecular systematics for analysing diversity must exist. The VAP fulfils that need. It 
provides a platform for researchers to start asking how VSGs affect disease and it 
lays the basis for systematic studies of genomic and gene expression diversity. It 
allows researchers to start asking whether the stable differences I observed in T. 
226
congolense VSG repertoire translate into phenotypic differences. In the future, the 
VAP can be used to better understand how VSG determine disease phenotype in a 
number of ways. For instance, the VAP can be used to identify and characterise 
programs of VSG expression. Studying patterns of antigenic variation and how VSG 
expression dynamics change through the course of infection can help explain 
pathogenesis through the association of particular VSGs or VSG patterns with 
disease course and syndromes. The existence of VSG expression ‘programs’, based 
on differential switching probabilities among VSG genes, is a long-standing 
hypothesis that has never been properly addressed for lack of analytic methods 
(Barry 1986). Now that even small changes in VSG expression can be detected, 
quantified and directly compared, this hypothesis can be revisited. 
As research improves, the VAP will be empowered by establishing genotype-
phenotype associations. Therefore, these data will also have epidemiological and 
diagnostic value that may be employed to improve AAT disease mapping. If certain 
VSGs or VSG expression patterns are linked to particular clinical outcomes, they 
become epidemiological markers. Such information can be used for resource 
management. For example, in high-risk areas, drugs can be quickly directed to 
infections predicted to cause acute, lethal disease rather than those linked to mild 
disease are circulating in the area. Similarly, epidemiological mapping of disease can 
help targeting vector control strategies to areas where virulent genotypes are 
circulating. 
The characterisation of VSG expression hierarchies can help identify early-stage 
VSGs. If employed in a multivalent vaccine, a rapid immune response to these VSG 
before the initial rise of parasitaemia in the bloodstream may be successfully control 
infection. Better still, the VAP can help identifying constitutively expressed mVSGs. 
Metacyclic-specific, highly expressed VSGs may be good candidates for vaccination 
because they would prime the immune system to fight disease before the 
establishment of a bloodstream infection and the resulting immune suppression. In 
chapter 3, I have demonstrated how the VAP provides a way to functionally 
discriminate among VSGs and identify constitutively expressed genes. I discovered 
that the mVSG expression profile in T. congolense isolate Tc148 is non-random, 
reproducible, and distinct from the genomic profile. I have identified phylotype 8 
genes as potentially preferentially expressed in the metacyclic life stage, which 
agrees with previous reports in the literature characterising mVSG expression in T. 
congolense (Eshita et al. 1992; Helm et al. 2009). Although questions still remain 
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about their expression profile in natural fly populations, these genes might be good 
candidates to include in a multivalent vaccine. 
Despite its well-described bloodstream stage, T. brucei has recently been discovered 
in other tissues, such as the skin and the adipose tissue (Capewell et al. 2016; 
Trindade et al. 2016). Tissue tropism may add another level of immune evasion in 
which antigenic variation may be different. The VAP can be applied to experimental 
infections of T. congolense and T. vivax, such as those previously performed to 
compare gene expression between parasites in the bloodstream and those in the 
adipose tissue in T. brucei (Trindade et al. 2016), to reveal differences in antigenic 
expression and variation. For instance, understanding how antigenic variation works 
in these tissue reservoirs may help explain why some trypanosome species, like T. 
vivax and T. brucei gambiense, are able to establish long chronic infections with 
barely undetectable parasitaemia (Malvy & Chappuis 2011; Fidelis Jr et al. 2016). 
Perhaps the patterns of VSG expression change when the parasites colonise 
different tissues. These changes in VSG ‘program’ might be essential for immune 
evasion in these tissues and ultimately allow long-term survival. 
In all these ways, the VAP could be applied to better understand the phenotypic 
consequences of VSG genetic and expression diversity. Yet, in terms of T. brucei, a 
VSG systematics is still lacking. Despite all the molecular and cell biology advances 
in T. brucei, its extremely dynamic VSG repertoire is a challenge for profiling 
approaches. Future research attempting to profile T. brucei VSG based on amino 
acid signatures may prove difficult because of the extreme degree of mosaicism 
(Marcello & Barry 2007b) and the ability to convert genes between very diverse 
donor regions (Hall et al. 2013). T. brucei VSG passed through a bottleneck 
selection, from which they emerged structurally homogenous and recombination-
prone (Jackson & Barry 2012). The T. brucei VSG repertoire is highly mosaic, even 
within isolates of shared backgrounds, as shown by the high levels of unmapped and 
multi-coupled VSGs shown in chapter 6. This dynamism and low sequence orthology 
between strains precludes a systematics based on conserved VSG or long VSG 
motifs. To overcome these challenges, a T. brucei VAP methodology may have to 
resort to the analysis of short amino acid motif combinations in a gene network 
analysis. Gene network analysis [reviewed in Emmert-Streib et al. (2014)] has had 
several successful implementations, particularly in immunology (Nacu et al. 2007), 
and cancer research (Madhamshettiwar et al. 2012). For T. brucei, this could 
potentially be achieved by identifying mosaic networks across the population 
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because mosaics formed from the same set of donors can have higher nucleotide 
identity than their donors (Hall et al. 2013). Therefore, the degree of association 
between gene segments may be more informative than the gene segments 
themselves.
Application of variant antigen profiling, for all trypanosome species, in the ways 
described above would likely transform our understanding. Similar knowledge of 
surface protein diversity has already led to substantial progress in other infectious 
diseases. In pregnancy-associated malaria, which causes anaemia, premature birth, 
and increased neonatal mortality, Plasmodium falciparum parasites colonise the 
placental tissues. While several genes are involved (Tuikue Ndam et al. 2008b), one 
of main processes in this tropism is the adhesion of infected erythrocytes to 
glycosaminoglycan chondroitin sulphate A (CSA) in the intervillous space of the 
placenta. This adhesion, which is mediated by var2csa (Rowe et al. 2002; Salanti et 
al. 2003), allows the infected erythrocytes to accumulate in the placenta whilst 
avoiding the spleen-mediated surveillance mechanisms. The var2csa gene is 
conserved among parasite strains (Salanti et al. 2003) and its transcription is 
significantly up-regulated in placental isolates compared to bloodstream isolates 
(Salanti et al. 2003; Tuikue Ndam et al. 2008a). After identification of this specific var 
gene, several studies have been developed with the aim to characterise binding 
activity, antigenicity and immunogenicity [reviewed in Fried & Duffy (2015)]. This 
work resulted in two VAR2CSA-based vaccine candidates currently in the path for 
human clinical studies (Fried & Duffy 2015). However, due to the large variation in 
clinical outcomes in malarial infections, understanding the diversity of the var2csa 
gene and its relationship to different disease phenotypes has been and will continue 
to be crucial (Patel et al. 2017). 
In influenza, surface antigen profiling has improved the prediction of antigenic drift 
required for the biannual re-evaluation of the flu vaccine (McHardy & Adams 2009). 
Influenza A viruses are classified into different sub-types according to the specific 
genetic combination of their surface glycoproteins [hemagglutinin (H1–16) and 
neuraminidase (N1–9)]. A vaccine, based on inactivated viruses, is available and 
elicits an antibody response targeting mainly the hemagglutinin glycoprotein. Due to 
the high frequency of antigenic drift in Influenza A, the vaccine is of limited 
protection. This inspired a global surveillance program to detect emerging antigenic 
variants and predict whether the changes in the surface glycoproteins would require 
an update of the existing vaccine strain. Such analysis is only possible because 
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large-scale genomics and antigenic typing identified patterns of viral circulation and 
antigenic diversity evolution (Smith et al. 2004; Russell et al. 2008).
There more examples of vaccines targeting surface proteins. In dengue, the 
envelope protein, a surface protein, is the preferred candidate antigen for the 
development of recombinant protein, DNA and subunit vaccines (Liu et al. 2016). 
Recent examples include the an E-based recombinant subunit vaccine V180 from 
Merck, which is currently in phase I clinical trials (Coller et al. 2011), and the 
tetravalent DNA vaccine based on the envelope genes of multiple Dengue virus 
serotypes (Raviprakash et al. 2000; Raviprakash et al. 2001; Blair et al. 2006). In 
Staphylococcus aureus infections, the most common cause of hospital acquired 
infections, vaccine assembly from surface proteins, has been extensively discussed 
(Stranger-Jones et al. 2006). In particular, one of the approaches was to target a 
combination of four surface antigens that induce an antibody response and may 
provide protection (Stranger-Jones et al. 2006). Simultaneously, research into the 
immunogenicity potential of SpA, a surface antigen constitutively expressed by all 
clinical isolates, is under way (Missiakas & Schneewind 2016).
All these examples show that understanding the diversity of a pathogen’s surface 
proteins and how they affect virulence can help the development of sustainable 
solutions for various diseases. The VAP provides the framework for such 
development in AAT. 
Translating the VAP into an epidemiologically-relevant metric will require, as noted, a 
much better definition of clinical outcome, linked to VSG profile, be that genomic or 
transcriptomic. Yet it will also require the translation of genomics into the clinical 
setting. One aspect that distinguishes this thesis is the analysis of natural 
populations rather than laboratory-adapted isolates. Antigenic variation is a complex 
phenomenon affected by an evolutionary arms race among the parasite, the vector, 
and the host, where the importance of species differences and gene diversity cannot 
be overstated. Working with field isolates has traditionally been confined to analyses 
of diversity of conserved markers and prevalence studies due to low parasitaemia in 
natural infections (and the consequent requirement of animal passage) and the great 
level of unexpected variation encountered. Nonetheless, experimental models of 
disease may not accurately represent the natural patterns of antigenic variation. 
Therefore, it is important that the advances in the laboratory-based molecular and 
cell biology are accompanied by field-based research. 
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Fortunately, the improvements in sequencing technology in recent years, such as the 
portable Oxford Nanopore technology and the selective sequencing technologies 
developed by multiple companies, may help bring research back to natural disease 
settings. Selective whole-genome amplification has been successfully implemented 
in P. falciparum (Oyola et al. 2016; Rutledge & Ariani 2017), albeit good coverage of 
the var gene repertoire is still to be achieved because the probes designed targeted 
AT-rich regions, despite the subtelomeres having a higher GC content (Oyola et al. 
2016). A more recent approach is target enrichment via hybridization-based capture 
(e.g. Agilent’s SureSelect Target Enrichment System or the myBaits target capture 
kits from Arbor Biosciences), which has been widely used for exome sequencing in 
the study of human biology and human diseases [for example in cancer research 
(Jones et al. 2010), in diabetes (Bonnefond et al. 2010), and in Mendelian disorders 
(Ng et al. 2009)]. In the infectious diseases field, it is still underexploited, but has 
great potential because the use of complex baits to capture selected DNA or RNA 
allows unprecedented enrichment of microbial genomes or transcriptomes from field 
samples. 
In trypanosomatids, multiplexed splice-leader sequencing has been developed for 
the transcriptome sequencing of Leishmania donovani clinical isolates (Cuypers et al. 
2017). This strategy offers an alternative to poly-A tail mRNA purification methods 
that is specific for parasite RNA, thus resulting in more efficient, deeper sequencing. 
This approach is ideal for parasite sequencing directly from field isolates. If such 
method can be applied to African trypanosome genomes, the possibilities for the 
analysis of VSG diversity in natural populations are endless. With these advances in 
methodology and technology, trypanosome research can return to the field and focus 
on genomic epidemiology and how genetic diversity links to disease phenotype, 
geography and transmission. It can also move towards understanding sylvatic and 
domestic transmission cycles, how they affect strain and species diversity in different 
regions, and how they associate to the different disease hosts. In fact, within 
trypanosome research, T. cruzi provides evidence of the benefits of studying disease 
in natural settings. T. cruzi genotyping in the field from both host and vector samples 
has been important to understand the complex eco-epidemiology of Chagas disease 
and the relationship between parasite genotypes, geography and disease outcome 
[reviewed by Messenger et al. (2015) and Zingales (2017)]. 
I anticipate great developments in the trypanosomiasis field research. The 
combination of genomics, transcriptomics and tools like the VAP will allow fast and 
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accurate analysis of complex big data. We can now ask more questions because we 
have the means to answer them. Personally, I am intrigued by the possibility of 
antigenic synchronicity among infected cattle of the same herd, or by the patterns of 
antigenic variation among trypanotolerant cattle. The future will certainly bring the 
opportunity to explore all these questions and many more, like how antigenic 
variation continues in chronic, natural infections of wild animals, where parasitaemia 
is barely detectable. Ultimately, the ability to take research from the lab back to the 
field is extraordinary. It allows the integration of local knowledge with the cutting-
edge methodological advances, it brings back awareness to where the problem is, 
and it promotes research that is focused on sustainable solutions to control 
trypanosomiasis and improve animal welfare and economic development.
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7.1 Conclusion
In this thesis I have shown how VSGs differ among African trypanosomes in terms of 
diversity, expression and evolution, and how their differences may be used to 
develop automated methods of VSG profiling from sequence data. Together with 
previously described differences in structure and codon bias, it is clear that while 
there may be a common phenotype of antigenic variation in all species, the 
mechanisms of antigenic switching and diversification are different. Variability in the 
antigenic variation system is likely to have had a considerable impact on current VSG 
expression patterns, transmission, disease progression, and virulence. Adaptation 
strategies are tightly dependent on interactions with the vector, host, parasite and 
environment, but they also associate closely with the degree of population 
structuring, mating frequency and patterns, and potentially VSG hierarchies. The 
need for further study of all of these aspects in T. congolense and T. vivax is clear 
and unquestionable. The selective pressures associated with VSG diversity 
generation in T. vivax and how they may relate to the different clinical outcomes also 
need addressing. The use of T. brucei as a model for antigenic variation has given us 
a deep understanding of VSG expression and switching in that species. However, 
the evidence that this might not apply to its closest relatives necessitates studies to 
understand how antigenic variation can be generated in different ways. Advances in 
functional transcriptomics and in understanding pathogenesis will be critical in this. 
Variant antigen profiling will have a role in these experiments, making the 
composition of VSG repertoires within these studies tractable, and as sequencing 
technologies evolve in sensitivity and depth, so will the VAP. 
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